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Abbreviations 
 
 
 
A/AS-posterior delay difference between time to peak global radial strain of anterior or 
anteroseptal and posterior segments. 
AS/MS-BL delay difference between time to peak global longitudinal strain of 
apicoseptal or midseptal to basallateral segments. 
Max delay 4C maximal difference in time to peak global longitudinal strain between 
six segments in 4-chamber view.  
 
AS-P delay  anteroseptal-posterior delay 
ATP   anti-tachy pacing  
AUC   area under the curve 
BS-BL delay  basal septal-basal lateral delay 
BI-BA   basal inferior-basal anterior 
CRT    cardiac resynchronization therapy  
CRT-D   cardiac resynchronization therapy with defibrillator 
HF    heart failure 
HR     hazard ratio  
ICD    implantable cardioverter defibrillator 
IVCD   intra-ventricular conduction delay 
LBBB   left bundle branch block  
LS    longitudinal strain 
LV    left ventricular 
LVEF   left ventricular ejection fraction 
LVEDD   left ventricular end-diastolic diameter 
LVESD   left ventricular end-systolic diameter  
LVEDV   left ventricular end-diastolic volume  
LVESV   left ventricular end-systolic volume 
MACE   major cardiac adverse event 
PSAX   parasternal short axis view  
RBBB   right bundle branch block 
RS    radial strain 
SPWMD   septal to posterior wall motion delay 
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INTRODUCTION  
 
Heart failure is a leading cause of cardiovascular morbidity and mortality worldwide and it is 
estimated that in developed countries 1–2% of all healthcare expenditure is devoted to heart 
failure [1]. Chronic heart failure is a condition in which a patient has varying symptoms of 
heart failure over a period of time [2]. Heart failure with reduced systolic left ventricular 
ejection fraction (LVEF) is the most common type of heart failure and also the best 
understood type of heart failure in terms of pathophysiology and treatment.  
Approximately 1–2% of the adult population in developed countries has heart failure, with 
increasing prevalence with age (Figure 1) [3]. The combination of increasing survival after 
acute myocardial infarction and increased longevity in Western developed nations leads to an 
increase in the overall prevalence of heart failure.  
 
Pathophysiologic mechanism and treatment of heart failure 
After myocardial injury, the changes in surviving myocytes and extracellular matrix lead to 
pathological ‘remodelling’ of the ventricle. Ventricular remodelling leads to dilatation and 
impaired contractility which results in reduced LVEF [4,5]. Ventricular remodelling and 
neurohumoral (renin-angiotensin-aldosterone and sympathetic nervous system) activation 
cause heart failure symptoms and signs, episodes of heart failure hospitalization and 
premature death. In some patient, the onset of conduction disorder with wide QRS contributes 
to worsening of ventricular remodelling. Interruption of this neurohumoral pathway is the 
basis of pharmacological treatment of heart failure [5].  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 1. Prevalence of heart failure increases with age. 
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There is a clear relationship between severity of heart failure symptoms and survival. 
However, also patients with mild symptoms still have a relatively high absolute risk of 
hospitalization and (sudden) death [5,6]. The most important goals in the treatment of heart 
failure patients are to relieve the symptoms and signs, prevent hospital admission, and 
improve survival. There are three groups of medications (ACE inhibitors/AT2 antagonists, 
beta-blockers and aldosterone antagonists) which block the neurohumoral pathway. All these 
drugs have significantly improved the survival of patients with heart failure. Although 
remarkable progresses have been achieved in medical treatment, the mortality rate remains 
unsatisfactorily high. Besides this pharmacological therapy, an implantable cardioverter 
defibrillator (ICD) can be added, which is designed to detect and correct high-risk 
arrhythmias [7–9]. Figure 2 shows the additional effects of medication and ICD on survival. 
 
Almost 50% of the deaths in heart failure patients, especially in those with milder symptoms, 
occurs suddenly and unexpectedly, and many of those are related to ventricular arrhythmias 
(Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The predicted effects on survival of sequentially adding medications and an ICD for a heart 
failure patient with an annual mortality of 20% and a mean survival of 4.1 years at baseline. Adding an 
ACE inhibitor (ACEI), a β-blocker, an aldosterone (Aldo) blocker, and an ICD decreases the annual 
mortality by 70% (20% to 6%) and increases the mean survival by 5.6 years (mean survival 4.1, 5.0, 6.6, 
8.2 and 9.7 years, respectively). Circulation 2006;113:1424−1433. 
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Therefore, prevention of sudden death is an important goal. The role of antiarrhythmic drugs 
such as amiodarone or sotalol on overall survival was investigated in AVID trial [10] and was 
inferior to ICD. Two important randomized controlled trials (MADIT II [11] and SCD-HeFT 
[12]) demonstrated relative risk reduction of ICD of 23–31% in mortality in heart failure 
patients with LVEF <30–35% when added to optimal medical therapy (Figure 4). These two 
trials changed the treatment of heart failure patients worldwide. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. One of our patients with heart failure and LVEF 25% developed ventricular arrhythmia with 
almost 320 bpm and converted to normal rhythm after ICD-shock. 
 
 
Figure 4. Survival curves of patients with or without ICD of the land-mark 
MADIT 2 trial. The difference in survival between the two groups was significant 
(p=0.007), the relative risk reduction was 31%. 
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Cardiac resynchronization therapy (CRT) in heart failure with intraventricular 
conduction delay 
Although single-lead shock-only ICD implantation may be very effective in preventing 
sudden death in heart failure patients with intraventricular conduction delay, it will not 
improve the symptoms and signs of heart failure.  
The primary and immediate aim of CRT (Figure 5) is to reduce the timing differences in 
electrical and mechanical activation as compared with the situation during the conduction 
abnormality. Since 2002, it has been demonstrated that CRT improves left ventricular 
function (reduction of LVESV, Figure 6), NYHA functional class and quality of life [13,14]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 5. CRT-device works by simultaneously pacing both the right and the left ventricle ‘bypassing’ 
the intrinsic conduction system.  
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Although initially CRT was seen as beneficial for the symptoms of heart failure [14,15], more 
recent trials investigated whether CRT can also improve survival. The Care-HF trial [16] as 
one of the first trials demonstrated the beneficial impact of cardiac resynchronization therapy 
with a pacemaker (CRT-P) on all-cause mortality when added to pharmacological therapy 
(Figure 7). A pooled analysis of five randomized trials with addition of CRT-P to pharma-
cological therapy showed 24% reduction in all-cause mortality [17]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Echocardiography of a patient from Zwolle, before CRT implantation and during follow-up, 
showing reduction of the left ventricular end-systolic diameter. 
 
 
Figure 7. Kaplan–Meier estimates of the time to all-cause mortality (Care-HF Trial). 
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Cardiac resynchronization therapy with defibrillator (CRT-D) in heart failure 
Whether the combination of CRT and ICD would create a synergistic effect has been an 
object of debate for many years. The beneficial effects of CRT-D to ICD alone on mortality 
and prevention of heart failure hospitalization in patients with intraventricular conduction 
delay were investigated in several landmark trials [14,15,18–21]. These trials demonstrated 
30–40% reduction in mortality or heart failure hospitalization (Figure 8). A pooled analysis of 
six randomized trials [17] that compared the additional value of CRT-D above ICD alone 
demonstrated a significant reduction of 17% in all-cause mortality. The general conclusion of 
these trials is that CRT-D can slow down the progression of heart failure and provide 
additional benefits in reducing morbidity and mortality among these patients. The evidence 
from these landmark CRT trials has led to formation of guidelines which were updated in 
2013 for the last time based on new evidence on QRS duration and left bundle-branch block 
(LBBB) (Figure 9). The comparison between CRT-D and CRT-P regarding all-cause 
mortality in Companion Trial [15] showed an additional 20% risk reduction in CRT-D 
patients. Comparing the characteristics of heart failure patients in early CRT trials [15,16] 
with a more recent trial [19] shows that early trials included heart failure patients with NYHA 
class III or IV; however, a more recent trial included patients with NYHA class II or even 
class I.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. MADIT-CRT study compared CRT-D with ICD only in patients with heart failure, EF<30% 
and QRS-duration  >130 ms. The hazard ratio in the CRT–ICD group was 0.66; 95% confidence interval 
0.52−0.84; p=0.001). The superiority of CRT was driven by a 41% reduction in the risk of heart failure 
events.  
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Response to cardiac resynchronization therapy: Approximately one-third of patients with 
heart failure have intraventricular conduction delay presented by a QRS duration of >120 ms, 
most commonly as LBBB pattern. This wide QRS induces alterations in cardiac structure and 
function that result in regions of early and late contraction, known as ‘mechanical 
dyssynchrony’ [22]. CRT helps to restore dyssynchrony, improving LV function, reducing 
functional mitral regurgitation, decreasing end-systolic volume and diameter of LV. Although 
response to CRT is multifactorial, resynchronization of mechanical dyssynchrony is 
considered to be the primary mechanism behind the response. Response to CRT is divided in 
echocardiographic and clinical response. The most common definition for ‘echocardiographic 
response’ is a reduction of LVESV >15% compared to baseline. ‘Clinical response’ is most 
commonly defined as a clinical composite score (CCS) combining all-cause mortality, heart 
failure hospitalization, and NYHA class improvement [23]. The rate of CRT response varied 
between different studies, and depends in part on the used definitions. The majority of studies 
reported a rate of echocardiographic response between 60–70%. However, as many as 30–
40% of patients did not benefit from this invasive and expensive therapy. These patients are 
called ‘non-responders’. It is important to discriminate between potential responders and non-
responders so as to avoid unnecessary CRT in those with high-risk of non-response and to 
(advice to) implant CRT in those with a high probability of response. 
 
Figure 9. Current guidelines for implanting CRT published in 2013. EHJ 2013;34:2281 −2329. 
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Prediction of response to cardiac resynchronization therapy 
In the last decade, several potential predictors of CRT response have been introduced. The 
predictors of CRT response predictors are classified in (1) patient’s characteristics, (2) 
electrocardiographic features, and (3) echocardiographic parameters that assess the mechan-
ical dyssynchrony.  
(1) Patient’s characteristics: A number of potentially important clinical, echocardiographic 
and neurohormonal factors were investigated to predict whether a patient will or will not 
respond to CRT. These studies demonstrated that ischemic aetiology, more severe mitral 
regurgitation and increased levels of N-terminal pro-brain natriuretic peptide were associated 
with an increased risk of death or unplanned cardiovascular hospitalization. Female gender 
and younger age were associated with better CRT response [24,25].  
(2) Electrocardiography: Electrocardiography is the corner stone for the indication for CRT 
and it is overly clear that patients with QRS <120 ms will not benefit from CRT. However, in 
those with QRS >120 ms, electrocardiography has several major limitations in identifying 
patients suitable for CRT. The threshold criteria of a QRS duration of >120 ms is not derived 
from prospective evaluation but rather from inclusion criteria of landmark clinical trials [14–
16,18–21]. In fact, the mean values of QRS durations in these trials were 155 to 160 ms. In 
current guidelines patients with LBBB and QRS >150 ms have class 1A indication for CRT, 
whereas patients with LBBB and QRS 120–150 ms have class 1B indication. Furthermore, 
echocardiographic studies have revealed a significant discordance between electrical and 
mechanical delay, with up to 30% of patients with QRS durations >150 ms and 50% of those 
with QRS durations >120 ms demonstrating no evidence of septal to lateral dyssynchrony 
[26]. The QRS morphology is also an important issue in patient selection. Only 70–75% of 
included patients in CRT trials had LBBB. Whether patients with RBBB or non-specific 
intraventricular conduction delay (IVCD) would derive the same benefit from CRT is still 
unclear. Although prospective and randomized data concerning the CRT response in patients 
with RBBB are not available, these patients are currently excluded from receiving a CRT. 
However, in patients with a QRS >120 ms predictions of CRT response based only on the 
ECG remains difficult.  
(3) Mechanical dyssynchrony: Over the past decade, echocardiography has emerged as a 
potentially useful tool to assess mechanical dyssynchrony. There are numerous advantages of 
echocardiography, including non-invasiveness, portability and widespread availability. The 
rationale behind CRT is that CRT candidates have some degree of LV mechanical 
dyssynchrony coinciding with their prolonged depolarization, which if optimally targeted by 
biventricular pacing should result in better synchronous LV function, reflected by higher 
stroke volume and cardiac output, improving morbidity and mortality. Therefore, 
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echocardiography has been used to assess the presence or lack of ‘mechanical dyssynchrony’ 
in order to predict response to CRT. 
 
 
ECHOCARDIOGRAPHIC ASSESSMENT OF ‘MECHANICAL DYSSYNCHRONY’  
 
The methods used to assess mechanical dyssynchrony are based on (1) time-based 
dyssynchrony: peak strain/speckle tracking, (2) global dyssynchrony: LV filling (Tei index) 
and interventricular mechanical delay (IVMD), and (3) pattern-based dyssynchrony: septal 
dyssynchrony and apical rocking. 
 
(1) Time-based dyssynchrony 
Time-based dyssynchrony dentifying segmental LV dyssynchrony focused mostly on the time 
difference between peak shortening/deformation/velocity of segments. SPWMD (septal-to-
posterior-wall-motion delay) by M-mode is one of the first LV dyssynchrony parameters and 
a cut-off value of >130 ms has been proposed as predictor of CRT. However, given the 
conflicting results between the studies in predictive value of SPWMD and numerous 
limitations of M-mode, it is not recommended for routine use in the prediction of CRT [27–
29].  
 
Tissue Doppler imaging (TDI) was used to assess tissue velocity or strain by myocardial 
deformation. TDI by pulsed-wave Doppler allows the assessment of longitudinal myocardial 
tissue velocity and has been the most investigated echo-technique for the evaluation of 
dyssynchrony. Septal-to-lateral delay (S-L) (Figure 10) and time-to-peak systolic velocity 
standard deviation (Ts-SD) were the wo parameters used to assess dyssynchrony, with good 
predictive value in single-center trials [30,31]. However, these parameters failed to predict 
CRT response in multicenter trial [23]. Color-coded Tissue Velocity Imaging is another 
technique that allows the simultaneous interrogation of time-to-peak velocity for multiple 
myocardial segments in 1 view and was therefore used to assess mechanical dyssynchrony. 
Although some studies demonstrated an association between these parameters and 
improvement of LVEF [32], the reproducibility of this method has been proven to be poor 
[23]. One of the major limitations for time-based dyssynchrony indices is that time 
differences for peak shortening or velocity relate only poorly to true dyssynchrony. 
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Figure 10. S-L delay. There is delay in the peak sustained systolic contraction in the septal (yellow 
curve) compared with the lateral wall (green curve). 
 
 
Figure 11. An example of time-based speckle tracking analysis in one of our patients as a marker of 
mechanical dyssynchrony. In this patient the maximal delay between earliest and latest activated 
segments is 220 ms.  
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Regional myocardial strain or deformation has been evaluated mostly by speckle tracking in 
order to assess mechanical dyssynchrony. Speckle tracking applies specific acoustic markers, 
‘speckles’, to the myocardium (Figure 11). Movements of these markers are tracked during 
the cardiac cycle to determine regional myocardial deformation or strain. Assessment of 
mechanical dyssynchrony with speckle tracking has advantages over TDI because it measures 
myocardial deformation instead of TDI which assesses the motion. Therefore, it can 
differentiate between passive translational motion of the myocardium and active systolic 
contraction. Another advantage of speckle tracking is its ability to assess circumferential and 
radial strain in addition to longitudinal strain. Most studies using speckle tracking were single 
center and reported associations between the parameters and CRT response [33–35]. 
However, a large prospective multicenter trial on this issue is yet to come. The general 
limitation of these parameters is high-quality imaging which is required to determine 
segmental differences. This is not always feasible, especially in patients with dilated 
ventricles due to heart failure. Moreover, this technique is limited by high inter-observer and 
intra-observer variability and poor reproducibility. Time-based dyssynchrony assessment 
might also be influenced by myocardial scar tissue. It is very difficult to determine the peak 
strain of scar segment/region because the strain curve is rather flat. How to deal with scar 
tissue in assessment of mechanical dyssynchrony by time-based markers is not clear yet.  
 
(2) Global dyssynchrony 
LV filling and Tei index: the segmental function assessment of mechanical dyssynchrony 
might not be an optimal way to determine the extent of dyssynchrony that contributes to 
reduced LV function and the patient’s symptoms. For this reason, recognition of the 
importance of using LV filling and ejection velocities has been proposed as a potential tool 
for assessing the impact of the sum of the segmental dyssynchrony on cavity filling and 
ejection [36]. This is based on the use of two isovolumic time analyses. Early systolic 
dyssynchrony results in delayed onset of LV ejection and early diastolic dyssynchrony which 
starts already during the isovolumic relaxation period causes delayed onset of LV filling. The 
sum of isovolumic contraction and relaxation time intervals in relation to ejection time (Tei 
index) predicts clinical response to CRT [37,38]. The sum of isovolumic contraction and 
relaxation time intervals ‘total isovolumic time’ (T-IVT) represents the global wasted time in 
the cardiac cycle when the LV cavity is neither filling nor ejecting and has been shown to be a 
better predictor of clinical response [39]. In general, the overall experience and the amount of 
evidence with global marker of dyssynchrony are limited and the impact of myocardial scar 
tissue on the evaluation of global dyssynchrony is not clear. 
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Interventriclur mechanical delay (IVMD): correction of interventricular dyssynchrony is one 
of the targets of CRT. Therefore, identifying interventricular dyssynchrony may help to 
predict the CRT response. IVMD (Figure 12) reflects the interventricular dyssynchrony and 
can be measured as the difference in pre-systolic period measured from the onset of the QRS 
complex on the ECG to the initiation of Doppler flow in the pulmonary artery and the aorta. A 
cut-off value of 40 ms has been used to determine dyssynchrony and has been shown to be 
associated with better survival [16]. However, IVMD has a linear relationship with response 
and a specific cut-off for response is unsuitable [40,41]. It is therefore not applicable for 
patient selection. 
 
(3) Pattern-based dyssynchrony 
Septal dyssynchrony: the septum provides information on interventricular interaction as well 
as intraventricular properties. The dyssynchronous electrical activation of the left ventricle 
causes the early activated septum to contract against a reduced load, which leads to pre-stretch 
of a not activated LV free wall. This pre-stretch increases the contractile force of LV free wall 
 
Figure 12. Interventricular Mechanical Delay (IVMD) by Pulsed Doppler. (Top) Time from onset of 
right ventricular (RV) ejection (arrows), obtained from the parasternal short-axis window. (Bottom) Time 
from onset of left ventricular (LV) ejection (arrows), obtained from the apical 5-chamber echo-
cardiographic view.  
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which, in turn, paradoxically stretches the septum in systole. This ‘wasted’ work expresses the 
poorly coordinated contraction, which also results in poorer pump function. The concept of 
shortening and stretching of the septum was studied by MRI tagging images [42] in which the 
internal stretch fraction (ISF) was defined as the ratio of stretch to shortening during ejection. 
ISF was a better predictor of reverse remodelling after CRT. The special contraction and 
stretching of the septum during systole has been proposed to assess mechanical dyssynchrony 
[43,44]. Septal rebound stretch (SRSsept) defined as the cumulative amount of systolic 
rebound stretch after initial shortening of the septum (Figure 13). SRSsept assesses the 
amount of wasted work for the septum that can be recruited by CRT and has been shown to 
predict the long-term outcome of CRT response [45]. However, the sensitivity and specificity 
of SRSsept has not been clearly reported yet. There are several advantages of dyssynchrony 
parameters using septum as region of interest. Echocardiographic imaging of the septum is 
almost always feasible and reproducible and its central position in the ultrasound window 
guarantees adequate imaging quality. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. An example of septal rebound stretch as a marker of mechanical dyssynchronyin one of our 
patients. The cumulative amount of stretch after initial shortening of septum is 9.44%. 
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Apical rocking: Apical rocking as visual assessment of mechanical dyssynchrony may be the 
most feasible method for routine clinical application. Apical rocking (Figure 14) is a 
relatively new dyssynchrony parameter. It is defined as a short initial septal contraction which 
results in a short inward motion of the septum and pulls the apex to the septum, and then the 
delayed activation of the lateral wall which pulls the apex laterally during the ejection time 
while stretching of the septum takes place. The predictive value of apical rocking on 
echocardiographic response to CRT is investigated in small numbers of patients [46]. The 
predictive value of apical rocking on long-term outcome has yet to be demonstrated. 
 
Super-response to cardiac resynchronization therapy 
Recent studies have shown that in certain patients there is an exceptional improvement of LV 
function after CRT, up to EF>50%. These patients are called ‘super-responders’. Super-
response is not only associated with short-term reduced heart failure deaths, ICD shocks and 
hospitalization, but also with an excellent long-term prognosis [47,48]. Because of this 
excellent prognosis it is important to be able to predict this super-response. Theoretically this 
could be of influence on the choice of device at the first implant or during replacement when 
elective replacement is indicated. Previous studies have tried to find easily identifiable 
clinical factors to predict super-response to CRT. Female gender, body mass index <30 kg/m2, 
typical LBBB, QRS duration >150 ms, smaller LV and left atrial dimensions, shorter duration 
 
Figure 14. An early electrical activation of the septum results in a short initial septal contraction and causes 
the apex to move septally while the septum moves leftward (yellow arrow in the middle panel). The delayed 
activation of the lateral wall pulls then the apex laterally during the ejection phase while stretching the 
septum. This typical sequence of the septal-to-lateral apex motion is described as ‘Apical Rocking’.  
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of heart failure symptoms, and non-ischemic cardiomyopathy were among the factors 
associated with super-response to CRT [13,49−52]. However, to the best our knowledge, 
there is no information on echocardiographic predictors of super-response to CRT yet.  
 
 
OUTLINE OF THE THESIS  
 
The main aim of this thesis was to improve the prediction of both response and super-
response to CRT in a real-world everyday clinical setting. For this purpose we used data from 
a large cohort of patients who underwent CRT implantation at the Isala hospital, Zwolle.  
The number of ICD implantations is growing fast due to expanding indications and aging of 
the population. Besides the greater advantages of ICD implantations there are also some small 
but important disadvantages connected to these devices. In Chapter 2 the complications of 
ICD or pacemaker implantation in our hospital are reported.  
Electrocardiography is one of the most important tools for the indication of pacemakers 
and/or CRT. Electrocardiographic, intrinsic LBBB is mimicked by right ventricular pacing 
(‘pacing-induced LBBB’). In Chapter 3, the differences in mechanical activations pattern 
between intrinsic LBBB and pacing-induced LBBB were studied. The predictive value of 
time-based speckle tracking imaging on prediction of CRT response has been a matter of 
debate. In Chapter 4, we focused on the prediction of CRT response by time-based speckle 
tracking. Little is known about the value of speckle tracking imaging during follow-up with 
regard to distinguishing the responders and non-responders to CRT. In Chapters 5, we 
studied changes in LV dyssynchrony as results of CRT during follow-up. Septal rebound 
stretch (SRSsept) reflects an inefficient deformation of the septum during systole and is a 
potential new echocardiographic tool to predict response to CRT. However, only limited data 
are available on the potential predictive value of SRSsept. In Chapter 6, we studied the 
predictive value of SRSsept on echocardiographic response to CRT with its sensitivity and 
specificity. Apical rocking” is frequently observed in asynchronously contracting ventricles 
and small studies suggested that it may predict CRT response. In Chapter 7, we studied 
prediction value of apical rocking on clinical and echocardiographic response to CRT. There 
are no data on the association of apical rocking with long-term outcome of CRT patients. 
Chapter 8 describes the prognostic value of apical rocking as dyssynchrony parameter. 
About 20−25% of CRT patients shows almost normalization of LVEF as results of CRT, 
these patients are called ‘super-responders’. It seems that these patients have a good long-term 
prognosis. In Chapter 9, we described the long-term prognosis and patient characteristics of 
super-responders. There are no data on echocardiographic predictor of super-responder. In 
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Chapter 10, we studied the association of apical rocking as LV dyssynchrony with super-
response to CRT. Chapter 11 contains the summary of our studies, future perspectives and a 
general discussion with implication of our results on prediction of CRT response and super-
response in daily practice. 
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ABSTRACT 
 
Background: The number of cardiac rhythm device implantations has been growing fast due 
to expanding indications and aging of the population. Complications of implantation were 
rare in the trials. However, these involved small numbers and selected patients. Prospective 
real-life data are necessary to assess cardiac device implantation procedure-related risks. 
Objective: To determine the incidence and predictors of lead-related re-intervention in a 
Dutch high-volume teaching hospital. 
Methods: Data from all patients who underwent cardiac rhythm device implantation between 
January 2010 and December 2011 were collected in a prospective registry. At least 1 year of 
follow-up regarding re-intervention was available for all patients. Lead-related reasons for re-
intervention were categorised into lead dislodgement, malfunctioning or perforation.  
Results: 1929 devices including 3909 leads were implanted. In 595 patients (30.8%) a CRT-
D/P was implanted. Lead-related re-intervention was necessary in 86 (4.4%) patients, it was 
more common in younger and male patients, and due either to lead dislodgement (66%), 
malfunctioning (20%) or perforation (18%). Coronary sinus lead dislodgement or mal-
functioning was 1.4%. Right atrial dislodgement (1.9%, p<0.001) or ICD lead dislodgement 
(1.8%, p=0.002) was more common than right ventricular dislodgement (0.3%). The 
incidence of lead malfunctioning was higher (0.8%) in ICD leads. Apical position of the right 
ventricular lead and lateral wall position of the right atrial lead were related to cardiac 
perforation. 
Conclusions: The incidence of lead-related re-intervention was comparable to the literature. 
The majority of re-interventions were due to lead dislodgements, particularly with right atrial 
and ICD leads. Re-intervention due to coronary sinus lead dislodgement was rare. 
 
 
INTRODUCTION 
 
The number of cardiac rhythm device implantations, including implantable cardioverter 
defibrillator (ICD) and cardiac resynchronization therapy (CRT) devices, has increased fast in 
the past decade due to expanding indications and aging of the population. Although the 
benefits of these devices were demonstrated in randomized controlled trials, this concerned 
selected patients and real life data are necessary to assess cardiac device implantation-related 
risks. Several prospective and retrospective studies reported both short- and long-term 
complications related to device implantation and pacing system upgrade. However, the 
majority of these reports are derived from randomized clinical trials which reflect selected 
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patients and circumstances [1] whereas other studies concern relatively old reports, also 
including leads with passive fixation, which are nowadays less commonly used [2−8]. 
The objective of this prospectively registry study was to assess the real-life incidence of lead 
dislodgement, malfunctioning or perforation during the first year following implantation in a 
Dutch high-volume teaching hospital.  
 
 
METHODS 
 
Data on all patients who underwent procedures of de novo cardiac rhythm device 
implantations and pacing system upgrades in our hospital between January 2010 and 
December 2011 were prospectively collected. The indications for the implantation of 
pacemakers, ICD and CRT devices were based on contemporary guidelines [9,10]. The 
procedures were performed by seven operators including two cardiac electrophysiology 
fellows under direct supervision of an attending cardiac electrophysiologist, in cardiac 
catheterization laboratories equipped according to the guidelines of the European Society of 
Cardiology [9]. The leads and devices were implanted according to the manufacturers’ 
recommendations. The baseline characteristics of patients, included age, gender, left 
ventricular ejection fraction (LVEF), presence of conduction disorders and functional New 
York Heart Association (NYHA) class were recorded in the prospective database. To identify 
the lead-related complications, the database was searched on re-intervention procedures 
during the first year following the implantation. In all lead-related re-intervention cases, data 
on the clinical manifestation and course, results on chest X-ray, echocardiography and 
technical data on lead performance were collected.  
 
 
DEFINITION OF COMPLICATIONS 
 
Lead dislodgement was defined if there was documentation of a change in the lead tip 
position on chest X-ray and changes in electrical lead parameters (rise in impedance, loss of 
sensing and pacing). 
Lead electrical malfunctioning was defined if lead impedance, electrogram amplitude or 
threshold was changed abruptly, necessitating surgical revision without clear changes in 
position of the lead on chest X-ray. 
Lead perforation was defined in case of high suspicion of cardiac perforation, e.g. an acute 
stabbing chest pain or dyspnoea, significant changes in electrical lead parameters and 
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significant amount of pericardial effusion requiring pericardiocentesis with or without 
extracardiac lead location on X-ray. 
Screw perforation was defined if there were pericarditis-like symptoms without clear 
changes in electrical lead parameters and absence of significant amount of pericardial 
effusion.  
 
Statistical analysis 
Statistical analysis was performed using SPSS statistical software (IBM Corp. Released 2011. 
IBM SPSS Statistics for Windows, Version 20.0., Armonk, NY: IBM Corp.). Continuous 
variables were expressed as mean±SD and p value was calculated by using ANOVA test. 
Categorical variables were presented as number and percentages, and significance of 
differences was analyzed using Chi2-test or Fisher exact test. The denoted p values were two-
sided, and p<0.05 was considered significant. 
 
 
RESULTS 
 
Over a period of 2 years, 1929 cardiac rhythm devices and 3909 leads were implanted in 1929 
consecutive patients with commonly accepted indications for either pacemaker, ICD or CRT 
device implantation. The baseline characteristics of patients and type of device implantation 
are summarized in Table 1. Patients with a pacemaker indication were older than those with 
an ICD indication, and 66% of patients with cardiac rhythm device implantation were male.  
 
 
 
Table 1. Clinical characteristics 
 
 
LVEF, left ventricular ejection fraction; NYHA class, New York Heart Association functional class.  
p value is calculated by using ANOVA test. 
Baseline  Single- 
chamber  
PM 
(n=259) 
Dual-
chamber 
PM 
(n=426) 
Single- 
chamber 
ICD 
(n=287) 
Dual- 
chamber 
ICD 
(n=364) 
CRT-P 
 
 
(n=91) 
CRT-D 
 
 
(n=504) 
p value 
Age (year) 78±11 74±11   61±13   65±11   72±12   69±9 p<0.001 
Male (%) 55 55   72.5   77   65   76 p<0.001 
LVEF (%) - -   30±9   31±12   40±13   26±11 p<0.001 
NYHA class - -  2.1±0.5  2.2±0.6  2.3±0.9  2.4±1 p=0.1 
QRS duration (ms) - - 112±33 112±40 143±60 161±59 p<0.001 
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All leads were actively fixed, except the coronary sinus leads. Device and lead manufacturers 
included Medtronic, St. Jude Medical, Biotronik, Sorin Group and Boston Scientific. Of all 
implanted devices 1148 (60%) were ICDs, and of all implanted leads 1148 (29%) were ICD 
leads. Details regarding implanted devices and leads are summarized in Figures 1 and 2.  
 
Thirty-one (1.5%) patients were re-admitted because of Cardiac Device Infection, and all had 
explantation of their device. One (3.2%) patient died within 30 days of hospitalization. 
Positive cultures were present in 27/31 (87%) cases. These consisted predominantly of micro-
organisms part of the skin flora (84%). 
 
Re-intervention 
A total of 90 (2.3% of the leads) lead-related complications occurred in 86 (4.4%) patients for 
which re-intervention was needed. The cause of re-intervention was mainly lead dislodgement 
(66%), followed by malfunctioning (20%) and perforation (18%). Re-intervention was more 
common in men compared to women (70% vs 30% p=0.001). Re-interventions occurred more 
often in younger patients (mean age 65±13 vs 70±13 years, p=0.001).  
 
Lead dislodgement or malfunction, and time of occurrence 
A total of 3909 leads were implanted. During the first year of follow-up, a total of 74 (1.9%) 
lead dislodgements or malfunctions occurred in 71 (3.7%) patients: 57 (1.4%) dislodgements 
and 17 (0.5%) malfunctions. Regarding lead dislodgement, RA lead (1.9%) showed the most 
frequent lead dislodgement compared to RV pacemaker lead (0.3%) or ICD lead (1.8%) 
(p=0.0007 and p=0.002), Table 2. Only 6 (1%) coronary sinus (CS) leads dislocated, requiring 
re-intervention. Regarding lead malfunction, ICD lead (0.8%) showed the most frequent lead 
malfunction compare to RA lead (0.1%) (p=0.002), Table 2.  
  
Figure 1. A total of 1929 cardiac rhythm devices 
implanted. 
 
Figure 2. A total of 3909 leads implanted. 
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Table 2. Lead dislodgement, malfunctioning and perforation 
 
Type of lead                                Number
implanted 
Dislodge-
ment 
(%) 
Malfunc-
tioning 
(%) 
Lead perforation 
(%) 
with 
pericardiocentesis 
Screw perforation 
(%) 
without 
pericardiocentesis 
Atrial leads                             1442 28 (1.9) a                      2 (0.1)                          5 (0.3)                           2 (0.1)  
Right ventricular 
   pacemaker leads           
  724     2 (0.3)                    4 (0.5)                          1 (0.1)                          7 (0.9) 
ICD leads                 1148 21 (1.8) b   9 (0.8) -   1 (0.08) 
Coronary sinus 
   leads              
  595   6 (1) c                         2(0.3)                               - - 
Total  3909 57 (1.5)                     17 (0.4)                        6 (0.15)                          10 (0.25)           
 
p value is calculated by using Fisher’s exact test. 
a p=0.0007 compared with RV pacemaker lead as reference.  
b p=0.002 compared with RV pacemaker lead as reference.  
c p=0.15 compared with RV pacemaker lead as reference. 
 
 
 
 
 
 
The timing of occurrence of lead dislodgement/malfunction is summarized in Figure 3. The 
majority of RA and RV lead dislodgements occurred before discharge, whereas the majority 
of RA and RV lead malfunction occurred after 2nd month following implantation. All CS-
lead dislodgements or malfunctions occurred after the 2nd month following implantation. In 
almost 1/3 of the cases the sleeves on the leads were not fixed adequately and in 2/3 of the 
cases the cause of dislodgement was unclear. All re-do interventions were conducted without 
further complications. 
 
Lead dislodgement per device type 
In this study 595 CRT-D/P devices were implanted. In the CRT-D group, significantly more 
lead dislodgments or malfunctions were observed compared to the single-chamber pacemaker 
(30 vs 3, p=0.006). The risk of any lead dislodgement or malfunctioning was higher in CRT-
D (5%, p=0.006) and dual-chamber ICD (5.8%, p=0.002) as compared to single-chamber 
pacemaker (1.2%). Numbers of lead dislodgements per type of device are summarized in 
Table 3. 
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Table 3. Lead dislodgement and type of device 
 
Type of device Number of 
lead  
dislodgement    
or 
malfunction            
Risk of any 
leads lead 
dislodgement      
or malfunction                  
Number of 
lead/screw 
perforation with  
or without  
pericardiocentesis                                                                      
Risk of lead/screw 
perforation with  
or without 
pericardiocentesis                                                              
Single-chamber   
PM                    
  3 1.2%   3 d 0.8% 
Dual-chamber 
PM                       
10 2.3% 12 e 3.0% 
Single-chamber 
ICD                   
10 a 3.5%   1 0.3% 
Dual-chamber 
ICD                      
21b 5.8%   0 0% 
CRT-D/P                                     30 c 5.0%   0 0% 
 
a p=0.09 compared with single-chamber pacemaker as reference.                                 
b p=0.002 compared with single-chamber pacemaker as reference.                              
c p=0.006 compared with single-chamber pacemaker as reference. 
d p=0.35 compare with single-chamber ICD as reference. 
e p=0.02 compared with single-chamber ICD as reference. 
 
Figure 3. Timing of either lead dislodgement, malfunctioning or perforation. The majority of lead 
dislodgements occurred before discharge and all perforations occurred after 2e month of implantation. 
LD 1: lead dislodgement before discharge; LM 1: lead malfunctioning before discharge; LP 1: lead 
perforation before discharge. LD 2: lead dislodgement between discharge and 2 months; LM 2: lead 
malfunctioning between discharge and 2 months; LP 2: lead perforation between discharge and 2 months. 
LD 3: lead dislodgement between 2 months and 1 year; LM 3: lead malfunctioning between 2 months 
and 1 year; LP 3: lead perforation between 2 months and 1 year. 
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Lead or screw perforation 
During follow-up 16 (0.4% of the leads) leads showed screw/lead perforation in 15 (0.8%) 
patients. They were re-admitted to the hospital with pericarditis-like symptoms suspected for 
cardiac perforation. The clinical presentation of all suspected cardiac perforations was 
subacute (±21 days after implantation). Fourteen patients were implanted with single- or dual-
chamber pacemaker and 1 patient with a single-chamber ICD. The majority of these patients 
were re-admitted after the first week of implantation, Figure 3. Ten patients were re-admitted 
with pericarditis-like symptoms with a slight amount (<0.5 cm) of pericardial effusion on the 
echocardiogram. In these patients only repositioning of the lead was sufficient without need 
for pericardiocentesis. The other five patients were re-admitted with symptoms of cardiac 
tamponade and a significant amount of pericardial effusion (>2 cm, with >25% respiratory 
mitral flow variation) on echocardiogram suspect of lead perforation without obvious 
extracardiac location of a lead on chest X-ray. In these five (0.26%) patients, with dual-
chamber pacemakers, pericardiocentesis was necessary and performed. In all cases a 
repositioning or implantation of a new lead was performed without further complications and 
without the need for thoracic surgical intervention. In all patients, the pericarditis-like 
symptoms disappeared after repositioning of the suspected lead. From the 16 (0.4%) 
lead/screw perforations, 7 were RA leads, 8 were right ventricular pacemaker leads and 1 was 
an active fixation ICD lead. RV pacemaker leads caused significantly more lead/screw 
perforation compared to ICD leads (p=0.02; Table 3). All RV leads that caused perforations 
were located in the RV apex region and 4 of the 7 RA leads that caused perforation were 
located in lateral wall of right atrium. 
  
Lead or screw perforation per type of device  
Most (12 cases) lead/screw perforations occurred in dual-chamber pacemakers compared to 
single-chamber pacemakers (2 cases) or single-chamber ICD (1 case) (p=0.02). There were no 
lead/screw perforations in dual-chamber ICD or CRT-D/P devices. The rate for lead/screw 
perforation in dual-chamber pacemakers was 3%, whereas this did not occur in CRT-D/P 
patients. Numbers of leads/screw perforations per type of device are summarized in Table 3. 
 
 
DISCUSSION  
 
In this prospective device complication registry of 1929 patients, 4.4% of patients suffered 
from a lead dislodgement, malfunctioning or perforation during the first year following the 
implantation. The overall rate of lead dislodgement, malfunctioning or perforation requiring 
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re-intervention was low (2.3% of 3909 leads) in our study. RA lead and ICD lead were the 
leads with the highest risk (1.9%) of dislodgement compared to RV-pacemaker and coronary 
sinus leads. The rate of lead malfunctioning was higher in ICD leads. The rate of coronary 
sinus lead dislodgement or malfunction within the first year following the implantation was 
very low in this study (1.4%). Dual-chamber ICD implantation was the procedure with the 
highest risk of lead dislodgement, and DDD pacemaker implantation had the highest risk of 
lead perforation. The overall lead dislodgement rate in our hospital is low and comparable 
(1.5− 3.3%) with published studies [2,6,10−14]. The CRT trials [2,13−15] reported any lead 
dislodgement rate varying from 2.9% to 10.6%. In our hospital, the rate of any lead 
dislodgement in CRT-D/P devices was 5%. In CRT devices the lead failure rate exceeds the 
rate of lead failure in one- or two-chamber devices. This is comprehensible since per device 
more leads are implanted. In our group, the low rate of 5% for any lead dislodgement could 
be explained by the low rate of coronary sinus lead dislodgements. The rate of coronary sinus 
lead dislodgement in the present study is low (1.4%) compared to previous reports (4.0−8.4%) 
[16,17]. There are several possible explanations. The coronary sinus leads are today more 
diverse with different shape and thickness. These properties enable the operators to choose the 
lead which fits best in the side branches of the coronary sinus. Also, the use of inner catheters 
and selective shackling of the side branches makes it easier to advance the lead inside the 
vessel and to achieve a stable position. A possible other explanation is the experience of the 
operator. Almost all coronary sinus leads were implanted by three very experienced operators 
in our hospital. Furthermore, since coronary sinus leads from a number of different 
manufactures are available in our hospital during implantation, and there is no preferred 
manufacturer assigned to a case, the most suitable lead can be chosen for implantation, 
according to the anatomy, enhancing the success rate. We tried to identify the causes of lead 
dislodgments. In almost 1/3 of the cases the sleeves on the leads were not fixed adequately 
and in 2/3 of the cases the cause of dislodgement was unclear. It means that in 1/3 of the cases 
a lead dislocation could be prevented by adequate fixation. In the present study all lead/screw 
perforations were subacute and the incidence was very low (0.8%) and comparable with 
(0.6−5.2%) published reports [1,5,7]. The DDD pacemakers caused the most perforations (12 
cases) and the majority of perforated leads were RV leads. There are several possible 
explanations: 
1.  All perforated RV-leads were located in RVapex which is the thinnest part of the right 
ventricle. In our routine practice we try to avoid the apex if possible and position the RV leads 
in a septal region if sufficient sensing and pacing values are present.  
2. The relatively small size of the lead, 6-7 French, which perforates the apex easier than 
the thick high-voltage ICD (8-9 French) lead and, according to the Laplace Low (p=F/A; 
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pressure is the amount of force acting per unit area), it is easy to understand that when the 
surface area is smaller, then the pressure will be higher on that surface area.  
3. Also, the experience of operators plays an important role. In our teaching hospital, most 
of pacemakers were implanted by less experienced operators, cardiologists in training, and the 
ICDs and CRTs by very experienced operators. The majority of perforated RA leads were 
located in the lateral wall, which is not the preferred site, due to its unstable position or 
insufficient electrical signals, and therefore the operator has been forced to choose this site.  
 
Strength and limitations of study 
This study demonstrates the real-world common daily practice of implanting large numbers of 
devices in a teaching hospital. Meticulous longitudinal follow-up was performed, with 
documentation of complications in all patients. This study also has certain limitations. We 
identified the re-intervention due to lead-related complication when the patients were returned 
to cardiac catheterization laboratories within the first year of implantation. Patients with lead-
related complication who did not return for re-intervention based on the opinion of their 
cardiologists could be missing in our registry. Furthermore, the follow-up period in the 
present study is no longer than 1 year. However, most lead dislocations and perforations are 
expected to occur within 1 year [1,7,11]. This is also supported by our own data. To obtain 
reliable information about the rate of complications, we used predefined definitions of 
complications. We focused on lead dislodgement, malfunctioning and perforations. Other 
device-related complications, including infection, were beyond the scope of this study. Our 
analysis did also not evaluate mortality and duration of hospitalization in the study 
population.  
 
 
CONCLUSIONS 
 
In this large observational study, lead-related re-intervention was necessary in 4.4% of 
patients, more common in younger and male patients, and due to either lead dislodgement 
(66%), malfunctioning (20%) or perforation (18%). With a total of 3909 leads implanted, the 
incidence of lead dislodgement, malfunction or perforation was low (2.3%). Right atrial and 
ICD leads caused more dislodgement compared to RV-pacemaker leads. Lead perforation was 
more common with RV- leads, especially when placed in the apex. In the patients with lead 
perforation, in only 1/3 pericardiocentesis was necessary. With 1929 devices implanted, more 
lead complications were observed in dual-chamber ICD and CRT-D/P. 
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ABSTRACT  
 
Aim: Although electrocardiographic and echocardiographic findings with right ventricular 
(RV) pacing mimic intrinsic left bundle branch block (LBBB), LV mechanical activation 
pattern may differ. We compared mechanical activation pattern of the LV in RV-pacing-
induced LBBB with intrinsic LBBB in symptomatic chronic heart failure patients.  
Methods: We studied 37 patients with chronic RV pacing and 37 with intrinsic LBBB who 
were referred for CRT. Echocardiographic study including 2D speckle tracking longitudinal 
strain and M-mode were performed at baseline. 
Results: Patients with intrinsic LBBB were younger, had higher prevalence of ischemic heart 
disease and had more severe depressed LV function. The basal-septal segments were the 
earliest activated sites in 11% of patients in RV-pacing-induced LBBB compared to 30% in 
intrinsic LBBB (p=0.04). The mid-and basallateral segments were the latest activated sites in 
57% of patients in RV-pacing-induced LBBB compared to 30% in intrinsic LBBB (p=0.03). 
LV dyssynchrony, using longitudinal strain, time delay >130 ms between either mid-septal or 
apico-septal and either basal or mid-lateral segments was present in 71% of patients with RV-
pacing-induced LBBB compared to 59% in intrinsic LBBB (p=0.03). Using M-mode, LV 
dyssynchrony was present in 11% of patients with RV-pacing-induced LBBB compared to 
59% in intrinsic LBBB (p=0.02).  
Conclusion: RV pacing results in less early basal activation and more often early mid-septal 
and late lateral wall activation in comparison with intrinsic LBBB. Imaging techniques that 
only visualize the basal or mid part of the LV may result in a serious underestimation of 
dyssynchrony in patients with pacing-induced LBBB.  
 
 
INTRODUCTION 
 
Cardiac resynchronization therapy (CRT) reduces mortality, improved symptoms and exercise 
tolerance in selected patients with left bundle branch block (LBBB) and severe chronic heart 
failure [1]. Right ventricular (RV) pacing has electrocardiographic and echocardiographic 
similarities with LBBB, but left ventricular (LV) activation pattern is probably different. 
Although it has been suggested that in patients with RV-pacing and heart failure the 
prevalence of dyssynchrony is comparable to patients with spontanous LBBB [2], the 
different left ventricular activation pattern may influence assessment of dyssynchrony and 
prediction whether patients have potential benefit of CRT. The aim of this study is to assess 
the mechanical activation pattern and LV dyssynchrony by 2D speckle tracking strain 
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imaging in patients with heart failure and pacing-induced LBBB, compared to patients with 
intrinsic LBBB and to investigate whether this influences assessment of dyssynchrony. 
 
 
METHODS 
 
We retrospectively studied a total of 74 subjects, 37 patients with pacing-induced LBBB (RV 
apex pacing) and 37 patients with intrinsic LBBB. Patients with RV pacing-induced LBBB 
were candidates for an upgrading to a biventricular device and had been chronically paced in 
RV apex for more than 1 year with more than 90% RV apex pacing and the ECG showed 
LBBB pattern with a left axis deviation. The RV lead position was determined by X-ray 
(antero-posterior and in lateral views) and ECG. These patients were in heart failure NYHA 
functional class II or III and had a LV ejection fraction <35%. Patients with intrinsic LBBB 
had symptoms of heart failure and met the current guidelines for cardiac resynchronization 
therapy (symptomatic heart failure, NYHA class III-IV/IV despite optimal medical therapy 
(OPT), LV ejection fraction <35%, left ventricular end-diastolic diameter (LVEDD) >55 mm, 
QRS >120 ms and in sinus rhythm). All patients were on optimal medical regimen according 
to guidelines. 
 
Echocardiography and data acquisition 
All patients underwent standard two-dimensional transthoracic echocardiography and Doppler 
imaging prior to implantation of the cardiac resynchronization device. The images were 
obtained using a 3.5 MHz transducer at a depth of 16cm in the parasternal (long axis) and 
apical (2- and 4-chamber) views. The images were stored in cineloop format by well-trained 
echocardiographists and reviewed by an independent cardiologist who was not involved in the 
study. Left ventricular end-diastolic diameter and volume (LVEDD and LVEDV), and left 
ventricular end- systolic diameter and volume (LVESD and LVESV) were obtained. The LV 
ejection fraction was calculated from the conventional apical 2- and 4-chamber imaging, 
using the Biplane Simpson’s technique [3]. The M-mode was used to determine the intra-
ventricular septal to posterior wall motion delay (SPWMD) in parasternal long-axis (PLAX) 
images. As reported by Pitzalis et al. [4], SPWMD >130 ms was used as a cut-off value for 
LV dyssynchrony. 
 
Strain analysis by 2D speckle tracking 
Longitudinal strain: Longitudinal strain was assessed in an apical 4-chamber view with a 
frame rate of at least 40 frames/s to allow for reliable operation of software. The endocardial 
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border was manually traced and the region-of-interest width was manually adjusted to include 
the entire myocardium. The software then automatically traced and accepted segments of 
good tracking quality and rejected poorly tracked segments and allowed the user to manually 
over-ride its decisions at the same time using visual assessments. The time from QRS onset to 
peak global longitudinal strain was determined for 6 separate segments, i.e., basal-septal, mid-
septal, apico-septal, apico-lateral, mid-lateral and basal-lateral. A total of 444 segments were 
analyzed on LV 4-chamber apical view images. Of these 444 segments, 10 segments (2.3%) 
were excluded from analysis because of poor tracking score. The location of the earliest and 
the latest activated segments and the maximal delay, defined as the time difference between 
the earliest and latest activated segments, were determined, Furthermore, the time delay 
between basal-septal to basal-lateral segments and the time delay between apico-septal or 
mid-septal to basal-lateral or mid-lateral segments were determined. LV dyssynchrony was 
defined as an interval >130 ms for the absolute difference in time-to-peak global longitudinal 
strain for basal-septal to basal-lateral segments [5]. Although no cut-off values are available 
for defining LV dyssynchrony in RV-pacing-induced LBBB, we defined an interval >130 ms 
for difference in time-to peak global longitudinal strain between apico-septal or mid-septal to 
basal-lateral or mid-lateral segments as cut-off value for LV dyssynchrony. The off-line 
analyses were performed on digitally stored images (EchoPac version 108.X.X) by one 
independent observer blinded to the clinical and other echocardiographic information.  
 
Statistical analysis 
Results are presented as mean±standard deviation and compared using two-tailed Student’s t- 
test for paired and unpaired data. p<0.05 was considered significant for all tests. 
 
 
RESULTS 
 
Patients  
Baseline characteristics of the 74 patients are summarized in Table 1. Patients with intrinsic 
LBBB were younger, had higher prevalence of ischemic heart disease and had more 
pronounced impaired LV function than the patients with RV-pacing-induced LBBB.  
 
Mechanical activation pattern 
There were several differences in LV mechanical activation pattern between RV-pacing-
induced LBBB and intrinsic LBBB. Differences in the earliest- and latest-activated segments 
between the two groups are depicted in Figures 1 and 2. The basal-septal segments were the 
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earliest activated sites in 11% of patients in pacing-induced LBBB compared to 30% in 
intrinsic LBBB (p=0.04). The mid- and basal-lateral segments were the latest activated sites 
in 57% of patients in pacing-induced LBBB compared to 30% in intrinsic LBBB (p=0.03). 
 
Left ventricular dyssynchrony 
The LV dyssynchrony parameters and assessment of LV dyssynchrony in both groups are 
summarized in Table 2. LV dyssynchrony, between either mid-septal or apico-septal and 
either basal or mid-lateral segments was present in 71% of patients with pacing-induced 
LBBB compared to 59% in intrinsic LBBB (p=0.03). Using M-mode in the basal segements 
alone, LV dyssynchrony was present in 11% of patients with pacing-induced LBBB 
compared to 59% in intrinsic LBBB (p=0.02). 
 
 
 
 
 
 
 
Table 1. Baseline characteristics of patients with intrinsic and pacing-induced LBBB 
 
 Intrinsic 
LBBB 
(n=37) 
Pacing-induced 
LBBB 
(n=37) 
p value 
Age (years±SD)   63.2 ±9.5   70±10    0.004 
Male gender (%)   62   70    0.461 
Sinus rhythm (%) 100   45    <0.001 
Ischemic (%)   54   29    0.034 
NYHA class(mean±SD) 2.65±0.42 2.77±0.61    0.063 
QRS (ms±SD) 174±19 174±31    0.970 
LV end-diastolic diameter (mm±SD)   64.4±7.7   57.1±7.1 < 0.01 
LV end-systolic diameter (mm±SD)   56.6±8.7   45.2±9.8 < 0.01 
LV end-diastolic volume (ml±SD) 208.1±76.6 127.1±47.9 < 0.01 
LV end-systolic volume (ml±SD ) 162.0±74.6   85.9±39.6 < 0.01 
LV EF (%±SD )   23.7±8.6   31.2±9.3 < 0.01 
 
SD, standard deviation. 
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Figure 1. Distribution of earliest  activated sites in pacing-induced LBBB and in intrinsic LBBB in apical 
4-chamber view by longitudinal strain speckle tracking. BS, basal-septal; MS, mid-septal; AS, apico-
septal; Al, apico-lateral; ML, mid-lateral; BL, basal-lateral. 
 
Figure 2. Distribution of latest activated sites in pacing-induced LBBB and in intrinsic LBBB in apical 
4-chamber view by longitudinal strain speckle tracking.  
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Table 2. Left ventricular dyssynchrony measurements in both groups  
 
 Intrinsic  
LBBB 
Pacing-induced 
LBBB  
p value 
SPWMD by M-Mode (ms±SD) 144±55 (n=37)   82±45 (n=36) 0.001 
BS-BL delay by LS (ms±SD) 154±16 (n=36)  110±87 (n=33) 0.165 
Max. delay 4C by LS (ms±SD) 277±118 (n=37) 251±133 (n=37) 0.135 
AS/MS-BL/ML delay by LS (ms±SD) 190 ±126 (n=37) 205±134 (n=35) 0.624 
AS/MS-BL/ML delay ≥130 ms   59%   71% 0.037 
Max delay 4ch by LS ≥130 ms   91%   86% 0.66 
BS-BL delay ≥130 ms   47%   27% 0.09 
SPWMD by M-mode ≥ 130 ms   59.4%   11% 0.02 
 
SPWMD, intraventricular septal to posterior wall motion delay; BS-BL delay, difference between time to peak global 
longitudinal strain of basal-septal and basallateral segments; Max delay 4C, maximal difference in time to peak global 
longitudinal strain between six segments in 4-chamber view; AS/MS-BL delay, difference between time to peak global 
longitudinal strain of apicoseptal or midseptal and basallateral segments; A/AS-posterior delay, difference between time to 
peak global radial strain of anterior or anteroseptal and posterior segments. 
 
 
 
DISCUSSION 
 
In pacing-induced LBBB the right ventricular (RV) pacing induces intra-ventricular 
conduction disturbance (IVCD). If the ventricular lead is placed in the apical region of RV, 
this pacing-induced IVCD usually presents electrocardiographically with a left bundle branch 
block (LBBB) pattern and left axis deviation. The etiology of intrinsic left bundle branch 
block (LBBB) represents a spectrum that ranges from conduction disease in the proximal 
parts of the left bundle branch (LBB) to more distal parts in the fascicles or advanced disease 
in the distal Purkinje fibers. The mechanical activation pattern of the LV depends in intrinsic 
LBBB on the level of block in the conduction system and in induced LBBB on the position of 
RV lead within the right ventricle. In the current study, we showed clear differences in 
mechanical activation pattern between intrinsic and pacing-induced LBBB by using speckle 
tracking longitudinal strain. This mechanical activation pattern also affects the assessment of 
LV dyssynchrony in these two groups. We demonstrated that in patients with a pacing-
induced LBBB the mid- and apico-septal regions of LV are in the majority of patients the 
earliest activated regions, whereas in intrinsic LBBB the basal-septal segment is most 
frequently the earliest activated region. Furthermore, there are differences in latest activation 
sites between these two groups: in pacing-induced LBBB one of the lateral segments (AL, 
ML, BL) is in 74% the latest activated segments and in contrast, in intrinsic LBBB the lateral 
wall is only in 35% of patients the latest segment. For the assessment of dyssynchrony we 
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used several methods of measuring the delays between LV segments. Measuring the delay in 
predefined segments like BS and BL showed that LV dyssynchrony was only present in 27% 
of patients with pacing-induced LBBB, whereas in intrinsic LBBB this was present in 47% of 
patients (p=0.09). Choosing other predefined segments (MS/AS versus BL/ML >130 ms) the 
number of patients with dyssynchrony, according to our definition, increased to 71% and 
59%, respectively, in patients with pacing-induced and intrinsic LBBB (p=0.03). When we 
assessed the maximum delay between any of the segment, the number of patients with 
dyssynchrony increased to 86% and 91%, respectively, in patients with pacing-induced and 
intrinsic LBBB. Also, the mean values of the different delays measured depend very much on 
which method was depicted (Table 2). Using M-mode, (again two basal segments), LV 
dyssnychrony was present in 11% of the patients with pacing-induced LBBB and in 59.4% of 
patients with intrinsic LBBB (p=0.02). The results of our study are in contrast with those of 
Witte et al. [2]. They suggested that patients with RV pacing and heart failure have similar 
dyssynchrony as patients with intrinsic LBBB. However, they used M-mode (SPWMD ≥130 
ms), interventricular mechanical (aortopulmonary) delay >40 ms and TDI >65 ms 
(intraventricular delay) as marker of dyssynchrony. An explanation why these basal segments 
fail to demonstrate LV dyssynchrony may be the fact that in RV apex pacing, not the basal- 
septal regions, but the apical regions (apico-septal, mid-septal and apico-lateral) are 
predominantly activated as first. These apical regions are not represented when M-mode 
(PLAX images) or longitudinal strain imaging of the basal segments is applied. Our findings 
are in agreement with Xiao et al. [6], they reported that electromechanical delay, contraction 
and relaxation times, and extent of incoordinate ventricular wall motion differ strikingly 
between intrinsic and pacing-induced LBBB. In pacing-induced LBBB, activation vector is 
directed from apical to basal and from right to left. In contrast, in patients with intrinsic LBB, 
the activation vector is usually directed from basal to apical and from septal to lateral. 
Therefore, pacing-induced LBBB and intrinsic LBBB are two different entities. 
At present time, to our knowledge, no studies have been reported concerning the effects of 
permanent RV apical pacing (pacing-induced LBBB) on timing of regional wall strain by 
longitudinal speckle tracking in heart failure patients. We used the longitudinal strain because 
of better visualizing of apex in relation to other segments of LV. In RV pacing-induced LBBB 
the assessment of LV dyssynchrony at the level of the basal LV segments causes serious 
underestimation of the dyssynchrony which is demonstrated by our results regarding the M-
mode measurements and basal longitudinal strain method. In RV apical paced patients the 
mid/apico-septal region is in the majority of patients the earliest activated segment. It is 
important to visualize and assess all segments of the LV (from basal to apex) rather than 
being restricted to the basal and mid-segments. The imaging techniques like M-mode, TVI 
and radial strain are often restricted to basal or mid-segments regions. Therefore, based on 
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this retrospective analysis, we suggest that speckle tracking might be a preferred method to 
investigate dyssynchrony, at least in patient with RV pacing. 
 
Study limitations 
The present study is a retrospective analysis. The data were collected systematically and 
echocardiograms were analyzed by an independent cardiologist. Validated and normal values 
for the assessment of LV dyssynchrony by 2D speckle tracking in patients with heart failure 
and RV pacing are lacking at the moment. We used the LV dyssynchrony cut-off value (130 
ms) that was used in echocardiographic studies measuring deformation by radial strain and m-
mode techniques in patients with intrinsic LBBB and heart failure. Whether a (maximum) 
delay >130 ms assessed by longitudinal strain is clinically relevant was not the purpose of this 
study. The clinical relevance of assessing regional LS in order of better patient selection for 
CRT is an important issue. The baseline characteristics of patients with induced LBBB and 
intrinsic LBBB were different and we can not exclude that this influenced our results.  
 
 
CONCLUSION 
 
In this study we demonstrated that RV-pacing-induced LBBB and intrinsic LBBB are not 
identical with regard to the mechanical activation pattern of the left ventricle: RV pacing 
results in less early basal activation and more often early mid-septal and late lateral wall 
activation and in comparison with the mechanical activation in intrinsic LBBB.  
Using imaging techniques that only visualize the basal or mid part of the LV may result in a 
serious underestimation of dyssynchrony in patients with pacing-induced LBBB, therefore 
speckle tracking is endorsed as method to evaluate dyssynchrony.  
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ABSTRACT 
 
Background: Response to cardiac resynchronization therapy (CRT) is still difficult to predict 
with previously investigated dyssynchrony indices. The predictive value of speckle tracking 
strain analysis has not been fully delineated yet. The objective of this study was to assess the 
predictive value of longitudinal (LS) and radial strain (RS) speckle tracking measurements on 
echocardiographic and clinical response to CRT. 
Methods: A total of 138 consecutive patients with functional class II−IV heart failure who 
underwent CRT were studied. Echocardiography was performed at baseline and during 
follow-up. Six different time-based LV dyssynchrony indices measured with LS and RS. 
Echocardiographic response to CRT was defined as a reduction in LV end-systolic volume 
≥15% and clinical response as survival without heart failure hospitalization. Multivariable 
analyses were performed to adjust for potential confounding factors. 
Results: Echocardiographic and clinical follow-up was 22±8 and 42±8 months, respectively. 
Ninety-six patients (70%) were classified as echocardiographic responders and 114 patients 
(83%) survived without heart failure hospitalization. QRS duration and non-ischemic etiology 
predicted echocardiographic response to CRT. None of the speckle tracking indices was 
different between echocardiographic responders and non-responders to CRT. Regarding 
clinical response, only maximal delay between six segments in 4-chamber view measured 
with LS was different between responders and non-responders, with 154 ms delay as the 
optimal cut-off value. Neither stratified analyses in patients with sinus rhythm nor 
multivariable analyses did change these findings.  
Conclusion: Of all time-based measured speckle tracking indices, only maximal delay 
between six segments in 4-chamber view as assessed with LS was associated with clinical 
response to CRT. 
 
 
INTRODUCTION 
 
Cardiac resynchronization therapy (CRT) is an established treatment for heart failure patients 
with prolonged QRS duration and reduced LV ejection fraction (LVEF) <35%. CRT goals 
include an increase in left ventricular ejection fraction, reduction of heart failure symptoms, 
and reduction of heart failure hospitalization and mortality [1−4]. However, indication for 
CRT based on LVEF and QRS duration results in 30–40% of non-responders and even 
worsening of cardiac function in some patients [5]. Echocardiographically determined 
intraventricular dyssynchrony has been used to enhance the rate of response to CRT. Several 
echocardiography techniques have been used to aide in patient selection for CRT prior to 
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implantation with promising results in observational single-center trials. However, no ideal 
echocardiographic approach for the assessment of dyssynchrony has yet been found. The 
largest prospective trial (PROSPECT) [6] showed poor predictive value of several 
conventional and tissue Doppler-based methods. In recent years, 2D-speckle tracking 
echocardiography, including radial, longitudinal, and circumferential strain analysis, has been 
used to assess left ventricular dyssynchrony [7,8]). However, the predictive value of speckle 
tracking strain analysis has not been fully delineated yet, as contradictory results have been 
presented with relatively short clinical and echocardiographic follow-up [9,10]. The aim of 
the current study was to evaluate the predictive value of 2D-speckle tracking longitudinal and 
radial strain on echocardiographic and clinical response to CRT in a large cohort of patients. 
 
 
METHODS  
 
Selection of patients 
From January 2008 to December 2009, 160 consecutive patients with chronic heart failure 
(New York Heart Association functional class II−IV), LVEF <35% and wide QRS complex 
≥120 ms who were scheduled for CRT were included in the present study. All patients were 
on optimal pharmacological therapy, including angiotensin-converting enzyme inhibitors and 
beta-blockers. Patients with a recent myocardial infarction (<3 months) or decompensated 
heart failure were excluded. Etiology was considered ischemic in the presence of significant 
coronary artery disease (>50% stenosis in 1 or more of the major epicardial coronary arteries) 
and/or history of myocardial infarction or prior revascularization by PCI or CABG. Twenty-
two patients with poor echocardiographic window at baseline were excluded from the 
analysis.  
 
Study protocol and Echocardiographic data acquisition  
All patients underwent two-dimensional echocardiography prior to biventricular ICD 
implantation and at follow-up in the second year after CRT implantation. The images were 
obtained on a Vivid 7 ultrasound machine (General Electric, Milwaukee, WI) using a 3.5 
MHz transducer at a depth of 16 cm in the parasternal (long- and short axis) and apical (2- 
and 4-chamber) views. The images were stored in cine-loop format by well-trained 
echocardiographists and reviewed by an independent cardiologist who was not involved in the 
study. The left ventricular end-diastolic diameter (LVEDD), left ventricular end-diastolic 
volume (LVEDV), left ventricular end-systolic diameter (LVESD) and left ventricular end-
systolic volume (LVESV) were measured and the LVEF was calculated using Simpson’s 
technique [11].  
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Figure 1. (A) An example of speckle tracking longitudinal strain analysis demonstrating LV dyssynchrony 
in 4-chamber view in a heart failure patient with LBBB. LV dyssynchrony is shown as maximal time-
delay between six segments. (B) The same patient defined as responder to CRT. LV dyssynchrony 
measured as maximal time-delay between six segments decreased from 246 ms at baseline (A) to 82 ms 
after CRT (B). 
 
 
Speckle tracking and CRT response 
_______________________________________________________________________________ 
54 
 
Left ventricular dyssynchrony measurements with 2D-speckle tracking  
Longitudinal and Radial strain imaging: In the present study, longitudinal and radial strain 
imaging techniques were used to assess left ventricular dyssynchrony. The analysis was 
performed using a commercially available software package (EchoPac version 7.0.1, General 
Electric) with a frame rate of at least 40 frames/s to allow for reliable operation of software 
and frame rate <40 frames/s considered as non-valid tacking. The endocardial border was 
manually traced by a point-and-click approach and the region-of-interest width was manually 
adjusted to include the entire myocardium. Segments of good tracking quality were 
automatically traced and accepted and poorly tracked segments were rejected. This allowed 
the user, based on visual assessments, to manually over-ride automatic software assessments. 
We used two imaging techniques, i.e., longitudinal and radial strain, to visualize the 
mechanical activation pattern of the left ventricle in three different ways. First, longitudinal 
strain was measured in the apical 4-chamber view to evaluate three septal segments (basal, 
mid and apical) and three lateral segments (apical, mid and basal) of the left ventricular wall. 
Second, longitudinal strain was measured in the 2-chamber apical view to evaluate three 
inferior segments (basal, mid and apical) and three anterior segments (apical, mid and basal) 
of the left ventricular wall. Third, radial strain was measured to evaluate the mid-regions of 
the left ventricle in short axis view to visualize six segments (anterior, antero-septal, septum, 
inferior, posterior and lateral) of the left ventricle.  
For the measurement of LV dyssynchrony we used the same method as described by 
Ypenburg et al. [12]. In the apical 4-chamber view, the time from QRS onset to peak 
longitudinal strain, during the entire cardiac cycle, was determined for six separate segments 
(basal-septal, mid-septal, septal-apical, lateral-apical, mid-lateral and basal-lateral walls). 
Subsequently, time delay between basal-septal and basal-lateral segments (BS-BL delay) and 
the maximal time delay between the earliest and latest activated segments were calculated 
(Figure 1). In the apical 2-chamber view the time from QRS onset to peak longitudinal strain 
was determined for six separate segments (basal inferior, mid inferior, apical inferior, apical 
anterior, mid anterior and basal anterior walls). Subsequently, time delay between basal 
inferior and basal anterior segment (BI-BA delay) and the maximal time delay between the 
earliest and latest activated segments were calculated. The same measurements as with 
longitudinal strain were performed with radial strain in six separate segments (anterior, 
antero-septal, septum, inferior, posterior and lateral) at the level of the papillary muscles. The 
maximal time delay between these six segments and time delay between antero-septal to 
posterior segment (AS-P delay) were calculated. The off-line analysis was performed on 
digitally stored images by an independent observer (A.G.) blinded to the clinical and other 
echocardiographic information. All speckle tracking left ventricular dyssynchrony measures 
were additionally performed by another independent, well trained, and experienced 
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cardiologist (P.P.D.). Furthermore, these measurements were repeated by the first observer, in 
order to assess inter-observer and intra-observer variability. Inter-observer and intra-observer 
variability was expressed as intraclass correlation coefficients. Values higher than 0.8 are 
considered as excellent, values between 0.6 and 0.8 as good, values between 0.4 and 0.6 as 
moderate, and values below 0.4 as poor concordance. 
 
Echocardiographic response to CRT 
Response to CRT was defined as a reduction of ≥15% in LVESV compared to baseline 
echocardiographic measurement, determined in the second year of echocardiographic follow-
up [13,14].  
 
Clinical response to CRT 
Survival without hospitalization due to worsening of heart failure during follow-up was 
defined as clinical response to CRT. Of note, clinical status was assessed by independent 
physicians before CRT and after a mean±SD of 42±8 months. 
 
Statistical analysis 
Statistical analysis was performed using SPSS statistical software (IBM Corp. Released 2011. 
IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp.). Continuous 
variables are expressed as mean±SD and a non-parametric Mann-Whitney U-test was used to 
analyze differences between groups. Categorical variables are presented as number and 
percentages and the Chi-squared test was used to analyze differences between groups. Paired 
observations (observations of the same variable at different time points) were analyzed using 
the non-parametric Wilcoxon test. Logistic regression analysis was performed to identify 
predictors of echocardiographic response. Cox regression was used to analyze predictors of 
clinical response. From six different dyssynchrony indices we selected those indices which 
differ in the univariate analyses between clinical responders and non-responders to CRT. In 
the multivariate logistic and Cox regression analyses we analyzed these indices after 
adjustment for clinical variables (LVEF, QRS width, ischemic/non-ischemic cardio-
myopathy). Because atrial fibrillation may potentially influence both speckle tracking 
measurements and response to CRT, stratified analyses performed in patients with sinus 
rhythm and atrial fibrillation. Because the number of included patients with atrial fibrillation 
was too small we only presented the results in patients with sinus rhythm. 
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Table 1. Baseline characteristics of study population, according to echocardiographic response to CRT  
 
 All patients  
(n=138) 
Non-responders 
(n=42) 
Responders 
 (n=96) 
p 
value 
Age (years)   68±8   70±9   67±8 0.05 
Male gender, n (%)   96/138 (70%)   29/42 (69%)   67/96 (70%) 0.93 
Ischemic, n (%)   71/138 (51%)   30/42 (71%)   41/96 (43%) 0.002 
Non-ischemic, n (%)   67/138 (49%)   12/42 (29%)   55/96 (57%)  
Atrial fibrillation, n (%)   32/138 (23%)   10/42 (24%)   22/96 (23%) 0.90 
Sinus Rhythm, n (%) 106/138 (77%)   32/42 (76%)   74/96 (77%)  
LBBB, n (%) 126/132 (95%)   38/41 (93%)   88/91 (97%) 0.37 
RBBB, n (%)     6/132 (4.5%)     3/41 (7%)     3/91 (3%)  
QRS duration (ms) 164±23 159 ± 20 167±23 0.05 
NYHA functional class  2.6±0.5  2.6±0.5  2.6±0.5 0.83 
LVEF (%)   26±7   25±6   26±7 0.52 
LV end-diastolic volume (ml) 147±56 150±54 146±57 0.47 
LV end-systolic volume (ml) 109±46 111±43 108±48 0.47 
Systolic blood pressure (mmHg) 123±18 121±19 124±17 0.20 
Diastolic blood pressure (mmHg)   73±11   72±10   73±11 0.36 
Diuretics, n (%) 110/138 (80%)   38/42 (91%)   72/96 (75%) 0.04 
Beta-blocker, n (%) 117/138 (85%)   35/42 (83%)   82/96 (85%) 0.75 
Ace-inhibitors or AT II, n (%) 102/138 (86%)   32/42 (85%)   70/96 (87%) 0.69 
Spironolacton, n (%)        61/138 (44%)   23/42 (55%)   38/96 (40%) 0.10 
Position of  LV lead    0.814 
    Posterior/postero-lateral    67%   64%   69%  
    Lateral   22%   21%   22%  
    Midcardiac vein     4%     5%     4%  
    Epicardial     7%   10%     5%  
Max delay six segments by LS 
   (4-chamber) ms 
196±89 191±92 198±88 0.42 
BS-BL delay by LS  
   (4-chamber) ms 
119±92 119±88 118±95 0.82 
Max delay six segments by LS  
   (2-chamber) ms 
196±99 208±117 191±90 0.55 
BI-BA delay by LS  
   (2-chamber) ms 
  93±76   99±82   90±74 0.55 
AS-Posterior delay by RS  
   (PSAX) ms 
110±95   82±77 121±100 0.15 
Max delay six segments by RS  
   (PSAX) ms 
144±108 116±86 157±115 0.10 
 
LVEF, left ventricular ejection fraction; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular systolic 
diameter; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LS, longitudinal 
strain; RS, radial strain; BS-BL delay, basal septal-basal lateral delay; BI-BA, basal inferior-basal anterior; AS-P delay, 
antero-septal-posterior delay; PSAX, parasternal short axis view.  
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Table 2. Baseline characteristics of study population, according to clinical response to CRT 
 
   All patients  
  (n=138) 
 Responders 
 (n=114) 
Non-responders  
(n=24) 
p  
value 
Age (years)   68±8    68±8   69±9 0.578 
Male gender, n (%)   96/138 (70%)   80/114 (70%)   16/24 (67%) 0.734 
Ischemic, n (%)   71/138 (51%)   56/114 (49%)   15/24 (63%) 0.233 
Non-ischemic, n (%)   67/138 (49%)   58/114 (51%)     9/24 (38%)  
Atrial fibrillation, n (%)   32/138 (23%)   27/114 (24%)     5/24 (21%) 0.764 
Sinus Rhythm, n (%) 106/138 (77%)   87/114 (76%)   19/24 (79%)  
LBBB, n (%) 126/132 (95%) 104/108 (96%)   22/24 (92%) 0.299 
RBBB, n (%)     6/132 (5%)     4/108 (4%)     2/24 (8%)  
QRS duration (ms) 164±23 165±23 160±23 0.314 
NYHA functional class  2.6±0.5  2.6±0.5  2.6±0.5 0.637 
LVEF (%)   26±7   26±7   25±7 0.587 
LV end-diastolic volume (ml) 147±56 145±51 156±76 0.931 
LV end-systolic volume (ml) 109 ± 46 108±43 115±60 0.882 
Systolic blood pressure (mmHg) 123±18 124±18 117±17 0.045 
Diastolic blood pressure (mmHg)   73±11   73±11   71±11 0.542 
Diuretics, n (%) 110/138 (80%)   89/114 (78%)   21/24 (88%) 0.296 
Beta-blocker, n (%) 117/138 (85%)   98/114 (86%)   19/24 (79%) 0.399 
Ace-inhibitors or AT II, n (%) 102/138 (86%)   85/114 (87%)   17/24 (85%) 0.687 
Spironolacton, n (%)        61/138 (44%)   47/114 (41%)   14/24 (58%) 0.125 
Position of LV lead    0.73 
    Posterior/postero-lateral    67%   65%   68%  
    Lateral   22%   21%   22%  
    Midcardiac vein     4%     6%     3%  
    Epicardial     7%     9%     6%  
Max delay six segments by LS  
    (4-chamber) ms 
196±89 205±90 156±70 0.010 
BS-BL delay by LS  
    (4-chamber) ms 
119±92 125±98   90±58 0.236 
Max delay six segments by LS  
    (2-chamber) ms 
196±99 193±98 213±102 0.358 
BI-BA delay by LS  
    (2-chamber) ms 
  93±76   91±74 104±84 0.507 
AS-Posterior delay by RS  
    (PSAX) ms 
110±95 111±99 104±78 0.915 
Max delay six segments by RS 
    (PSAX) ms 
144±108 146±110 136±101 0.780 
 
All abbreviations explained in Table 1. 
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RESULTS 
 
Baseline characteristics 
Of the 160 patients initially included, 22 patients were excluded because of poor quality of the 
echocardiographic images. Therefore, 138 patients were eventually analyzed. The baseline 
parameters of the study population according to echocardiographic and clinical response to 
CRT are summarized in Tables 1 and 2. Mean age was 68±8 years with 70% male gender. 
59% had functional class 3 heart failure. Mean QRS duration was 164±23 ms and mean LV 
EF was 26±7% with 51% ischemic etiology. All patients had optimal medical therapy, 
including angiotensin-converting enzyme or angiotensin-receptor antagonist (86%), beta-
blockers (85%), diuretics (80%) and spironolactone (44%) at maximally tolerated dosages. 
There were no differences in age and etiology of cardiomyopathy between patients with and 
without atrial fibrillation. Patients with atrial fibrillation were more often male (p=0.01). 
Furthermore, the QRS duration was significantly shorter in patients with atrial fibrillation 
compared to sinus rhythm (151±21 ms versus 169±22 ms, p<0.001). Only one time-based LV 
dyssynchrony index, i.e., maximal delay between six segments by longitudinal strain, showed 
at baseline a significant difference between patients with and without atrial fibrillation 
(170±80 ms versus 204±90 ms, respectively, p=0.02). 
 
Echocardiography 
2484 segments were evaluated using longitudinal strain and radial strain analysis, 310 
(12.5%) segments were excluded from analysis because of non-valid tracking or poor 2D 
images. The inter- and intra-observer variability for the LV dyssynchrony measurements were 
assessed in 10 randomly selected patients. Intra class correlation for inter-observer variability 
was 0.71 and 0.68 for intra-observer variability.  
 
Response to CRT 
Long-term echocardiographic follow-up was performed at 22±8 months. According to the 
predefined echocardiographic criterion of a reduction in LVESV >15%, 96 (70%) patients 
were classified as responders to CRT and 42 (30%) as non-responders. Of these 42 non-
responders, 30 (71%) had an ischemic cardiomyopathy. 114 patients (83%) survived without 
heart failure hospitalization and were classified as clinical responders to CRT, 24 patients 
(17%) died or were hospitalized with heart failure and were classified as clinical non-
responders to CRT. During follow-up, there were no significant differences in LVEF and 
numbers of clinical events between patients with baseline atrial fibrillation compared to sinus 
rhythm. LVEF was 38±13% in patients with atrial fibrillation and LVEF was 39±13% in 
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patients with sinus rhythm (p=0.51). Death or heart failure hospitalization was observed in 
16% of patients with atrial fibrillation and in 18% of patients with sinus rhythm (p=0.76).  
 
Effects of CRT on echocardiographic parameters 
During follow-up, responders to CRT showed a significant reduction in end-systolic and 
diastolic LV volumes compared with non-responders. LVESV, decreased from 108±48 ml to 
60±33 in responders to CRT (p<0.001) and in non-responders LVESV did not change 
significantly (LVESV 111±43 ml at baseline versus 120±41 ml during follow-up, p=0.1). 
Furthermore, a significant improvement in LVEF was noted in responders to CRT compared 
with non-responders, i.e., LVEF increased from 26% ±7 to 45% ±10 in the responder group 
(p<0.001), whereas LVEF did not change significantly in the non-responder group (LVEF 
25% ±6 at baseline versus LVEF 26% ±6 during follow-up (p=0.25). 
 
Effects of CRT on clinical outcome 
Clinical outcome was assessed after a mean follow-up of 42±8 months. During follow-up 24 
clinical events occurred (13 patients died and 15 were hospitalized due to worsening heart 
failure). Four patients who died had also been hospitalized due to heart failure during follow-
up. Total mortality was 9.4% (13 patients); 6 (6.5%) patients in echocardiographic responders 
and 7 (16.7%) patients in non-responders (p=0.064). In the entire population, a significant 
improvement in clinical status was noted, with a significant reduction in NYHA functional 
class from 2.6±0.5 to 1.78±0.71 (p<0.001). During follow-up, the NYHA class in the 
responder group was 1.7±0.7 versus 2.0±0.6 in the non-responder group (p=0.03). 
 
 
 
 
 
Table 3. Uni- and multivariate predictors of echocardiographic response to CRT 
 
 Univariate analysis  Multivariate analysis a 
OR  95%CI p value OR 95%CI p value 
Max delay six segments by  
  LS 4-chamber (per 10 ms) 
1.01 0.97−1.05 0.676     
QRS duration (ms)                                                                     1.02 1.00−1.04 0.049     
Non-ischemic etiology 3.35 1.53−7.33 0.002  3.386 1.515−7.571 0.003 
LVEF 1.03 0.97−1.08 0.349     
 
a Maximal delay between six segments by LS adjusted for QRS duration, LVEF at baseline and ischemic/non-ischemic 
etiology. 
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Table 4. Uni- and multivariate predictors of clinical response to CRT 
 
 Univariate analysis  Multivariate analysis a 
  HR              95% CI                      p value                 HR             95% CI                   p value 
  Max delay six segments by  
    LS 4-chamber (per 10 ms) 
0.94 0.89−0.99 0.020  0.93 0.890−0.991 0.02 
  QRS duration (ms)                                                                     0.99 0.97−1.01 0.273     
  Non-ischemic etiology 0.61 0.27−1.39 0.239     
  LVEF 0.98 0.93−1.04 0.566     
 
a Maximal delay between six segments by LS adjusted for QRS duration, LVEF at baseline and ischemic/non-ischemic 
etiology. 
 
 
Baseline speckle tracking indices and echocardiographic response 
In univariate logistic regression analysis, QRS duration and non-ischemic etiology were 
significantly associated with response to CRT (Table 3). In multivariate logistic regression 
analysis, non-ischemic etiology independently predicted the echocardiographic response to 
CRT, after adjustment for confounders (Table 3). Maximal delay between six segments LS 
failed in both uni-and multivariate analysis to predict echocardiographic response.  
 
Baseline speckle tracking indices and clinical response 
The maximal delay between six segments LS was significantly longer in responders compared 
to non-responders (205±90 ms versus 156±70 ms, p=0.01, respectively), see Table 2. In 
univariate Cox regresssion analysis, this dyssynchrony index was significantly associated 
(p=0.02) with the time until the composite endpoint of death and heart failure hospitalization 
(Table 4). Also, in multivariate Cox regresssion analysis this index independently predicted 
the time until the composite endpoint, after adjustment for confounders (Table 4). Receiver 
operating characteristic curve analysis was performed to define the optimal cut-off value for 
maximal delay between six segments to predict the clinical response. The area under the 
curve for this index was 0.67 (CI 0.55−0.79), and the optimal cut-off value to predict clinical 
response to CRT was 154 ms, yielding a sensitivity and specificity of, respectively, 63% and 
69% (Figures 2 and 3). Stratified analyses were performed in ischemic and non-ischemic 
cardiomyopathy patients. The max delay six segments at baseline was not different between 
ischemic and non-ischemic patients (197±90 ms versus 195±88 ms, p=0.97). Moreover, the 
association between max delay six segments and both echocardiographic and clinical 
response were identical in the ischemic and non-ischemic group (adjusted OR 1.01 and 0.94, 
respectively). Due to the smaller sample sizes, the association between max delay six 
segments and clinical response was statistically not significant in neither the ischemic nor 
non-ischemic group. 
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Figure 2. Survival without hospitalization due to worsening of heart failure in 138 patients treated with 
CRT according to maximal delay between six segments measured at baseline with speckle tracking LS. 
 
Figure 3. Receiver operating characteristics curves for maximal delay six segments by LS. AUC, area 
under the curve. 
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Table 5. Maximal delay between six segments as measured by longitudinal strain by 2x2 table 
 
 Clinical  
response 
Clinical  
non-response 
p  
value 
Total  
number 
Echocardiographic response 202±87 ms 
n=82 
168±94 ms 
n=11 
0.24   93 
Echocardiographic non-response 212±101 ms 
n=28 
147±43 ms 
n=13 
0.02   41 
p value 0.856 0.865   
Total  110 24  134 
 
 
 
Association between degree of dyssynchrony and outcome 
We demonstrated that in patients with echocardiographic and clinical non-response the 
maximal delay between six segments was significantly shorter compared to patients with 
echocardiographic non-response and clinical response (147 vs 212 ms, p=0.02). However, in 
the group of echocardiographic responders, the maximal delay between six segments was not 
significantly different between the clinical responders and non-responders (Table 5). 
 
Prediction of response to CRT in sinus rhythm 
Stratified analyses of the prediction by speckle tracking imaging of either echocardiographic 
or clinical response to CRT in patients with sinus rhythm did not change the previous finding. 
In patients with sinus rhythm, there was only an association between maximal delay between 
six segments in 4-chamber view and clinical response to CRT (after adjustment, HR 0.92, CI 
0.87−0.98, p=0.009).  
 
 
DISCUSSION 
 
In the present study we assessed the association of baseline longitudinal and radial strain 
measures with echocardiographic and clinical response to CRT. This is, to our knowledge, 
one of the largest study populations described at present. We demonstrated that the maximal 
delay between six segments measured with longitudinal strain in 4-chamber view, was 
significantly associated with clinical response to CRT. The cut-off value for this maximal 
delay between six segments in 4-chamber view was 154 ms, with relatively low sensitivity 
and specificity (63% and 69%, respectively). The six indices that measure the time to 
maximal deformation of certain segment failed to show a significant and consistent 
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association with echocardiographic response to CRT. In the current study, we used two 
imaging techniques, longitudinal and radial strain, to visualize the deformation pattern of the 
left ventricle in three different ways. The longitudinal strain in apical 4-chamber view 
visualizes the septal and lateral wall of LV and may identify better the early and late activated 
segments as expected in left bundle branch block (LBBB). Because the electric signal 
conducts in diffuse manner in LBBB, both early and late activated segments can be seen in 
both the longitudinal and short axis view. The radial strain especially visualizes the mid-
portion of the LV; however, the apical and basal regions of the LV are difficult to visualize in 
this view. 
In current study, the dyssynchrony indices which visualized only small portion of LV like BS-
BL delay, BI-BA delay, AS-P delay failed to predict the response to CRT. The maximal delay 
in apical 4-chamber view, as assessed in this study, is able to identify early and late segments 
with maximal deformation and therefore predicts response to CRT. One of the major 
limitations of time-based indices assessed with speckle tracking is that it measures the timing 
of maximal deformations. It does not provide information whether this is an active contraction 
or passive contraction. The value of several 2D speckle tracking imaging techniques were 
studied in the assessment of ventricular dyssynchrony and its relationship with CRT response 
and showed varying results. In our study, time-differences between predefined segments 
measured with longitudinal strain did not predict echocardiographic response to CRT. Our 
findings are in line with most previous studies [7,10,15,16). One reason for these varying 
findings between the studies could be that longitudinal and radial strain was assessed in 
different ways. In present study, we measured the time to peak strain while other studies 
measured the time to peak systolic strain. In some studies [7,15] the longitudinal and radial 
strain have been used to determine the timing of maximal strain but in other studies the 
longitudinal, radial and circumferential strain were used to calculate the average difference 
between peak and end-systolic strain to predict response to CRT [16]. In one study [16], the 
strain dyssynchrony index (SDI) assessed with combined longitudinal, radial and 
circumferential strain could predict both short and long-term outcome after CRT while the 
baseline values of time delay (measured with longitudinal strain) between basal-septal and 
basal-lateral segments, time-difference between early- and late-activated segments and time-
delay between two opposite walls (septal to lateral) could not predict long-term response to 
CRT. Our findings confirm a portion of the latter results. Another reason for these varying 
findings between the studies could be the different endpoints. The majority of studies defined 
6 months echocardiographic response as endpoint [7,16] and other studies defined 
echocardiographic and clinical outcome as endpoints [9,13]. In the current study, echo-
cardiographic response was assessed at mean 22±8 months which might be very long and may 
explain the different results to previous studies [7,9]. 
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Although, several data are available about the predictive value of radial strain on 
echocardiographic response to CRT, they show conflicting results [7,10,15,16]. In the present 
study LV dyssynchrony measured by radial strain was unable to predict response to CRT. 
One study [10] demonstrated that radial strain could not predict response to CRT. More data 
on the predictive value of radial strain were provided by Delgado et al. [7]. They 
demonstrated that AS-P delay >130 ms measured by radial strain could predict acute and 
long-term response to CRT with good sensitivity (83−90%) and specificity (75−80%). 
However, more recently, Miyazaki et al. [15] demonstrated in a large prospective study that 
radial strain was unable to predict the reverse remodeling or clinical response to CRT. The 
STAR study [9] demonstrated that radial strain was able to predict LVEF response with 86% 
sensitivity and 67% specificity. The most recent trial, EchoCRT trial [17], studied the benefit 
of CRT in patients with chronic heart failure and narrow QRS. For the assessment of LV 
dyssynchrony several echocardiographic techniques including radial strain were used. These 
echo parameters did not predict the clinical response to CRT. Our current data demonstrate 
that radial strain was not able to predict echocardiographic or clinical response to CRT.  
The time-based dyssynchrony measurement, which looks only at the timing of deformation of 
a certain segment, provides only information about the timing of maximal deformation of 
certain segment and does not provide any information about stretching of the opposite 
segment. Therefore, time-based measurement may not be very important for the assessment of 
dyssynchrony as we demonstrated in this study. It is conceivable that the opposite wall 
motion pattern, which looks at the possible stretching of one wall when the opposite wall is 
contracting almost at the same time, may be more important in prediction of CRT to response, 
as it provides both mechanical and timing information. However, more research is needed to 
delineate these issues. 
 
In patients with atrial fibrillation, echocardiographic measurements, including speckle 
tracking analysis, may be more difficult. This study included 23% patients with atrial 
fibrillation and showed that although the QRS duration at baseline is significantly smaller in 
patients with baseline atrial fibrillation, the echocardiographic and clinical response to CRT 
was comparable to patients with sinus rhythm. However, we could not perform stratified 
analyses in patients with atrial fibrillation, because the number of included patients with atrial 
fibrillation was too small. Future studies including more patients with atrial fibrillation should 
answer whether maximal delay between six segments measured with longitudinal strain in 4-
chamber as measured by spackle tracking has predictive value in these patients. A previous 
study [18] assessed the position of LV lead and demonstrated that the extent of cardiac 
resynchronization therapy benefit was similar for leads in the anterior, lateral or posterior 
position. However, the apical lead location was associated with a significantly increased risk 
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for heart failure/death. Also, in our study there was no association between lead position and 
neither clinical nor echocardiographic response. Unfortunately, we have no data on apical 
versus basal position of the LV lead. 
 
Potential clinical implications 
The maximal delay between six segments measured with longitudinal strain in 4-chamber 
view may be helpful in prediction of clinical response to CRT. Besides, we demonstrated that 
radial strain in prediction of response to CRT is not useful. 
 
Future study 
Time-related indices use simply the time to maximal strain or deformation of certain 
segments and do not provide sufficient information about the synchrony of global 
deformation. Visualization of other elements of the contraction pattern by speckle tracking 
may provide additional information about dyscoordination of certain segments which could 
be corrected by CRT [19]. Segmental differences in time to the start of strain, or segmental 
differences in duration of strain could be related to CRT response. Speckle tracking 
dyssynchrony measures could be expressed for the specific regions where first activation from 
RV and LV leads (are expected to) take place. Apical rocking and septal rebound stretch 
[20,21] are reported as measures that provide more information regarding LV global 
dyscoordination and their relationship with radial and longitudinal strain indices should be 
assessed. 
 
Strengths and Limitations 
The present study is a retrospective analysis of a large single-center cohort of consecutive 
patients treated with CRT. We realize that retrospective analysis is inferior to prospective 
investigations with pre-specified endpoints and cut-off values. The data were, however, 
collected systematically by independent physicians. Furthermore, echocardiograms were 
analyzed and validated by independent cardiologists. A substantial number (n=22) of patients 
were excluded from analysis because of poor imaging quality and 12.5% of evaluated 
segments were excluded from analysis because of poor quality [6,15]. Contrary to most other 
studies, and because of our long-term follow-up, we provided not only echocardiographic 
outcome measures, but also clinical endpoints, such as death and heart failure hospitalization. 
We realize that the number of endpoints is relatively small, and we are careful with the 
interpretation of results. Scar tissue is an important issue in the prediction of CRT response. 
The most reliable imaging modality to assess scar tissue is cardiac MRI. Unfortunately we did 
not perform a cardiac MRI before CRT implantation in our study population. Assessment of 
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scar tissue by echocardiography has some limitations due to poor image quality. Therefore, 
we have not collected data on scare tissue in our study population.  
 
 
CONCLUSION 
 
We assessed six different time-based LV dyssynchrony indices measured with speckle 
tracking longitudinal and radial strain and demonstrated that only maximal delay between six 
segments in 4-chamber view measured with LS was significantly longer in clinical responders 
to CRT. The value of time-based peak speckle tracking measurements to predict clinical and 
echocardiographic response to CRT seems to be limited. 
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ABSTRACT 
 
Purpose: Echocardiographic assessment of left ventricular (LV) dyssynchrony is used to 
predict response to cardiac resynchronization therapy (CRT). However, the association 
between reduction in the extent of speckle tracking based LV dyssynchrony and 
echocardiographic response to CRT has not been explored yet. The aim of this study was to 
assess the changes in the extent of LV dyssynchrony as a result of CRT and its association 
with echocardiographic response to CRT in a large consecutive series of patients. 
Methods: We studied 138 patients with standard CRT indication. Time-based speckle 
tracking longitudinal strain (maximal delay between six segments in 4-chamber view) was 
performed to assess LV dyssynchrony at baseline and after a mean follow-up of 22±8 months. 
Echocardiographic CRT response was defined as a reduction in LV end-systolic volume 
≥15%.  
Results: Mean age was 68±8 years (30% female). Mean LV ejection fraction (LVEF) was 
26±7%. Ninety-six patients (70%) were classified as echocardiographic responders. In the 
total study group, LV dyssynchrony decreased from 196±89 ms at baseline to 180±105 ms 
during follow-up, p=0.01. Of note, in responders there was a pronounced reduction in LV 
dyssynchrony (198±88 ms at baseline versus 154±50 ms after CRT, p<0.001), whereas in 
non-responders there was a significant increase (191±92 ms at baseline versus 243±160 ms 
after CRT, p=0.04). After multivariate analysis, decreased in LV dyssynchrony, wider QRS 
duration and non-ischemic etiology were independently and significantly associated with 
CRT response. 
Conclusion: Changes in the extent of LV dyssynchrony as measured by speckle tracking after 
CRT are independently associated with response to CRT. 
 
INTRODUCTION 
 
Several landmark trials have demonstrated that cardiac resynchronization therapy (CRT) 
reduces symptoms, mortality, heart failure hospitalization and reverses the ventricular 
remodeling in 50−70% of patients with symptomatic heart failure and reduced left ventricular 
ejection fraction (LVEF ≤35%) with wide QRS [1−5]. Selection of patients who benefit from 
CRT is of major importance, and 2D speckle tracking echocardiography may be helpful in the 
selection of patients for CRT [6−8]. Although previous studies showed that LV dyssynchrony 
before CRT as measured by time-based speckle tracking was associated with better long-term 
survival and could predict improvement of LV ejection fraction (LVEF) after CRT, the 
definite role of speckle tracking for patient selection in CRT candidates is still not established. 
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One of the important purposes of CRT is reduction of dyssynchrony and thereby improving 
LVEF. Previous studies demonstrated an average increase in LVEF in the range of 3−11% 
after CRT [5,9,10]. Significant reduction in the amount of dyssynchrony as result of CRT, 
measured as the longest intraventricular delay between six basal LV segments, was related to 
‘superior response’ to CRT [10]. CRT significantly reduced LV dyssynchrony measured by 
longitudinal and radial speckle tracking in CRT responders compared to CRT non-responders 
[11]. Most reports relate baseline LV dyssynchrony to CRT response. However, data 
regarding the changes in LV dyssynchrony assessed by time-based speckle tracking imaging, 
and its association with long-term CRT response are sparse [10−12]. The aim of the current 
study was to evaluate the CRT-induced changes in the extent of LV dyssynchrony as 
measured with time-based speckle tracking. Furthermore, we investigated the relationship 
between CRT-induced LV dyssynchrony changes with response to CRT in a large cohort of 
patients treated with CRT for chronic heart failure. 
 
 
METHODS 
 
Selection of patients   
From January 2008 to December 2009, 160 consecutive patients with chronic heart failure 
(New York Heart Association functional class II-IV), LVEF <35% and wide QRS complex 
>120 ms with LBBB, RBBB or IVCD (intra-ventricular conduction delay) who were 
scheduled for primary CRT-D (cardiac resynchronization therapy with defibrillator) 
implantation, were included in the present study. Retrospective data collection was approved 
by the hospital ethics committee, and patients gave written informed consent. Patients with 
CRT-P (cardiac resynchronization therapy with pacemaker), pre-implantation LVEF >35% 
according to echocardiographic data, recent myocardial infarction (<3 months) or 
decompensated heart failure were excluded. Etiology was considered ischemic in the presence 
of significant coronary artery disease (>50% stenosis in one or more of the major epicardial 
coronary arteries) and/or history of myocardial infarction or prior revascularization by PCI or 
CABG. The patients who died before follow-up echocardiography were excluded from the 
study. The QRS duration was calculated from the 12-lead ECG. Conventional criteria for 
LBBB was used which include QRS duration >120 ms, QS or rS in lead V1, and a 
monophasic R wave in with no Q waves in leads V6 and I. All patients were on optimal 
medical therapy, including angiotensin-converting enzyme inhibitors and beta-blockers. 
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Figure 1. An example of speckle tracking longitudinal strain analysis demonstrating LV dyssynchrony in 
4-chamber view. (A) Baseline LV dyssynchrony is shown as maximal time-delay between six segments 
197 ms. (B) The same patient defined as responder to CRT. LV dyssynchrony measured as maximal 
time-delay between 6 segments decreased from 197 ms at baseline to 95 ms after CRT. 
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The study protocol and echocardiographic data acquisition 
All patients underwent 2D echocardiography prior to biventricular ICD implantation and at 
follow-up in the second year after CRT implantation. The images were obtained on a Vivid 7 
ultrasound machine (General Electric, Milwaukee, WI) using a 3.5 MHz transducer at a depth 
of 16 cm in the parasternal (long- and short axis) and apical (2- and 4-chamber) views. The 
images were stored in cine-loop format by well-trained echocardiographists and speckle 
tracking analysis was performed offline by an independent cardiologist who was not involved 
in the study. The left ventricular end-diastolic diameter (LVEDD), left ventricular end-
diastolic volume (LVEDV), left ventricular end-systolic diameter (LVESD) and left 
ventricular end-systolic volume (LVESV) were measured and the LVEF was calculated using 
Simpson’s technique [13].  
 
Left ventricular dyssynchrony measurements with 2D-speckle tracking longitudinal 
strain imaging  
Recently we assessed the predictive value of baseline speckle tracking measurements on 
response to CRT [14]. We demonstrated that baseline maximal delay between six segments 
assessed in 4-chamber view with longitudinal strain as the only LV dyssynchrony parameter 
that independently was associated with clinical response to CRT. Therefore, in the present 
study we chose for this LV dyssynchrony parameter to assess the CRT-induced changes in the 
extent of LV dyssynchrony and its relationship with echocardiographic response to CRT. The 
analysis was performed using EchoPac version 7.0.1, General Electric. The acquisition of the 
2D images is performed with at least 40 fps to allow for proper speckle tracking analysis off 
line. The endocardial border was manually traced by a point-and-click approach and the 
region-of-interest width was manually adjusted to include the entire myocardium. The 
software then automatically traced and accepted segments of good tracking quality and 
rejected poorly tracked segments and allowed the user to manually over-ride its decisions 
using visual assessments. We used longitudinal strain imaging technique in 4-chamber view 
to visualize the timing of maximal deformation in each segment of septal and lateral wall. To 
determine the timing of maximal deformation of three septal segments (basal, mid and apical) 
and three lateral segments (apical, mid and basal) we measured the time from QRS onset to 
peak longitudinal strain during entire cardiac cycle for six separate segments (basal-septal, 
mid-septal, septal-apical, lateral-apical, mid-lateral and basal-lateral walls). Subsequently, the 
time delay between earliest and the latest segments with peak strain were determined, i.e., 
maximal time delay between the six segments in 4-chamber view (Figure 1). The off-line 
analysis was performed on digitally stored images by an independent observer (A.G.) blinded 
to the clinical and other echocardiographic information. All speckle tracking LV 
dyssynchrony indices measures were additionally performed by another independent, well 
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trained and experienced cardiologist (P.P.D.). Furthermore, these measurements were 
repeated by the first observer, in order to assess inter-observer and intra-observer variability. 
Inter-observer and intra-observer variability was expressed as intra-class correlation 
coefficients. Values higher than 0.8 are considered as excellent, values between 0.6 and 0.8 as 
good, values between 0.4 and 0.6 as moderate, and values below 0.4 as poor concordance [15] 
 
Definition of response to CRT 
Echocardiographic Response to CRT was defined as a reduction of >15% in LV end-systolic 
volume (LVESV) at the second year of follow-up [10,16−18].  
 
Statistical analysis 
Statistical analysis was performed using SPSS statistical software (IBM Corp. Released 2011. 
IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp.) and SAS version 
9.2 (SAS Institute Inc., Cary, NC, USA). Continuous variables are expressed as mean±SD 
and a non-parametric Mann-Whitney U-test was used to analyze differences between groups. 
Categorical variables are presented as number and percentages and the Chi-squared test was 
used to analyze differences between groups. Paired observations (observations of the same 
variable at different time points) were analyzed using the non-parametric Wilcoxon test. 
Analysis of variance was used to analyze whether the change in LV dyssynchrony index was 
different between responders and non-responders and whether other variables (age, gender, 
LVEF at baseline, QRS width, LBBB/RBBB, non-ischemic/ ischemic etiology) were 
confounders or effect-modifiers of this relationship. In case of unequal variances between 
groups, the Satterthwaite test was calculated. Logistic regression analysis was performed 
to investigate whether a change in LV dyssynchrony index was associated with echocardiographic 
response. In the multivariate logistic regression analysis the relationship between the LV 
dyssynchrony parameter and echocardiographic response was analyzed after adjustment for 
clinical variables (age, gender, LVEF at baseline, QRS width, LBBB/RBBB, non-
ischemic/ischemic cardiomyopathy). p values of <0.05 were considered statistically 
significant in all analyses.  
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RESULTS 
 
Baseline characteristics 
Of the 160 patients initially included, 22 patients were excluded because of poor image 
quality (Figure 2). Therefore, 138 patients were eventually analyzed. Mean age was 68±8 
years, 70% was male. 59% had functional class 3 heart failure. Mean QRS duration was 
164±23 ms and mean EF was 26±7% with 51% ischemic etiology. The patients who died 
before follow-up echocardiography were excluded from the study. All patients had optimized 
medical therapy, including angiotensin-converting enzyme or angiotensin-receptor antagonist 
(86%), beta-blockers (85%), diuretics (80%) and spironolactone (44%) at maximally tolerated 
dosages. Using longitudinal strain analysis 1656 segments were evaluated, 207 (12.5%) 
segments were excluded from analysis because of non-valid tracking or poor 2D imaging. The 
inter- and intra-observer variability for the LV dyssynchrony measurements were assessed in 
10 randomly selected patients. Intra class correlation coefficient for inter-observer variability 
was 0.71 and 0.68 for intra-observer variability.  
 
 
Figure 2. Flowchart of study population. 
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Table 1. Baseline characteristics according to response to CRT 
 All patients  
(n=138) 
Non-responders 
(n=42; 30%) 
Responders 
(n=96; 70%) 
p value 
Age (years)   68±8   70±9   67±8 0.05 
Male gender    70%   69%   70% 0.93 
Ischemic   51%   71%   43% 0.002 
Atrial fibrillation   23%   24%   23% 0.90 
LBBB (complete LBBB + IVCD)   95%   93%   97% 0.37 
RBBB     5%     7%     3%  
QRS duration (ms) 164±23 159±20 167±23 0.05 
NYHA functional class 2.6±0.5 2.6±0.5 2.6±0.5 0.83 
LVEF (%)   26±7   25±6   26±7 0.52 
LV end-diastolic volume (ml) 147±56 150±54 146±57 0.47 
LV end-systolic volume (ml) 109±46 111±43 108±48 0.47 
Position of LV lead    0.814 
      Posterior/postero-lateral    67%   64%   69%  
      Lateral   22%   21%   22%  
      Mid-cardiac vein     4%     5%     4%  
      Epicardial     7%   10%     5%  
 
Abbreviations: LBBB, left bundle branch block; RBBB, right bundle branch block; LVEF, left ventricular ejection fraction; 
LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; IVCD, intra-ventricular 
conduction delay. 
 
 
 
 
 
 
Response to CRT 
Long-term echocardiographic follow-up was performed at 22±8 months after CRT-D 
implantation. According to the predefined echocardiographic criterion of a reduction in 
LVESV >15%, 96 (70%) patients were classified as responders to CRT and 42 (30%) as non-
responders. Differences in baseline parameters between responders and non-responders are 
summarized in Table 1. Younger age, non-ischemic cardiomyopathy and wider QRS duration 
were significantly associated with response to CRT. Mean LVEF in responders increased 
from 26±7% at baseline to 45% ±10 during follow-up (p<0.001), whereas in non-responders 
there were statistically no significant changes in LVEF (p=0.24). In univariate analysis, QRS 
duration, non-ischemic etiology and maximal delay between six segments in 4-chamber view 
were significantly associated with response to CRT. 
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Table 2. LV dyssynchrony measured by maximal delay between six segments at baseline and after CRT in 
several subgroups and differences in changes between these subgroups 
 
         Baseline Follow-up 
 
Change 
(mean ± SD) 
p  
value 
Responders 
Non-responders 
198±88  
191±92 
154±50 
 243±160 
-43±101 
  52±182 
<0.001  
  0.04 
Age  <68 
Age  >68 
203±93 
189±83 
184±124 
176±80 
-19±154 
-13±119 
  0.04 
  0.14 
Male  
Female  
183±83 
224±95 
176±110 
189±91 
-  7±139 
-35±132 
  0.12 
  0.04 
Ischemic etiology 
Non-ischemic etiology 
196±90 
195±87 
189±117 
171±89 
  -7±155 
-24±118 
  0.20 
  0.03 
Atrial fibrillation 
Sinus rhythm 
169±80 
203±90 
165±66 
185±113 
  -4±96 
-18±148 
  0.68 
  0.01 
LBBB (complete LBBB + IVCD) 
Without LBBB 
200±89 
136±41 
181±107 
186±78 
-19±139 
  50±98 
  0.006 
  0.50 
QRS duration  >150 ms 
QRS duration  <150 ms 
202±92 
174±74 
189±113 
152±62 
-12±147 
-21±102 
  0.03 
  0.18 
LVEF  <26% 
LVEF  >26% 
206±95 
186±81 
171±78 
188±123 
-35±119 
    2±150 
  0.01 
  0.25 
Baseline NYHA class 1 or 2 
Baseline NYHA class 3 
204±91 
190±86 
174±72 
184±122 
-30±127 
  -6±144 
  0.05 
  0.11 
LVESV  <100 ml 
LVESV  >100 ml 
180±77 
211±96 
164±66 
196±131 
-16±103 
-16±167 
  0.10 
  0.06 
LVEDV <135 ml 
LVEDV >135 ml 
182±76 
209±98 
165±66 
195±130 
-16±102 
-13±166 
  0.08 
  0.07 
Location of  LV lead :            
    - Posterior/posterolateral/lateral  
    - Mid-cardiac vein 
 
196±89 
192±89 
 
182±107 
164±74 
 
-13±142 
-28±88 
 
  0.02 
  0.36 
 
All abbreviations explained in Table 1. 
 
 
Change of LV dyssynchrony during follow-up 
In the total study group, the extent of LV dyssynchrony decreased from 196±89 ms at 
baseline to 180±105 ms during follow-up, p=0.01. Of note, a significant decrease in the extent 
LV dyssynchrony was observed in younger patients, females, sinus rhythm, non-ischemic 
etiology, LBBB, QRS >150 ms, LVEF <26%, baseline NYHA 1 or 2, in patients with 
posterior, posterolateral or lateral position of LV lead and in responders (Table 2). In 
responders the extent of LV dyssynchrony was decreased significantly, whereas, in non-
responders a significant increase in the extent of LV dyssynchrony was observed (Table 2).  
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Table 3. Predictors of response to CRT 
 
 Univariate  Multivariate a 
 OR  of 
response 
95% CI p 
value 
 OR  of 
response 
95% CI p  
value 
Decrease in max delay six 
segments by LS (4-chamber) 
(per 10 ms) 
 
1.06 1.02−1.10 0.001  1.08 1.03−1.12 0.001 
Age 0.96 0.92−1.01 0.081  0.96 0.91−1.01 0.144 
Male gender 1.04 0.47−2.27 0.930  2.10 0.74−5.93 0.162 
QRS duration (ms) 1.02 1.00−1.04 0.049  1.03 1.01−1.06 0.010 
LVEF baseline 1.03 0.97−1.08 0.349  1.03 0.96−1.10 0.447 
LBBB versus RBBB 2.32 0.45−12.00 0.317  2.74 0.32−23.40 0.357 
Non-ischemic versus ischemic 3.35 1.53−7.33 0.002  3.87 1.45−10.34 0.007 
 
a Difference in Max delay six segments by LS analyzed after adjustment for age, gender, QRS duration, EF at baseline, 
LBBB/RBTB and non-ischemic ischemic etiology 
 
 
 
 
 
After multivariate analysis, adjusting for differences in age, gender, QRS duration, LVEF at 
baseline, LBBB/RBTB and non-ischemic/ischemic etiology, a decrease in maximal delay 
between six segments in 4-chamber view was independently and significantly associated with 
response to CRT (Table 3). 
 
Difference of changes in maximal delay between six segments in subgroups 
Difference of changes in the extent of LV dyssynchrony was compared in 11 subgroups 
(responders vs non-responders, male vs female, age >68 vs <68 years, ischemic vs non-
ischemic etiology, atrial fibrillation vs sinus rhythm, LBBB vs RBBB, QRS duration >150 ms 
vs <150 ms, LVEF <26% vs >26% etc.). Only responders to CRT had a significant different 
change of LV dyssynchrony as compared to non-responders (p<0.003). In all other subgroups 
there was no significant difference of CRT-induced change. ANOVA test was used to 
investigate whether the significant difference in the LV dyssynchrony changes between 
responders and non-responders was influenced by either confounding or effect modifying 
factors. None of these 11 factors were a confounder or effect modifier in relation to the 
difference of the LV dyssynchrony change between responders and non-responders (Table 4). 
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Table 4. Analysis of variance of the difference between max delay six segments in 4-chamber view before 
and after CRT 
 
  Mean difference 
max delay 
ANOVA  
p value a 
 Non-responders +52  
 Responders 
 
-43 0.003 
1 Age <68 (years) -19   
 Age >68 (years) -13 0.866 
2 Male    -7  
 Female  -35 0.080 
3 Ischemic etiology   -7  
 Non-ischemic etiology -24 0.586 
4 Atrial fibrillation   -4  
 Sinus rhythm  -18 0.214 
5 RBTB +50  
 LBBB -18 0.442 
6 QRS duration  <150 ms -21  
 QRS duration  >150 ms -12 0.923 
7 EF  <26 % -35  
 EF  >26 %  +2 0.320 
8 NYHA=1 of  2 -30  
 NYHA=3   -6 0.775 
9 LVESV <100 (ml) -16  
 LVESV >100 (ml) -16 0.242 
10 LVEDV <135 (ml) -16  
 LVEDV >135 (ml) -13 0.351 
11 lateral/posterior/posterolateral -13  
 Mid-cardiac vein -28 0.939 
 
a Because the responder and non-responder groups have unequal variances of difference in max delay the Satterthwaite test 
is calculated. 
 
None of these 11 factors were a confounder or effect modifier in relation to the difference of the LV dyssynchrony change 
between responders and non-responders. 
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DISCUSSION 
 
This retrospective single center study, describes the CRT-induced changes in LV 
dyssynchrony in a large cohort of patients. This study assessed the utility of serial 
longitudinal strain imaging technique to quantify the changes in the extent of LV 
dyssynchrony in CRT patients. Furthermore, we investigated the association of these changes 
with response to CRT. This study demonstrates that the reduction of LV dyssynchrony 
measured with longitudinal strain imaging is independently and significantly associated with 
echocardiographic response to CRT.  
The predictive value of baseline time-based speckle tracking techniques have been 
investigated [6−8,19−21] and showed conflicting results. Recently, we assessed the predictive 
value of baseline speckle tracking measurements on response to CRT [15]. We demonstrated 
that baseline maximal delay between six segments in 4-chamber view measured with 
longitudinal strain was the only LV dyssynchrony parameter that independently predicted the 
clinical response to CRT. Only few data [5,6,9,17−18] are available on changes in LV 
dyssynchrony after CRT. One small-sized study [10] with 37 patients investigated the 
reduction of dyssynchrony, as measured by IVMD (inter-ventricular mechanical delay) and 
the longest intraventricular delay between six basal LV segments, and showed a significant 
reduction in longest intraventricular delay between six basal LV segments in ‘super 
responders’ to CRT compared to non-responders. Another small-sized study [17] used two 
echocardiographic indices measured with longitudinal and radial strain and showed only a 
significant decrease in CRT responders. In the current study, we used longitudinal strain 
imaging technique to visualize the deformation pattern of the septal and lateral wall of the left 
ventricle to measure the maximal delay between six segments. This dyssynchrony parameter 
showed a significant reduction in the amount of LV dyssynchrony in responders to CRT and 
showed an increase in the amount of LV dyssynchrony in non-responders. Furthermore, after 
adjustment for potential confounders, this dyssynchrony parameter was independently 
associated with CRT response. This means that by every 10 ms reduction in LV dyssynchrony 
increased the odds ratio of response to CRT (CRT response increased with 8% per 10 ms 
reduction in the extent of LV dyssynchrony). This relationship increased exponentially after 
30 ms reduction in the extent of LV dyssynchrony (Table 3). In current study we 
demonstrated that the extent of LV dyssynchrony significantly was increased in non-
responders to CRT. Patients without LBBB showed increased LV dyssynchrony during 
follow-up, which may express suboptimal effects of CRT. In the recent years, it has been 
demonstrated that both LBBB morphology and QRS duration are powerful predictor of CRT 
response. However, a recent meta-analysis [22] of five randomized trials demonstrated that 
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QRS duration is a powerful predictor of the effects of CRT on morbidity and mortality and 
that QRS morphology did not provide additional information. The current study demonstrated 
that QRS duration is one the predictors of CRT response and is in line with this meta-analysis 
[22]. 
 
Technical issues of speckle tracking analysis 
There are some difficulties using speckle tracking analysis like frame rates/s, tracing of 
endocardial border, region of interest and non-valid tracking. Speckle tracking analysis is 
always offline. Therefore, frame rate should be at least 40 frames/s to allow for reliable 
operation of software. The endocardial border should be manually traced and the region-of-
interest width should be manually adjusted to include the entire myocardium if necessary. 
Segments of poorly tracked (non-valid tracking) should be rejected which allows the user to 
over-ride automatic software assessments. Despite these technical issues, speckle tracking is a 
reliable tool to assess LV dyssynchrony in experienced hands. 
 
Clinical application of using speckle tracking  
Non-response is an important and unresolved issue in CRT. In this study we demonstrated 
that speckle tracking analysis at follow-up is one of the methods to assess efficacy of CRT, 
and can be further helpful to discriminate those with and without response to CRT. The most 
important benefit of speckle tracking analyzing during follow-up is recognizing of ‘non-
responders’ who require possible more intensive monitoring. Moreover, the effect of AV/VV 
delay optimization in non-responders can be evaluated by speckle tracking analysis to see 
whether the extent of LV dyssynchrony decreases after optimization. Speckle tracking has 
been used prior to implantation to determine the latest activation segments for implantation of 
left ventricular lead [16]. Speckle tracking has also the potential to be used during the 
implantation to guide the location of left ventricular lead in order to measure the acute 
response to CRT. This simultaneous speckle tracking analyzing may minimize the non-
responders rate in CRT patients. However, this needs to be investigated in prospective study.  
 
Limitations 
The present study is a retrospective analysis of a large single-center cohort of consecutive 
patients treated with CRT. We realize that retrospective analysis is inferior to prospective 
investigations with pre-specified endpoints and cut-off values. The data were, however, 
collected systematically by independent physicians. Furthermore, echocardiograms were 
analyzed and validated by independent cardiologists. In this study, we focused on 
echocardiographic response to CRT rather than clinical response due to small numbers of 
clinical events. Intra-class correlation coefficient for reproducibility of LV dyssynchrony was 
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not excellent in our cohort and variability in assessment of dyssynchrony is one of the most 
common problems in echocardiography. Non-response to CRT is probably not solely due to 
insufficient patient selection. Suboptimal LV lead placement must also be considered. 
However, there were no differences between responders and non-responders regarding the 
location of LV lead. Also unfavorable pacemaker settings can contribute to non-response to 
CRT. Unfortunately we were not able to perform systematically echo-guided optimization 
after device implantation. 
 
 
CONCLUSION 
 
We assessed the changes in the extent of LV dyssynchrony using maximal delay between six 
segments in 4-chamber view measured with time-based speckle tracking longitudinal strain. 
This LV dyssynchrony parameter showed a pronounced reduction in the extent of LV 
dyssynchrony in responders and significant increase in non-responders to CRT. Furthermore, 
the reduction of LV dyssynchrony was independently and significantly associated with 
response to CRT.  
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ABSTRACT 
 
Aim: Septal rebound stretch (SRSsept) reflects an inefficient deformation of the septum 
during systole and is a potential new echocardiographic tool to predict response to Cardiac 
Resynchronization Therapy (CRT). However, there are only limited data on the potential 
predictive value of SRSsept on echocardiographic response. We evaluated the predictive 
value of SRSsept on echocardiographic response to CRT in a large population. 
Methods and results: A total of 138 consecutive patients with functional class II−IV heart 
failure who underwent CRT were studied. Echocardiography was performed at baseline and 
after a mean follow-up period of 22±8 months. Echocardiographic response to CRT was 
defined as a reduction in LV end-systolic volume >15%. Receiver operating characteristic 
curve analysis was performed to define the optimal cut-off value for SRSsept. Multivariable 
analyses were performed to adjust for potential confounders. 
Mean age was 68±8 years (30% female). Mean baseline LV ejection fraction was 26±7%, 
51% had ischemic etiology. LBBB or LBBB like morphology was present in 95% of patients. 
Mean SRSsept was 4.4±3.2%, 56% of patients had SRSsept >4%. Ninety-six patients (70%) 
were echocardiographic responders. Baseline SRSsept was significantly higher in responders 
compared to non-responders (5.1±3.2 vs 3.0±2.7, p<0.001). The optimal cut-off value for 
SRSsept to predict response to CRT was 4.0%. After both univariate (OR 3.74, 95% CI 
1.72−8.10) and multivariate analyses (OR 3.71, 95% CI 1.49−9.2), baseline SRSsept >4% 
independently predicted the response to CRT. 
Conclusions: Baseline septal rebound stretch is independently associated with 
echocardiographic response to CRT.  
 
 
INTRODUCTION 
 
Cardiac resynchronization therapy (CRT) has proven effectiveness in the treatment of severe 
heart failure, improving symptoms and quality of life as well as decreasing mortality in a 
majority of treated patients [1−5]. Unfortunately, CRT is ineffective in 30−40% of patients 
and in some cases it can even worsen symptoms [6]. Several echocardiography techniques 
have been used to aid in patient selection for CRT prior to implantation with promising results 
in observational single-center trials. However, no ideal echocardiographic approach for the 
assessment of dyssynchrony has yet been found. The largest prospective trial (PROSPECT) 
[7] showed poor predictive value of several conventional and tissue Doppler-based 
echocardiographic methods. In recent years, 2D-speckle tracking echocardiography has been 
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used to assess left ventricular (LV) dyssynchrony with inconsistent results [8−11]. These 
time-based mechanical LV dyssynchrony measurements did however not take into account 
the inefficient regional myocardial deformation during systole, which can be reverted by 
CRT. Stretching in the septum during systole can be echocardiographically quantified by 
Septal Rebound Stretch (SRSsept) and is a novel measure for inefficient septal deformation. 
Although SRSsept has the potential to predict CRT response, only few studies have been 
performed [12−14]. Moreover, these studies were small sized and had methodological 
limitations. The aim of our current study was to assess the predictive value of SRSsept on 
echocardiographic response to CRT in a large study population. 
 
 
METHODS  
 
Selection of patients 
From January 2008 to December 2009, 160 consecutive patients with chronic heart failure 
(New York Heart Association functional class II−IV), LVEF <35% and wide QRS complex 
>120 ms who were scheduled for CRT, were included in the present study. Patients with pre-
existent pacemaker or ICD implantations were excluded in order to avoid chronic RV pacing 
which may affect the assessment of SRSsept. Also patients with a recent myocardial 
infarction (<3 months) or decompensated heart failure were excluded. Etiology was 
considered ischemic in the presence of significant coronary artery disease (>50% stenosis in 
one or more of the major epicardial coronary arteries) and/or history of myocardial infarction 
or prior revascularization by PCI or CABG. 22 patients with poor echocardiographic window 
at baseline were excluded from the analysis (Figure 1). All patients were on optimal medical 
therapy, including angiotensin-converting enzyme inhibitors and beta-blockers. This 
prospective registry was approved by the institutional board. Baseline characteristics included 
age, gender, etiology of heart failure, clinical history, medical therapy, NYHA functional 
class, ECG and procedural data were collected prospectively and analysed retrospectively. 
Routine follow-up visits were scheduled at 2 months post implant, and then every 6 months 
thereafter. The routine follow-up in some of our patients took place in referring hospitals. The 
clinical status of all survivals at the closure of the study (December 2013) was verified. Data 
on mortality and hospitalization were collected from reviewing our hospital records, referring 
hospitals and by contacting general practitioners.  
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The study protocol and echocardiographic data acquisition 
All patients underwent two-dimensional echocardiography prior to biventricular ICD 
implantation and at follow-up in the second year after CRT implantation. The images were 
obtained on a Vivid 7 ultrasound machine (General Electric, Milwaukee, WI) using a 3.5 
MHz transducer at a depth of 16 cm in the parasternal (long-and short axis) and apical (2- and 
4-chamber) views. The images were stored in cine-loop format by well-trained 
echocardiographists and reviewed by an independent cardiologist who was not involved in the 
study. The left ventricular end-diastolic diameter (LVEDD), left ventricular end-diastolic 
volume (LVEDV), left ventricular end-systolic diameter (LVESD) and left ventricular end-
systolic volume (LVESV) were measured and the LVEF was calculated using Simpson’s 
technique [15].  
 
LV dyssynchrony measurement with Septal Rebound Stretch (SRSsept) 
The analysis was performed using EchoPac version 7.0.1, General Electric. The acquisition of 
the 2D images was performed with at least 40 fps to allow for proper speckle tracking 
analysis off line. The analysis was performed by a blinded cardiologist to whom only gray-
scale imaging of the septal wall and aortic flow recordings was available. Longitudinal 
speckle tracking technique was used to assess the deformation in the septal wall. The region 
of interest was set along the endocardial border from the base to the apex, excluding the 
 
Figure 1. Flowchart of study population. 
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apical cap, and adapted to match the wall thickness and checked visually and adjusted if 
necessary. Global wall deformation (i.e., calculated over the entire length of the wall) was 
used for analysis. SRSsept was defined as the cumulative amount of systolic stretch after 
prematurely terminated shortening in septum (Figure 2). The effective septal shortening was 
defined as the end-systolic (i.e., at aortic valve closure) value of deformation.  
Furthermore, we used the inter-ventricular mechanical delay (IVMD) to assess the 
interventricular mechanical dyssynchrony as it has been reported by previous study [7] as a 
predictor of response to CRT, however, with low sensitivity and specificity.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Example of septal rebound stretch (SRSsept) measurement. Global longitudinal deformation 
measured over the entire length of the septum is represented by the dash white lines. Negative slope of 
the deformation curve indicates shortening, positive slope indicates stretching. Systolic stretch that 
occurs after initial shortening defines systolic rebound stretch. If more than 1 episode of stretch occurs, 
the absolute amount of stretch is summed to calculate systolic rebound stretch. In this patient with high 
amount of SRSsept, systolic shortening is interrupted early during systole, resulting in prominent 
systolic stretching. Note that stretching and shortening occurring after AVC ( aortic valve closure) are 
ignored for rebound stretch measurement. 
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The off-line analyses were performed on digitally stored images by an independent observer 
(A.G.) blinded to the clinical and other echocardiographic information. All SRSsept measures 
were additionally performed by another independent, well trained, and experienced 
cardiologist (P.P.D.). Furthermore, these measurements were repeated by the first observer, in 
order to assess inter-observer and intra-observer variability. Inter-observer and intra-observer 
variability were expressed as standard error of measurement (SEM). 
 
Echocardiographic response to CRT 
Response to CRT was defined as a reduction of >15% in LVESV compared to baseline 
echocardiographic measurement, at the second year of echocardiographic follow-up [7,11].  
 
Statistical analysis  
Continuous variables are expressed as mean±SD and a non-parametric Mann-Whitney U-test 
was used to analyze differences between groups. Categorical variables are presented as 
number and percentages and the Chi-squared test was used to analyze differences between 
groups. Paired observations (observations of the same variable at different time points) were 
analyzed using the non-parametric Wilcoxon test. Logistic regression analysis was performed 
to identify whether SPSsept and IVMD predicted echocardiographic response. In the 
multivariate logistic regression analyses baseline SRSsept as continuous variable and as 
dichotomized variable defined by the optimal cut-off value, as well as IVMD were analyzed 
separately after adjustment for clinical variables (age, gender, LVEF, QRS width, 
LBBB/RBBB, ischemic/non-ischemic cardiomyopathy). Receiver operating characteristic 
curve analysis was performed to find the optimal cut-off value for baseline SRSsept to predict 
echocardiographic response. In subsequent analyses, SRSsept was analyzed as a continuous 
variable and as a dichotomous variable as defined by the optimal cut-off value. In all analyses 
p values of <0.05 were considered statistically significant. Statistical analysis was performed 
using SPSS statistical software (IBM Corp. Released 2011. IBM SPSS Statistics for 
Windows, Version 20.0. Armonk, NY: IBM Corp.).   
 
 
RESULTS 
 
Baseline characteristics 
Of the 160 patients initially included, 22 patients were excluded due to poor 2D image 
quality. Therefore, 138 patients were eventually analyzed. The baseline characteristics of 
study population according to echocardiographic response are summarized in Table 1. Mean 
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age was 68±8 years with 70% male gender. 59% had functional class 3 heart failure. Mean 
QRS duration was 164±23 ms with 95% LBBB or LBBB like morphology and mean EF was 
26±7% with 51% ischemic etiology. Echocardiographic follow-up was performed at 22±8 
months. According to the predefined criterion of a reduction in LVESV >15%, 96 (70%) 
patients were classified as responders to CRT and 42 (30%) as non-responders. 30 of 42 
(71%) non-responders had an ischemic cardiomyopathy. All patients had optimized medical 
therapy, including angiotensin-converting enzyme or angiotensin-receptor antagonist (86%), 
beta-blockers (85%), diuretics (80%) and spironolactone (44%) at maximally tolerated 
dosages. 
 
Echocardiographic analysis 
LV dyssynchrony indices were analyzed at baseline and at mean follow-up of 22±8 months. 
During analysis of SRSsept, 828 segments were evaluated and only 3% of segments were 
excluded from analysis due to non-valid tracking. The inter- and intra-observer variability for 
SRSsept was assessed in 20 randomly selected patients. The standard error of measurement 
(SEM) for the inter-observer variability was 0.67. The SEM for the intra-rater variability was 
1.04. 
 
Effects of CRT on echocardiographic parameters 
During the follow-up, responders showed a significant reduction in end- systolic and diastolic 
LV volumes compared with non-responders (LVESV in responders reduced from 108±48 ml 
to 60±33, p<0.001 and in non-responders from 111 ml ±43 to 120 ml ±41, p=0.1). 
Furthermore, a significant improvement in LVEF was noted in responders compared with 
non-responders (from 26% ±7 to 45% ±10, p<0.001 and from 25% ±6 to 26% ±6, p=0.25, 
respectively). 
 
Effects of CRT on clinical outcome 
Clinical outcome was assessed after a mean follow-up of 57±12 months. During follow-up 32 
combined clinical events occurred. 20 patients died 11/42 (26.2%) in non-responders group 
and 9/96 (9.4%) in responders (p=0.010). Due to worsening of heart failure, 20 patients were 
hospitalized (11 in non-responders group and 9 in responders, p=0.010). Eight patients who 
died were also hospitalized due to heart failure during follow-up. In the entire population a 
significant improvement in clinical status was noted, with a reduction in NYHA functional 
class from 2.6±0.5 to 1.78±0.71 (p<0.001). The NYHA class during follow-up in the 
responder group was 1.7±0.7 and in the non-responder group was 2.0±0.6 (p=0.03). 
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Table 1. Baseline characteristics of study population according to echocardiographic response to CRT  
 
 All patients  
(n=138) 
Non-responders 
(n=42; 30%) 
    Responders 
    (n=96; 70%) 
p  
value 
Age (years)   68±8   70±9   67±8   0.05 
Male gender    70%   69%   70%   0.93 
Ischemic    51%   71%   43%   0.002 
Non-ischemic    49%   29%   57%  
Atrial fibrillation    23%   24%   23%   0.90 
Sinus rhythm    77%   76%   77%  
LBBB or LBBB like morphology    95%   93%   97%   0.37 
RBBB      5%     7%     3%  
QRS duration (ms) 164±23 159±20 167±23   0.05 
NYHA functional class  2.6±0.5  2.6±0.5  2.6±0.5   0.83 
LVEF (%)   26±7   25±6   26±7   0.52 
LV end-diastolic volume (ml) 147±56 150±54 146±57   0.47 
LV end-systolic volume (ml) 109±46 111±43 108 ±48   0.47 
Systolic blood pressure (mmHg) 123±18 121±19 124±17   0.20 
Diastolic blood pressure (mmHg)   73±11   72±10   73±11   0.36 
Medication use     
     Diuretics    80%   91%   75%   0.04 
     Beta-blocker    85%   83%   85%   0.75 
     Ace-inhibitors or AT II    86%   85%   87%   0.69 
     Spironolacton    44%   55%   40%   0.10 
SRSsept (%)   4.4±3.2   3.0±2.7   5.1±3.2 <0.001 
IVMD (ms)  43.4±25.5 35.9±21.6 47.2±26.7   0.045 
Position of  LV lead      0.814 
      Posterior/postero-lateral    67%   64%   69%  
      Lateral   22%   21%   22%  
      Midcardiac vene     4%     5%     4%  
      Epicardial     7%   10%     5%  
 
Abbreviations: LVEF, left ventricular ejection fraction; LVEDD, left ventricular end-diastolic diameter; LVESD, left 
ventricular systolic diameter; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; 
SRSsept, systolic rebound stretch in septum; IVMD, inter-ventricular mechanical delay. 
 
 
 
 
Baseline SRSsept and response to CRT 
The cumulative amount of systolic stretch after prematurely terminated shortening in septum 
could be quantified in 97% of patients. As displayed in Table 1, the baseline value of SRSsept 
in non-responders and responders was significantly different (3.0% ±2.7 vs 5.1% ±3.2, 
respectively, p<0.001). Receiver operating characteristic curve analysis was performed to 
define the optimal cut-off value for SRSsept to predict the echocardiographic response. The 
area under the curve for SRSsept was 0.70 (CI 0.59−0.80), and the optimal cut-off value to 
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predict response to CRT was >4%, yielding a sensitivity and specificity of, respectively, 66% 
and 66% (Figure 3). When patients divided in two groups according to SRSsept >4% versus 
<4%, 56% of patients had SRSsept >4%. Furthermore, SRSsept <4% was more common in 
male gender and in patients with ischemic cardiomyopathy. SRSsept >4% was more common 
in patients with wider QRS duration (Table 2). In univariate and multivariate analysis, 
SRSsept >4% independently predicted the response to CRT (Table 3). In univariate analysis, 
the QRS duration and non-ischemic etiology independently predicted the response to CRT. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 3.  ROC curve for responder. Receiver operating characteristics curves for SRSsept with reverse 
remodelling as outcome. AUC, area under the curve. 
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Table 2. Baseline characteristics of study population according to SRSsept  ≥4% vs <4% 
 
 All patients  
(n=138) 
SRSsept  
<4%  
(n=59; 44%) 
 SRSsept  
 ≥4% 
(n=76; 56%) 
p 
 value 
Age (years)   68±8   67±9   69±8   0.226 
Male gender    70%   80%   62%   0.026 
Ischemic    51%   63%   42%   0.018 
Non-ischemic    49%   37%   58%  
Atrial fibrillation    23%   27%   20%   0.312 
Sinus rhythm    77%   73%   80%  
LBBB or LBBB like morphology   95%   93%   97%   0.236 
RBBB      5%     7%     3%  
QRS duration (ms) 165±23 156±23 171±20 <0.001 
NYHA functional class  2.6±0.5  2.6±0.5  2.6±0.5   0.885 
LVEF (%)   26±7   27±7   25±7   0.219 
LV end-diastolic volume (ml) 147±56 146±56 148±57   0.912 
LV end-systolic volume (ml) 109±47 107±46 110±47   0.776 
Systolic blood pressure (mmHg) 123±18 125±19 122±17   0.422 
Diastolic blood pressure (mmHg)   73±11   72±12   73±10   0.455 
 
All abbreviations explained in Table 1. 
 
 
 
Table 3. Uni- and multivariate predictors of response to CRT by logistic regression analysis 
 
 Univariate analysis       Multivariate analysis a  
 Odds 
ratio 
95%CI 
 
p value  Odds 
ratio 
95%CI 
 
p value 
Age 0.96 0.92−1.01 0.082     
Male gender 1.04 0.47−2.27 0.930     
Non-ischemic etiology 3.35 1.53−7.33 0.002     
QRS duration (ms) 1.02 1.00−1.04 0.049     
LBBB versus RBBB 2.32 0.45−12.0 0.317     
LVEF (%) 1.03 0.97−1.08 0.349     
SRSsept % 1.31 1.12−1.54 0.001  1.38 1.13−1.70 0.002 
SRSsept (>4% vs <4%) 3.74 1.72−8.10 0.001  3.71 1.49−9.22 0.005 
IVMD 1.02 1.00−1.04 0.033  1.01 0.98−1.03 0.582 
 
All abbreviations explained in Table 1. 
a Predictors analyzed separately after adjustment for age, gender, QRS duration, EF at baseline, LBBB/RBBB and 
ischemic/non-ischemic etiology. 
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DISCUSSION  
 
In this study with the largest study population until now, we demonstrated a strong and 
independent association between baseline SRSsept and echocardiographic response to CRT. 
These findings are in line with previous small studies, and possibly this will be an important 
new echocardiographic tool in predicting response to CRT.  
Speckle tracking imaging technique provides information on deformation of certain segments 
of the myocardial wall. The timing of maximum deformation of a certain segment of the 
myocardial wall has been used to assess the LV dyssynchrony. This method, also known as 
time-based index, has been studied to predict the response to CRT. These studies 
demonstrated, however, conflicting results regarding the value of time-based radial and 
longitudinal dyssynchrony indices in prediction of CRT response [8,9,11,16−20]. In the 
EchoCRT trial [21], studying potential benefit of CRT in patients with chronic heart failure 
and narrow QRS, several echocardiographic techniques including radial strain (time-based 
index) did not predict mortality after either CRT or no CRT. One of the plausible reasons that 
these time-based indices failed to predict reverse remodelling after CRT is that these indices 
look only to the timing of maximum deformation of a certain segment and do not provide 
information about stretching (push away) of another segment at the same time [14].  
 
It is important to stress that septal rebound stretch (SRSsept) measurement, performed by 
longitudinal speckle tracking analyses, does not look at the timing of deformation. However, 
SRSsept is based on the amount of stretch in the septal wall after the initial contraction during 
systole [12]. SRSsept selectively measures the amount of systolic stretch that occurs after 
early shortening and disregards the systolic pre-stretching and post-systolic shortening, both 
are inefficient deformations associated with the delayed activated segments. SRSsept assesses 
the amount of dyssynchrony-related wasted energy that can be recruited by CRT. Conversion 
of SRSsept into shortening is one of the primary working mechanisms through which CRT 
improves ventricular function [12]. The value of baseline SRSsept in predicting long-term 
prognosis, improvement in LV remodelling and neurohormonal activation after implantation 
of CRT device has been recently demonstrated [13]. Furthermore, SRSsept rather than time 
delay indices provided significant incremental value over clinical characteristics in prediction 
of CRT response [14]. In the current study baseline SRSsept independently predicted the 
echocardiographic response to CRT. Our study, as far as we can ascertain, is the largest study 
with 138 included patients with echocardiographic follow-up in all patients at a mean of 22±8 
months and provides further evidence for the predictive value of SRSsept in response to CRT. 
Definition of response to CRT is still a matter of debate. In the present study, we assessed LV 
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reverse remodelling as response to CRT after a mean 2-year follow-up. Previous study 
(REVERSE study) showed that the maximal amount of functional and LV remodelling 
improvements was reached at 2 years following CRT and these improvements sustained in 5-
year follow-up [22]. Therefore, we used the available echocardiograms at 2 years following 
the implantation to define the echocardiographic response to CRT. The most optimal cut-off 
value of SRSsept for predicting response to CRT can be questioned. A previous study [13] 
used a baseline SRSsept of >4.7% in predicting survival without heart transplantation or 
assist device. However, they did not report sensitivity and specificity of the SRSsept. In our 
study the area under the curve for SRSsept was 0.70 and the optimal cut-off value to predict 
response to CRT was 4% with both a sensitivity and specificity of 66%. We acknowledge that 
sensitivity and specificity are not high and it may be a limitation for SRSsept as dyssynchrony 
index.  
 
Clinical application of SRSsept 
Non-response is an important and unresolved issue in CRT. The costs and potential 
procedure-related complications of CRT underline the importance of identifying CRT non-
responders. Although current patient selection guidelines for CRT utilize QRS width as a 
surrogate for dyssynchrony, the results of our study support the additional value of SRSsept. 
Based on our study, a cut-off value of SRSsept >4% can be used, but future studies should 
confirm our findings.  
 
 
LIMITATIONS 
 
The present study is a retrospective analysis of prospective registry of a large single-center 
cohort of consecutive patients treated with CRT. We realize that retrospective analysis is 
inferior to prospective investigations with prespecified endpoints and cut-off values. The data 
however was collected systematically and longitudinally by independent physicians. 
Furthermore, echocardiograms were analyzed and validated by independent cardiologists. 
Although measurement variability might have been negatively influenced by the inclusion of 
patients with atrial fibrillation, the current study population most closely resembles daily 
practice. Strain measurement is sensitive to acute change in load and the calculations for 
SRSsept require measurements of timing of aortic valve closure to define end-systole. 
However, these measurements were at different times potentially different loading conditions 
and heart rates from which the LV images were acquired. Thus, the marking of the end-
systolic phase may add a source of potential error to the measurements of SRSsept. Non-
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response to CRT is probably not solely due to insufficient patient selection. Suboptimal LV 
lead placement must also be considered. However, there were no differences between 
responders and non-responders regarding the location of LV lead in our study population. 
Also unfavorable pacemaker settings can contribute to non-response to CRT. Unfortunately, 
we were not able to perform echo-guided optimization after device implantation.  
 
 
CONCLUSION 
 
We demonstrated that stretch-based assessment of LV dyssynchrony measured with SRSsept 
was able to predict echocardiographic response to CRT. These findings indicate that baseline 
SRSsept >4% helps identifying potential CRT responders.  
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ABSTRACT 
 
Purpose: Identification of patients who will benefit from cardiac resynchronization therapy 
(CRT) is challenging. ‘Apical rocking’ is frequently observed in asynchronously contracting 
ventricles and small studies suggested that it may predict CRT response. We assessed the 
predictive value of  LV apical rocking on echocardiographic and clinical response to CRT in a 
large cohort of patients treated with CRT. 
Methods: Echocardiography was performed in 137 consecutive patients prior to CRT, and 
repeated during follow-up. Apical rocking was defined as motion of the left ventricular (LV) 
apical myocardium perpendicular to the LV long axis. Echocardiographic response to CRT 
was defined as a reduction in LV end-systolic volume >15% and clinical response as survival 
without heart failure hospitalization. All echocardiograms were assessed by independent 
cardiologists, blinded for baseline, clinical and follow-up data. Multivariable analyses were 
performed to adjust for potential confounders. 
Results: Mean echocardiographic and clinical follow-up was 22±8 and 57±12 months, 
respectively. Apical rocking was present in 49% of the patients. Apical rocking was more 
common in females, younger patients, and in patients with non-ischemic cardiomyopathy. 
Echocardiographic response to CRT was observed in 69%, clinical response in 77% of the 
patients. Apical rocking was associated with both echocardiographic response (OR 10.77, 
95%CI 4.12−28.13) and clinical response to CRT (HR 2.73, 95%CI 1.26−5.91). Also, after 
multivariable analyses, apical rocking was associated with both echocardiographic (OR 9.97, 
95%CI 3.48−28.59) and clinical response to CRT (HR 2.13, 95%CI 0.94−4.83).  
Conclusions: Apical rocking is independently associated with both echocardiographic and 
clinical response to CRT. 
 
 
INTRODUCTION 
 
Cardiac resynchronization therapy (CRT) reduces symptoms, morbidity and mortality and 
improves cardiac function in the majority of patients with symptomatic heart failure and 
reduced left ventricular ejection fraction (LVEF <35%) with wide QRS (>120 ms) [1−5]. 
However, indication for CRT based on left ventricular ejection fraction (LVEF) and QRS 
duration, results in 30–40% of non-responders and even worsening of cardiac function in 
some patients [6,7].The challenges of correctly identifying patients who will benefit from this 
costly therapy, however, remains. One of the factors which may influence the likelihood of 
response to CRT is lack of presence of baseline left ventricular dyssynchrony. The definition 
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and evaluation of LV dyssynchrony are still subject to debate. Different echocardiographic 
parameters, including speckle tracking, have been proposed to identify potential CRT 
responders, without consensus on the predictive value of any of these parameters [8−13]. In 
the past 2−3 years, left ventricular apical rocking has been introduced as a new parameter for 
the assessment of left ventricular dyssynchrony [14,15]. A short initial septal contraction 
within the isovolumic contraction period results in a short inward motion of the septum and 
causes the apex to move septally. The delayed activation of the lateral wall then pulls the apex 
laterally during the ejection time while stretching the septum. This typical motion pattern of 
the apex of left ventricle is described as ‘apical rocking’. Only few studies have assessed the 
value of apical rocking in predicting CRT response [14,15]. Moreover, these studies were 
small sized and described only echocardiographic CRT response. The aim of our current 
study was to assess the independent predictive value of apical rocking on echocardiographic 
and long-term clinical response to CRT in a large study population. 
 
 
METHODS  
 
Selection of patients and data collection 
From January 2008 to December 2009, 160 consecutive patients with chronic heart failure 
(New York Heart Association functional class II−IV), depressed left ventricular ejection 
fraction (LVEF) <35% and wide QRS complex >120 ms who were scheduled for CRT were 
included in the present study. Patients with pre-existent pacemaker or ICD implantations were 
excluded in order to avoid chronic RV pacing which may affect the assessment of apical 
rocking. All patients were on optimal medical therapy, including angiotensin-converting 
enzyme inhibitors and beta-blockers. Patients with a recent myocardial infarction <3 months 
or decompensated heart failure were excluded. Etiology was considered ischemic in the 
presence of significant coronary artery disease (>50% stenosis in one or more of the major 
epicardial coronary arteries) and/or history of myocardial infarction or prior revascularization 
by PCI or CABG. Twenty-three patients with poor echocardiographic window at baseline 
were excluded from the analysis. This study is based on a prospective registry and was 
approved by the institutional board. Baseline characteristics included age, gender, etiology of 
heart failure, clinical history, medical therapy, NYHA functional class, ECG and procedural 
data were collected prospectively and analyzed retrospectively. Routine follow-up visits were 
scheduled at 2 months post implant, and then every 6 months thereafter. The routine follow-
up in some of our patients took place in referring hospitals. The clinical status of all survivals 
at the closure of the study (December 2013) was verified. Data on mortality and 
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hospitalization were collected from reviewing our hospital records, referring hospitals and by 
contacting general practitioners. Furthermore, the Dutch national population registry, which 
keeps records of all deaths, was checked in all patients.  
 
The study protocol and echocardiographic data acquisition  
All patients underwent two-dimensional echocardiography before biventricular ICD 
implantation and at follow-up in the second year after CRT implantation. The images were 
obtained on a Vivid 7 ultrasound machine (General Electric, Milwaukee, WI) using a 3.5 
MHz transducer at a depth of 16 cm in the parasternal (long- and short axis) and apical (2- 
and 4-chamber) views. The images were stored in cine-loop format by well-trained 
echocardiographists and reviewed by an independent cardiologist who was not involved in the 
study. The left ventricular end-diastolic diameter (LVEDD), left ventricular end-diastolic 
volume (LVEDV), left ventricular end-systolic diameter (LVESD) and left ventricular end-
systolic volume (LVESV) were measured and the left ventricular ejection fraction (LVEF) 
was calculated using Simpson’s technique [16].  
 
Visual assessment of LV-apical rocking 
Apical rocking was defined as a short initial septal contraction which results in short inward 
motion of the septum and pulls the apex to the septum and then the delayed activation of the 
lateral wall which pulls the apex laterally during the ejection time while stretching of the 
septum takes place. This definition was used to assess visually the presence of apical rocking. 
The presence of apical rocking was visually assessed in 4-chamber apical view by three 
cardiologists each with more than 6 years of echocardiography experience. All cardiologists 
had only access to the grey scale image loops of the three apical image planes. The 
echocardiographers acquiring images and three cardiologist involved in offline analysis were 
not blinded to some general data like age, sex and QRS duration. But they were blinded to the 
relevant data as medical history and measured LVEF. Inter-observer and intra-observer 
agreement were expressed as kappa coefficients. Values higher than 0.8 are considered as 
excellent, values between 0.6 and 0.8 as good, values between 0.4 and 0.6 as moderate, and 
values below 0.4 as poor agreement.  
 
Endpoints 
Echocardiographic response to CRT was defined as a reduction of >15% in LVESV 
compared to baseline echocardiographic measurement, at the second year of 
echocardiographic follow-up [17,18]. Survival without hospitalization due to worsening of 
heart failure during follow-up was defined as clinical response to CRT. Furthermore, 
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functional status was assessed by independent physicians before CRT and after 57±12 
months. 
 
Power calculation 
For power calculation the assumption was that apical rocking was present in 50% of patients, 
that in 90% of patients with apical rocking echocardiographic response could be observed 
compared to 50% in patients without apical rocking. Furthermore, it was assumed that the 
sensitivity should be 0.6–0.7 and specificity of 0.8–0.9.To test whether the sensitivity is 
different from 0.5, a minimum of 134 patients would be needed (at a power of 0.9 and a 5% 
alpha). Furthermore, to test whether the specificity is different from 0.5, a minimum of 77 
patients would be needed (at a power of 0.9 and an alpha of 5%). 
 
Statistical analysis 
Statistical analysis was performed using SPSS statistical software (IBM Corp. Released 2011. 
IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp.). Continuous 
variables are expressed as mean±SD and significance of differences are calculated using the 
non-parametric Mann-Whitney U-test. Categorical variables are presented as number and 
percentages and significance of differences between groups was calculated using the Chi-
squared test. Significance of differences between paired observations (observations of the 
same variable at different time points) were analyzed using the non-parametric Wilcoxon test. 
Logistic regression analysis was performed to estimate the association between apical rocking 
and echocardiographic response. Clinical variables (age, gender, LVEF, QRS width, 
LBBB/RBBB, ischemic/non-ischemic cardiomyopathy) were entered into the logistic 
regression analysis as confounders. Time until long-term clinical outcome (death and/or 
hospitalization) was plotted using Kaplan-Meier estimates, and groups were compared using 
log-rank tests. We performed Cox regression analysis to estimate the association between 
apical rocking and clinical outcome, using the same confounders as for the echocardiographic 
response. p values of <0.05 were considered statistically significant in all analyses. 
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RESULTS  
 
Baseline characteristics 
Of the 160 patients initially included, 23 patients were excluded because of poor image 
quality. Therefore, 137 patients were eventually analyzed (Figure 1). General characteristics 
of study population according to echocardiographic response are summarized in Table 1 and 
according to clinical response are summarized in Table 2. Mean age was 68±8 years with 
70% male gender. 59% had functional class 3 heart failure. LBBB was present in 95% of 
patients, mean QRS duration was 164±22 ms and mean EF was 26±7% with 51% ischemic 
etiology. All patients had optimized medical therapy, including angiotensin-converting 
enzyme or angiotensin-receptor antagonist (86%), beta-blockers (85%), diuretics (80%) and 
spironolactone (44%) at maximally tolerated dosages. Echocardiographic and clinical non-
responders had significantly more diuretics, including spironolactone.  
 
Presence of apical rocking  
Apical rocking was present in 49% of patients (68/137). Apical rocking was significantly 
more common in females than in males (63% vs 43%, p=0.03), in patients with non-ischemic 
cardiomyopathy (65% vs 34%, p<0.001) and in younger patients (see Table 3). Almost one 
quarter of patients (23%) had atrial fibrillation at baseline. Apical rocking was present in 50% 
of these patients which was comparable to patients in sinus rhythm.  
 
Figure 1. Proportion of patients with only echocardiographic, clinical and both echo-
cardiographic and clinical response to CRT 
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Table 1. General characteristics of study population according to echocardiographic response to CRT 
 
 All patients  
(n=137) 
Non-responders 
(n=42; 31%) 
 Responders 
 (n=95; 69%) 
p  
value 
Age (years)   68±8   70±9   67±8   0.05 
Male gender   70%   69%   70%   0.93 
Ischemic   51%   71%   43%   0.002 
Atrial fibrillation   23%   24%   23%   0.91 
LBBB   95%   93%   97%   0.37 
RBBB     4.5%     7%     3%  
QRS duration (ms) 164±23 159±20 167±23   0.05 
NYHA functional class  2.6±0.5  2.6±0.5  2.6±0.5   0.83 
EF (%)   26±7   25±6   26±7   0.52 
LV end-diastolic volume (ml) 147±56 150±54 146±57   0.47 
LV end-systolic volume (ml) 109±46 111±43 108±48   0.47 
Systolic blood pressure 
    (mmHg) 
123±18 121±19 124±17   0.20 
Diastolic blood pressure  
    (mmHg) 
  73±11   72±10   73±11   0.37 
Medication use     
     Diuretics   80%   90%   75%   0.04 
     Beta-blocker   85%   83%   85%   0.75 
     Ace-inhibitors/ ARBs   86%   90%   84%   0.34 
     Spironolactone 
 
  44%   55%   40%   0.10 
Position of LV lead      0.814 
     Posterior/postero-lateral    67%   64%   69%  
     Lateral   22%   21%   22%  
     Midcardiac vene     4%     5%     4%  
     Epicardial     7%   10%     5%  
Presence of apical rocking    49%   14%   64% <0.001 
 
Abbreviations: LVEF, left ventricular ejection fraction; LVEDD, left ventricular end-diastolic diameter, LVESD, left 
ventricular end-systolic diameter; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic 
volume. 
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Table 2. General characteristics of study population according to clinical response to CRT 
 
 All patients  
(n=137) 
Non-responders 
(n=32; 23%) 
    Responders 
    (n=105; 77%) 
p value 
Age (years)   68±8   71±8   67±8 0.02 
Male gender   70%   69%   70% 0.90 
Ischemic   51%   63%   48% 0.15 
Atrial fibrillation   23%   25%   23% 0.78 
LBBB   95%   94%   96% 0.63 
RBBB     5%     6%     4%  
QRS duration (ms) 164±23 160±21 166±23 0.16 
NYHA functional class  2.6±0.5  2.6±0.5  2.6±0.5 0.89 
EF (%)   26±7   24±7   26±7 0.10 
LV end-diastolic volume (ml) 147±56 158±69 144±51 0.35 
LV end-systolic volume (ml) 109±46 120±57 106±42 0.27 
Systolic blood pressure 
     (mmHg) 
123±18 117±16 125±18 0.02 
Diastolic blood pressure 
     (mmHg) 
  73±11   70±10   74±11 0.08 
Medication use     
     Diuretics   80%   91%   76% 0.08 
     Beta-blocker   85%   84%   85% 0.94 
     Ace-inhibitors/ARBs   86%   81%   87% 0.44 
     Spironolactone    44%   63%   39% 0.02 
     
Position of LV lead    0.73 
      Posterior/postero-lateral    67%   65%   68%  
      Lateral   22%   21%   22%  
      Midcardiac vene     4%     6%     3%  
      Epicardial     7%     9%     6%  
Presence of apical rocking    49%   28%   55% 0.007 
 
All abbreviations explained in Table 1.  
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Table 3. Characteristics of study population according to presence of apical rocking 
 
Baseline characteristics All  
patients  
(n=137) 
Apical rocking 
present  
(n=68) 
Apical rocking 
absent 
(n=69) 
p value 
Age (years)   68±8   67±8   70±8   0.03 
Male gender   70%   61%   79%   0.03 
Ischemic   52%   36%   67% <0.001 
Atrial fibrillation   23%   24%   23%   0.89 
LBBB   95%   98%   92%   0.21 
RBBB     5%     2%     8%  
QRS duration  >150 (ms) 
QRS  ≤150 ms 
  72% 
  28% 
  78% 
  22% 
  67% 
  33% 
  0.17 
NYHA functional class 2.6±0.5 2.5±0.6 2.6±0.5   0.23 
EF (%)   26±7   26±7   26±7   0.82 
LV end-diastolic diameter (mm)   62±7   62±7   61±7   0.98 
LV end-systolic diameter (mm)   53±8   53±8   53±8   0.67 
LV end-diastolic volume (ml) 147±56 149±61 145±51   0.10 
LV end-systolic volume (ml) 109±46 110±51 108±42   0.86 
 
All abbreviations explained in Table 1. 
 
 
 
 
 
 
Table 4. Uni- and multivariate predictors of echocardiographic response to CRT by logistic regression 
analysis 
                                                 
Variable Univariate analysis   Multivariate analysis a 
Odds 
ratio 
95% CI 
 
p value Odds 
ratio 
95% CI 
 
p value 
Age   0.96 0.92−1.01   0.08     
Male gender   1.04 0.47−2.27   0.93     
Non-ischemic etiology   3.35 1.53−7.33   0.002     
QRS duration (ms)   1.02 1.00−1.04   0.04     
RBBB   0.43 0.08−2.24   0.31     
EF (%)   1.03 0.97−1.08   0.34     
Presence of apical rocking 10.77 4.12 −28.13 <0.001  9.97 3.48 −28.59 <0.001 
 
a After adjustment for age, gender, QRS duration, EF at baseline, LBBB/RBTB and ischemic/non-ischemic etiology. 
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Reproducibility of apical rocking 
To quantify inter- and intra-observer variability for assessment of apical rocking we reviewed 
the total study population by three cardiologists. For inter-observer variability the kappa was 
0.85 and for intra-observer variability the kappa was 0.90. 
 
Apical rocking and echocardiographic response 
All patients were analyzed at baseline and at mean follow-up of 22±8 months. According to 
the predefined echocardiographic criterion of a reduction in LVESV >15%, 95 (69%) patients 
were classified as echocardiographic responders to CRT. 30 of 42 (71%) non-responders had 
an ischemic cardiomyopathy. During follow-up, end-systolic volumes (LVESV) decreased 
significantly in responders, from 108±48 ml to 60±33, p<0.001 and in non-responders there 
was a non-significant increase in LVESV from 111±43 ml to 120±41, p=0.1). Furthermore, 
during follow-up end-diastolic volumes (LVEDV) decreased significantly in responders, from 
146±57 ml to 100±40, p<0.001 and there was a non-significant increase in non-responders 
from 150±54 ml to 158±56, p=0.37). In addition, a significant improvement in LVEF was 
noted in responders compared with non-responders (from 26% ±7 to 45% ±10, p<0.001 and 
from 25% ±6 to 26% ±6, p=0.25, respectively). At baseline, the presence of apical rocking 
between echocardiographic responders and non-responders was significantly different (64% 
versus 14%, p<0.001, see Table 1). In univariate and multivariate analysis, the presence of 
apical rocking was independently associated with echocardiographic response to CRT (Table 
4). The presence of apical rocking predicted the echocardiographic response to CRT with a 
sensitivity of 64% and specificity of 86%. The area under the curve was 0.75 (CI=0.66−0.84). 
The positive predictive value was 91%, the negative predictive value 51%, with an accuracy 
of 71%. 
 
Apical rocking and clinical outcome 
Clinical outcome was assessed after a mean follow-up of 57±12 months. 105 patients (77%) 
who survived without heart failure hospitalization were classified as clinical responders and 
32 patients (23%) who died or were hospitalized with heart failure were classified as clinical 
non-responders to CRT. During follow-up, clinical events occurred in 32 patients (20 patients 
died and 20 were hospitalized due to worsening of heart failure). Eight patients who died were 
also hospitalized due to heart failure during follow-up. In the entire population, a significant 
improvement in functional status was noted, with a reduction in NYHA functional class from 
2.6±0.5 to 1.8±0.7 (p<0.001). The NYHA functional class during follow-up in the clinical 
responder group was 1.7±0.7 vs 2.3±0.6 in the non-responder group (p=0.008). Presence of 
apical rocking between clinical responders and non-responders was significantly different 
(55% vs 28%, p=0.007). Results of both univariate and multivariate analyses of the potential 
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association between apical rocking and clinical response are summarized in Table 5. The 
apical rocking predicted clinical response (survival without heart failure hospitalization) to 
CRT with a sensitivity of 55% and a specificity of 72%. The positive predictive value of 
apical rocking in predicting clinical response was 87% and the negative predictive value was 
33% and the accuracy was 59%. Absence of apical rocking was associated with a higher 
mortality and heart failure hospitalization (Figure 2). 
 
Apical rocking and QRS duration 
We included 137 patients, mean±SD QRS duration was 164±23 ms. In total 126 patients had 
QRS >130 ms and 11 patients QRS <130 ms. The presence of apical rocking was different 
between these 2 groups. In patients with QRS >130 ms 64 (50.8%) patients had apical rocking 
whereas, in patients with QRS <130 ms 3 (27%) patients had apical rocking.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Survival without heart failure hospitalization after CRT in patients with or without LV apical 
rocking. 
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Table 5. Uni- and multivariate predictors of clinical events (death and/or HF-hospitalization) by Cox 
regression analysis 
 
Variable Univariate analysis   Multivariate analysis a 
Hazard 
ratio 
95% CI 
  
p value Hazard 
ratio 
95% CI 
  
p value 
Age 1.05 1.00 −1.10 0.04        
Male gender 0.97 0.46 −2.04 0.92        
Non-ischemic etiology 0.59 0.29 −1.20 0.14        
QRS duration (ms) 0.99 0.97 −1.00 0.16        
RBBB 1.61 0.38 −6.74 0.51        
EF (%) 0.95 0.90− 1.00 0.06        
Presence of apical rocking 0.35 0.16 −0.76 0.008  0.44 0.19 −0.99 0.046 
 aAfter adjustment for age, gender, QRS duration, EF at baseline, LBBB/RBTB and ischemic/non-ischemic etiology. 
 
 
 
DISCUSSION  
 
In the present study we assessed the association of apical rocking with echocardiographic and 
clinical response to CRT. This study showed that apical rocking is independently associated 
with both echocardiographic and clinical response to CRT.  
In the past years, several dyssynchrony indices have been developed to identify patients who 
will respond to CRT with promising results in single center trials. Unfortunately, these indices 
have performed poorly in larger clinical trials, showing high inter-observer variability and 
failing to accurately segregate responders and non-responders to CRT before the implantation 
[7,10,11,13,17−20]. 
 
Apical rocking 
Apical rocking is a typical early septal contraction in patients with left bundle branch block, 
which pulls the apex towards the septum. Delayed activation of the lateral wall pulls then the 
apex laterally during the ejection time while the septum is stretching. Apical rocking can be 
visualized in a standard echocardiographic 4-chamber view in patients with left ventricular 
dyssynchrony. This is in contrast to several dyssynchrony measures, which require well 
trained echocardiographist and special imaging software and techniques. Both regional 
myocardial functional abnormalities (due to scar tissue) and temporal abnormalities (due to 
activation delay) contribute to apical rocking, and thus both are incorporated in a single 
echocardiographic parameter [21,22]. Apical rocking retains important regional information 
on the myocardial contraction sequence [23] and overcomes several limitations of peak 
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velocity parameters and avoids the challenges of myocardial deformation measurements. The 
ability of apical rocking to reflect LV mechanical dyssynchrony has already been 
demonstrated by its superior predictive power for echocardiographic CRT response [14]. 
Previous studies compared a quantitative measurement of apical rocking, defined as the 
percentage of the cardiac cycle with reverse motion of the septum and the apex, with visual 
assessment of apical rocking and demonstrated a comparable accuracy in predicting CRT 
response [14,24]. Therefore, we decided in this study to use only visual assessment, which in 
theory could be more easily assessed. Our study demonstrated that visual assessment of apical 
rocking was feasible and reproducible. Our study, as far as we can ascertain, is the largest 
study with 137 included patients. Additionally, in contrast to previous studies, our study has 
both long-term echocardiographic and clinical follow-up.  
Definition of response to CRT is still a matter of debate. The trials which assessed the value 
of LV dyssynchrony parameters in prediction of CRT response, have used LVESV >15% as 
endpoint and the trials which assessed the clinical benefit of CRT, have used survival without 
heart failure hospitalization as endpoint. In present study, we assessed LV reverse remodeling 
as echocardiographic response to CRT after a mean 2 years follow-up. A previous study 
(REVERSE study) showed that the maximal amount of functional and LV remodeling 
improvements was reached at 2 years following CRT and these improvements sustained in 5 
years follow-up [25]. Younger age, male gender and non-ischemic etiology were associated 
with apical rocking. These parameters are known for their association with CRT response. 
Additionally, apical rocking was still significantly associated with CRT response, after 
correction for these and other clinical variables associated with CRT response.  
 
Atrial fibrillation did not affect the assessment of apical rocking. Presence of apical rocking in 
AF patients was similar to patients in sinus rhythm. In the current study, the presence of 
apical rocking was associated with clinical response to CRT and the absence of apical rocking 
was associated with significantly higher death rates and/or heart failure hospitalization during 
follow-up. As far as we can ascertain, there are no published data on predictive value of apical 
rocking for long-term clinical response to CRT. Our results are the first evidence for 
association of apical rocking and long-term clinical response. One of the major issues in 
assessment of LV dyssynchrony is the applicability of such a dyssynchrony index in daily 
clinical practice. One of the advantages of visual assessment of apical rocking, contrary to 
several dyssyncrony indices, is that it can be assessed relatively easy and is not time 
consuming. One of the disadvantages of apical rocking is that not every patient with classic 
CRT indication shows apical rocking. In our study population, apical rocking was present in 
only 49%, whereas 69% of the study population responded to CRT. In 64% of CRT 
responders, apical rocking was present, which means that 1/3 of patients could not be 
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recognized as potential CRT responders. Although we predefined our endpoints carefully, and 
found a strong association between apical rocking and both echocardiographic and clinical 
response, we realize that our results should be confirmed in large multicenter trials. 
 
Relationship between QRS duration and apical rocking 
A meta-analysis of five randomized trials demonstrated that QRS duration is a powerful 
predictor of the effects of CRT on morbidity and mortality in heart failure patients [26]. One 
of the recent trials, which studied the effects of CRT in patients with QRS <130 ms and LV 
dyssynchrony, demonstrated that CRT in such patients was harmful [27]. However, this trial 
used speckle tracking radial strain to assess LV dyssynchrony. In our study, we demonstrated 
that the presence of apical rocking was different between patients with QRS >130 ms and 
<130 ms. In patients with QRS <130 ms, 3 (27%) patients had apical rocking and 8 (72%) 
patients had no apical rocking. Although these numbers were too small, we observed that the 
majority of patients with QRS <130 ms had no apical rocking. We observed that apical 
rocking was associated with response to CRT and that the majority of patients (8 out of 11) 
with QRS <130 ms did not have apical rocking. Therefore, our results support the existing 
evidence that CRT in patients with QRS <130 ms should not be recommended. To assess the 
real value of apical rocking in patients with QRS <130 ms, future studies with more patients 
should be conducted. 
 
Clinical application of apical rocking 
Visual assessment of apical rocking is relatively easy and is reproducible. Although current 
patient selection guidelines for CRT utilize QRS width as a surrogate for dyssynchrony, the 
results of our study support the additional value of apical rocking. Due to its relatively high 
positive predictive value, the presence of apical rocking is associated with echocardiographic 
and clinical CRT response. Large prospective and multicenter center studies are needed to 
confirm our findings. The future trials should include more patients with QRS <150 ms or 
even <130 ms to assess the value of apical rocking in these patients. 
 
Limitations 
The present study is a prospective registry of a large single-center cohort of consecutive 
patients treated with CRT. We held 137 patients after excluding patients with CRT-P, 
upgrading from other devices to CRT-D, patients who went back to their own hospitals after 
the implantation and patients with poor image quality. We have not performed power 
calculation. Visual assessment of apical rocking may be inferior to measuring of the motion 
and velocities of myocardial walls in mm and cm/s. Since the start of the study, several new 
echocardiographic dyssynchrony indices have been introduced, with particularly calculation 
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of apical transverse motion [15,21]. However, the study by Tournoux et al. [15] compared a 
quantitative measurement of apical rocking, defined as the percentage of the cardiac cycle 
with reverse motion of the septum and the apex, with visual assessment of apical rocking and 
demonstrated a comparable accuracy in predicting CRT response. In order to enhance the 
reliability of visual assessment of apical rocking, a substantial number (n=23) of patients were 
excluded from analysis because of limited acoustic windows. The current study population 
resembles most closely daily practice with inclusion of patients with atrial fibrillation and we 
demonstrated that visualization of apical rocking was not negatively influenced by the 
inclusion of patients with atrial fibrillation. In contrary to most other studies, and because of 
our long-term follow-up, we provided not only echocardiographic outcome measures, but also 
hard clinical endpoints such as all-cause mortality and heart failure hospitalization. Non-
response to CRT is probably not solely due to insufficient patient selection. Suboptimal LV 
lead placement must also be considered. However, care was taken to minimize this risk by 
coronary venogram-guided lead placement and all leads were placed in the posterior or lateral 
region if possible. Unfortunately, we were not able to perform echo-guided optimization after 
device implantation. In the present study the echocardiograms and assessment of apical 
rocking were performed at rest. Recent publication suggested [28], however, that low-dose 
dobutamine stress echocardiography could result in more dyssynchrony and might improve 
the predictive value of apical rocking. 
 
 
CONCLUSION 
 
We demonstrated that apical rocking was, as visually assessed, independently associated with 
echocardiographic and clinical response to CRT. Moreover, when apical rocking was present 
the probability of echocardiographic and clinical response was high. 
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ABSTRACT 
Aim: Correctly identifying patients who will benefit from cardiac resynchronization therapy 
(CRT) is still challenging. ‘Apical rocking’ is observed in asynchronously contracting 
ventricles and is associated with echocardiographic response to CRT. The association of 
apical rocking and long-term clinical outcome is however unkown at present. We assessed the 
predictive value of LV apical rocking on long-term clinical outcome in patients treated with 
CRT. 
Methods and results: Consecutive heart failure patients treated with primary indication for 
CRT-D between 2005 and 2009 were included in a prospective registry. Echocardiography 
was performed prior to CRT to assess apical rocking, defined as motion of the left ventricular 
(LV) apical myocardium perpendicular to the LV long axis. Major adverse cardiac event 
(MACE) was defined as combined endpoint of cardiac death and/or heart failure 
hospitalization and/or appropriate therapy (ATP and/or ICD shocks). All echocardiograms 
were assessed by independent cardiologists, blinded for clinical data. Multivariable analyses 
were performed to adjust for potential confounders. 295 patients with echocardiography prior 
to implantation were included in final analyses. Apical rocking was present in 45% of the 
study patients. Apical rocking was significantly more common in younger patients, females, 
patients with sinus rhythm, non-ischemic cardiomyopathy, in patients with LBBB and wider 
QRS duration. During a mean clinical follow-up of 5.2±1.6 years, 92 (31%) patients reached 
the endpoint of the study (MACE). Patients with MACE had shorter QRS duration, more 
ischemic cardiomyopathy and were more often on Amiodarone. In univariate analyses, 
MACE was associated with shorter QRS duration, ischemic etiology and absence of apical 
rocking. After multivariable analyses, apical rocking was associated with less MACE (HR 
0.44, 95% CI 0.25−0.77).  
Conclusions: Apical rocking is an independent predictor of favorable long-term outcome in 
CRT-D patients. 
 
 
INTRODUCTION  
 
Several clinical trials have demonstrated that cardiac resynchronization therapy (CRT) 
reduces heart failure symptoms, hospitalization and mortality. CRT improves cardiac function 
in the majority of patients with symptomatic heart failure and reduced left ventricular ejection 
fraction (LVEF <35%) with wide QRS (>120−130 ms) [1−4]. However, present guidelines 
for selection of CRT candidates result in 30–40% non-responders and even worsening of 
cardiac function in some patients [5,6]. The challenges of correctly identifying patients who 
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will benefit from this costly therapy therefore remain. One of the factors which may influence 
the likelihood of response to CRT is the lack or presence of left ventricular dyssynchrony. 
The definition and evaluation of LV dyssynchrony are still subject to debate. Different 
echocardiographic parameters have been proposed to identify potential CRT responders, 
without consensus on the predictive value of any of these parameters [7−12]. In the past 
years, left ventricular apical rocking has been introduced as a new parameter for the 
assessment of left ventricular dyssynchrony [13,14]. A short initial septal contraction within 
the isovolumic contraction period results in a short inward motion of the septum and causes 
the apex to move septally. The delayed activation of the lateral wall then pulls the apex 
laterally during the ejection time while stretching the septum. This typical motion pattern of 
the apex of left ventricle is described as ‘apical rocking’. Only few studies have assessed the 
value of apical rocking in predicting CRT response [13−15]. Moreover, these studies were 
small sized and described only echocardiographic CRT response. The aim of our current 
study was to assess the independent predictive value of apical rocking on long-term clinical 
outcomes in a large study population. 
 
METHODS 
 
Selection of patients 
From January 2005 to December 2009, 347 consecutive patients with primary indication for 
CRT-D implantation were included in a prospective registry and followed for a median of 5.2 
years (inter-quartile range [IQR] 4.5−6.5). This registry was approved by the institutional 
review board. Patients were excluded from the analyses if: (1) patients received cardiac 
resynchronization therapy without defibrillation therapy (CRT-P), (2) pre-implantation LVEF 
was >35% according to echocardiographic data, (3) patients had a recent myocardial 
infarction or CABG (<3 months). To be included in the final analysis, the patients were 
required to have an echocardiogram before CRT-D implantation and during follow-up. Based 
on these criteria, a total of 295 patients were included in the analyses (Figure 1). Indication 
for CRT-D implantation was determined according to the guidelines at the time of 
implantation. In all patients, LVEF was <35% and QRS duration was >120 ms because of 
LBBB, RBBB or non-specific intra-ventricular conduction disorders (IVCD). Heart failure 
was diagnosed according to the European Society of Cardiology guidelines and the severity of 
symptoms was categorized into four functional classes as defined by the New York Heart 
association (NYHA) criteria. Etiology was considered ischemic in the presence of significant 
coronary artery disease (>50% stenosis in 1 or more of the major epicardial coronary arteries) 
corresponding with the area of wall motion abnormality, and/or history of myocardial 
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infarction or prior revascularization by PCI or CABG. Medical therapy was optimized to 
reach the highest tolerated dosages of angiotensin-converting enzyme inhibitors and beta-
blockers.  
 
Device implantation 
Cardiac resynchronization therapy devices from all major manufacturers (Medtronic Inc., St. 
Jude Medical, Boston Scientific, Biotronik and Sorin Group) were implanted. The majority of 
coronary sinus leads were bipolar and were positioned in the lateral, posterolateral or 
posterior region when feasible (83%). The anterior and anterolateral positions were 
considered suboptimal and avoided if possible (8%). 9% of left ventricular leads were 
positioned epicardially during open heart surgery prior to CRT-D implantation. After 
implantation, tailored device programming was performed before discharge with three 
consecutive zones in the large majority of patients. A monitor zone between 170−200 
beats/min, anti-tachycardia pacing (ATP) and shock therapy zone between 200−230 beats/min 
and a shock zone >230 beats/min. In the ATP and shock therapy zone, arrhythmias were 
initially attempted to be terminated by two bursts and one ramp and defibrillator shocks were 
used if the arrhythmia continued. Routine follow-up visits were scheduled at 2 months post 
implant, and every 6 months thereafter. As part of usual care, during follow-up, ICD printouts 
were obtained to determine the number and type of arrhythmias and number of appropriate 
and inappropriate shocks. The routine follow-up in some of our patients took place in 
referring hospitals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Flowchart of study population. 
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Data collection 
Baseline characteristics included age, gender, etiology of heart failure, clinical history, 
medical therapy, NYHA functional class. ECG and procedural data were collected 
prospectively and analyzed retrospectively. The clinical status of all patients was verified at 
the closure of the study (December 2013). 
 
Echocardiographic data acquisition  
All patients underwent two-dimensional echocardiography before biventricular ICD 
implantation and at follow-up in the second year after CRT implantation. The images were 
obtained on a Vivid 7 ultrasound machine (General Electric, Milwaukee, WI) using a 3.5 
MHz transducer at a depth of 16 cm in the parasternal (long- and short axis) and apical (2- 
and 4-chamber) views. The images were stored in cine-loop format by well-trained 
echocardiographists and reviewed by an independent cardiologist who was not involved in the 
study. The left ventricular end-diastolic diameter (LVEDD), left ventricular end-diastolic 
volume (LVEDV), left ventricular end-systolic diameter (LVESD) and left ventricular end-
systolic volume (LVESV) were measured and the left ventricular ejection fraction (LVEF) 
was calculated using Simpson’s technique [16]. 
  
Visual assessment of LV apical rocking 
Apical rocking was defined as a short initial septal contraction which results in short inward 
motion of the septum and pulls the apex to the septum and then the delayed activation of the 
lateral wall which pulls the apex laterally during the ejection time while stretching of the 
septum takes place. This definition was used to assess visually the presence of apical rocking. 
The presence of apical rocking was visually assessed in 4-chamber apical view by three 
cardiologists each with more than 6 years of echocardiography experience. All cardiologists 
had only access to the grey-scale image loops of the three apical image planes and were 
unaware of any patient data including information about response to CRT. Inter-observer and 
intra-observer agreement were expressed as kappa coefficients. Values higher than 0.8 are 
considered as excellent, values between 0.6 and 0.8 as good, values between 0.4 and 0.6 as 
moderate, and values below 0.4 as poor agreement. 
 
Event sub-classification and definitions 
Data on mortality were collected from reviewing our hospital records, referring hospitals and 
by contacting general practitioners. Causes of death were categorized into two groups, cardiac 
death and non-cardiac death according to previous study [17]. The cardiac death was further 
categorized into death from ventricular tachyarrhythmia, heart failure-related death and 
sudden cardiac death. Non-cardiac death was further divided in malignancy, infection 
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including sepsis and pneumonia, COPD and aortic dissection. In 2 patients, the cause of death 
was classified as unknown (in 1 patient the family physician was unknown and in another 
patient digital file was not present). 
 
Endpoint 
Major adverse cardiac event (MACE) was defined as the combined endpoint of cardiac death 
and/or heart failure hospitalization and/or appropriate therapy (ATP and/or ICD shocks).  
 
Statistical analysis 
Statistical analysis was performed using SPSS Statistics for Windows, Version 22.0 (IBM 
Corp., Armonk, NY). Continuous variables are expressed as mean±SD and significance of 
differences between independent groups was calculated using the non-parametric Mann-
Whitney U-test. Categorical variables are presented as number and percentages and 
significance of differences between groups were calculated using the Chi-squared test or 
Fisher’s exact test as appropriate. Cox regression analysis was performed to assess the 
association of apical rocking with MACE. Clinical variables (age, gender, LVEF, sinus 
rhythm or atrial fibrillation, QRS width, LBBB/RBBB and ischemic/non-ischemic 
cardiomyopathy) were entered into the Cox regression analysis as confounders. Time until 
MACE was plotted using Kaplan-Meier estimates, and groups were compared using log-rank 
tests. We evaluated the additional value of apical rocking above clinical variables (age, 
gender, LVEF, sinus rhythm or atrial fibrillation, QRS width, LBBB/RBBB and 
ischemic/non-ischemic cardiomyopathy) in prediction of MACE by means of the likelihood 
ratio test. The likelihood ratio test is the difference between the -2 log likelihood of the model 
with and the model without apical rocking which is Chi-square distributed with 1 degree of 
freedom. p values of <0.05 were considered statistically significant in all analyses. 
 
 
RESULTS  
 
Initially 347 patients with prophylactic CRT-D indication were registered in our hospital 
database. In 50 patients echocardiographic evaluation before the implantation was not 
available, in 2 patients the assessment of apical rocking was not possible due to poor image 
quality. Therefore, the study population consisted of 295 patients. Mean age was 67±9 years 
with 30% female gender. Mean NYHA functional class was 2.5±0.6 and 81% had LBBB with 
mean QRS duration of 155±30 ms. Mean LVEF was 24.8% ±6.6, non-ischemic etiology was 
present in 49% of patients. Apical rocking was present in 45% of patients. Apical rocking was 
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significantly more common in younger patients, females, patients with sinus rhythm, non-
ischemic cardiomyopathy, in patients with LBBB and wider QRS duration. All patients were 
on optimal medical therapy for heart failure. General characteristics of total study population 
and according to the presence or absence of apical rocking are summarized in Table 1. 
 
Inter- and intra-observer variability 
To quantify the inter- and intra-observer variability for assessment of apical rocking we 
reviewed 140 (47%) patients by three cardiologists. The inter-observer variability kappa was 
0.85 and intra-observer variability kappa was 0.90. 
 
 
 
 
 
 
Table 1. General characteristics of study population according to apical rocking  
 
 All patients 
(n=295) 
Patients with 
apical rocking 
(n=133) 
Patients without  
apical rocking 
(n=162) 
p value 
Age (years)    67±9   65±10   69±8   0.001 
Female    30%   41%   22% <0.001 
LVEF (%) 24.8±6.6  25.0±6.8  24.7±6.5   0.929 
Sinus rhythm    75%   81%   71%   0.038 
QRS duration (ms) 155±30 164±29 148±29 <0.001 
LBBB    81%   91%   73% <0.001 
RBBB      6%     3%     9%   0.055 
IVCD    12%     6%   18%   0.003 
NYHA functional class  2.5±0.6  2.5±0.7  2.5±0.6   0.637 
Non-ischemic etiology    49%   71%   31% <0.001 
Diuretics   82%   77%   86%   0.044 
Beta-Blocker   82%   85%   80%   0.290 
AT-II receptor blockers   43%   48%   40%   0.137 
ACE-inhibitors   76%   77%   75%   0.782 
Spironolacton   44%    42%   45%   0.611 
 
LVEF, left ventricular ejection fraction; LBBB, left bundle branch block; RBBB, right bundle branch block; 
IVCD, intra-ventricular conduction disorder; NYHA, New York Heart Association. 
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Table 2. Clinical endpoints of the study population according to apical rocking during long-term follow-up 
 
 
All patients 
 
(n=295) 
Patients with 
apical rocking 
(n=133) 
Patients without  
apical rocking 
(n=162) 
p 
value 
Clinical follow-up duration (years)   5.2±1.6   5.5±1.5   5.0±1.6   0.016 
NYHA functional class follow-up 
   (mean±SD) 
  2.0±0.8   1.8±0.8   2.1±0.7   0.003 
LVEF follow-up (%)  
   (mean±SD) 
36.6±12.2 42.8±10.5 31.6±11.2 <0.001 
Percentage biventricular pacing  93.8±13.4 95.3±9.0 92.6±16.2   0.061 
Appropriate ATP therapy   6%   4%   7%   0.181 
Appropriate ICD shock    9%   5% 12%   0.036 
Inappropriate ICD shock  10%   9% 12%   0.451 
All-cause mortality  21% 13% 28%   0.001 
Non-cardiac and unknown  
   cause of death 
10%   8% 12%   0.328 
MACE 31% 19% 41% <0.001 
   Appropriate therapy 
   (ATP and/or shock) 
12%   9% 15%   0.130 
   Heart failure hospitalization  21% 11% 29% <0.001 
   Cardiac death 11%   5% 17%   0.001 
 
ATP, anti-tachy pacing; ICD, implantable cardioverter defibrillator;  MACE, major cardiac adverse event. 
 
 
 
Long-term outcome 
Patients were followed for 5.2±1.6 years and 85.5% completed at least 4 years of follow-up. 
During follow-up, 63 (21%) patients died. In 97% patients the mode of death was obtained, 
52% (33 patients) had a cardiac death. During follow-up, 21% (62/295) of patients were 
admitted to the hospital due to worsening of heart failure. Appropriate CRT-D (ATP or ICD-
shock) intervention occurred in 12% (36/295) of patients and inappropriate CRT-D 
intervention in 10% (31/295) of patients. Total MACE occurred in 31% of the patients (Table 
2). During follow-up, the patients with apical rocking had significantly better NYHA 
functional class, higher LVEF and experienced higher percentage of biventricular pacing 
compared to patients without apical rocking. All-cause mortality was significantly lower in 
patients with apical rocking compared to patients without apical rocking (13% vs 28% 
p<0.001). Furthermore, MACE was significantly lower in patients with compared to patients 
without apical rocking (19% vs 41%, p<0.001), Table 2. 
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Table 3. General characteristics of study population according to MACE 
 
 All patients 
(n=295) 
Patients without 
MACE 
(n=204) 
Patients with 
MACE 
(n=91) 
p value 
Age (years)    67±9   67±9   68±9   0.176 
Female    30%   32%   27%   0.432 
LVEF (%) baseline   24.8±6.6   25.0±6.9   24.3±6.0   0.513 
LVEF (%) follow-up    36.6±12.2   39.5±11.2   30.2±11.8 <0.001 
Sinus rhythm    75%   79%   68%   0.064 
QRS duration (ms) 155±30 159±31 147±27   0.001 
LBBB    81%   81%   82%   0.904 
RBBB      6%     7%     5%   0.590 
IVCD    12%   12%   13%   0.794 
NYHA functional class  2.5±0.6  2.5±0.6  2.6±0.6   0.248 
Non-ischemic etiology    49%   54%   38%   0.013 
Diuretics   82%   80%   86%   0.225 
Βeta-blocker   82%   83%   80%   0.604 
AT-II receptor blockers   43%   43%   43%   0.929 
ACE-inhibitors   76%   75%   77%   0.703 
Spironolacton   44%   42%   47%   0.490 
LV lead position     
  Posterior/poterolateral 204 (69%) 138 (67%)   66 (72%)    NS 
  Lateral   47 (16%)   34 (17%)   13 (14%)    NS 
  Anterolateral/anterior    13 (4%)   10 (5%)     3 (3%)    NS 
  Mid-cardiac vein     8 (3%)     6 (3%)     2 (2%)    NS 
  Epicardial    23 (8%)   16 (8%)     7 (7%)    NS 
  Apical position   89 (33%)   55 (29%)   34 (40%)    NS 
  Non-apical position 183 (67%) 133 (71%)   50 (59%)    NS 
Clinical follow-up duration (years)     5.2±1.6     5.5±1.4     4.6±1.7 <0.001 
NYHA class follow-up (mean±SD)     2.0±0.8     1.9±0.8     2.3±0.7   0.001 
Percentage biventricular pacing    93.8±13.4   95.5±9.8   90.1±18.8   0.005 
Presence of apical rocking   45%   53%    27% <0.001 
 
All abbreviations explained in Table 1. 
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Apical rocking and MACE 
A total of 204 patients (69%) survived without heart failure hospitalization or appropriate 
therapy (ATP and/or ICD shocks). A total of 91 (31%) patients died from cardiac death or 
were hospitalized with heart failure or treated appropriately with ICD, and were classified as 
patients with MACE. Patients with MACE had significantly shorter QRS duration, had more 
ischemic aetiology and were more on amiodarone. Furthermore, NYHA functional class was 
higher and percentage of biventricular pacing was lower compared to patients without MACE 
(Table 3). Presence of apical rocking between the patients with and without MACE was 
significantly different (27% vs 53%, respectively, p<0.001) (Table 3 and Figure 2). Results of 
both univariate and multivariate analyses of the association between apical rocking and 
MACE are summarized in Table 4. In univariate analyses, MACE was associated with shorter 
QRS duration, ischemic aetiology and absence of apical rocking. In multivariate analyses, the 
incidence of MACE was lower in patients with apical rocking (HR 0.44, 95%CI 0.25−0.77, 
p=0.004) and those with shorter QRS duration (HR 0.87, 95%CI 0.79−0.96, p=0.005). The 
value of the likelihood ratio test of the comparison of the model with and the model without 
apical rocking is 8.90 (df=1) with significant p value (p=0.003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
Figure 2. Survival without heart failure hospitalization after CRT in patients with or without LV apical 
rocking. 
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Table 4. Uni- and multivariable predictors of MACE  
 
 Univariable  Multivariable 
 HR 95%CI p value  HR 95%CI p value 
Age (years)  1.02 1.00−1.05   0.086  1.02 0.99−1.05 0.197 
Female 0.79 0.50−1.25   0.317  1.43 0.85−2.39 0.176 
LVEF (%) baseline 0.99 0.96−1.02   0.580  0.98 0.95−1.02 0.364 
Sinus rhythm vs Afib  0.59 0.37−0.93   0.024  0.65 0.37−1.14 0.136 
QRS duration (per 10 ms) 0.91 0.85−0.97   0.005  0.87 0.79−0.96 0.005 
LBBB vs non-LBBB 0.94 0.53−1.68   0.843  0.59 0.31−1.12 0.108 
Non-ischemic etiology 0.58 0.38−0.88   0.010  0.63 0.37−1.07 0.084 
Presence of apical rocking 0.39 0.25−0.62 <0.001  0.44 0.25−0.77 0.004 
    
All abbreviations explained in Table 1. 
 
 
 
Apical rocking in patients with QRS <150 ms 
Sub-analysis of patients with QRS <150 ms identified 108 patients. Apical rocking was 
present in 30% (33) of patients compared to 53% in patients with QRS >150 ms (p<0.001). 
MACE was more common in patients without apical rocking compared to patients with apical 
rocking (49% vs 24%, p=0.015). 
 
Apical rocking in patients with ischemic etiology 
Wall motion abnormalities (scar tissue due to myocardial infarction) were assessed in all 150 
(51%) patients with ischemic etiology. 43% of patients had wall motion abnormalities in the 
anterior or antero-septum segments. Among this group only 3% had apical rocking compared 
to 35% apical rocking in patients without wall motion abnormality in anterior or antero-
septum segments. 
 
 
DISCUSSION  
 
In the present study we assessed the association of baseline apical rocking with major adverse 
cardiac events during long-term follow-up in patients who underwent CRT-D implantation. 
This study showed that the presence of apical rocking before CRT is independently associated 
with a lower incidence of long-term MACE. The significant p value of the likelihood ratio test 
supports the additional value of apical rocking above clinical variables in prediction of long-
term MACE. 
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Apical rocking 
In the past years, several dyssynchrony indices have been developed to identify patients who 
will respond to CRT with promising results in single-center trials. Unfortunately, these 
indices have performed poorly in larger clinical trials, showing high inter-observer variability 
and failing to accurately segregate responders and non-responders to CRT before the 
implantation [6,9,10,12,18−21]. 
Apical rocking is a typical early septal contraction in patients with left bundle branch block, 
which pulls the apex towards the septum. Delayed activation of the lateral wall pulls then the 
apex laterally during the ejection time while the septum is stretching. Apical rocking can be 
visualized in a standard echocardiographic 4-chamber view in patients with left ventricular 
dyssynchrony. This is in contrast to several dyssynchrony indices, which require well trained 
echocardiographist and special imaging software and techniques. Both regional myocardial 
functional abnormalities (due to scar tissue) and temporal abnormalities (due to activation 
delay) contribute to apical rocking, and thus both are incorporated in a single echo-
cardiographic parameter [22,23]. In current study, among the group of patients with scar 
tissue in distal part of septum or antero-septum due to myocardial infarction only 3% had 
apical rocking compared to 35% in patients with scar tissue in other part of LV. It suggests 
that scar tissue in distal part of septum or antero-septum affects the presence of apical 
rocking. Apical rocking retains important regional information on the myocardial contraction 
sequence [24] and overcomes several limitations of peak velocity parameters and avoids the 
challenges of myocardial deformation measurements. The ability of apical rocking to reflect 
LV mechanical dyssynchrony has already been demonstrated by its superior predictive power 
for echocardiographic CRT response [13]. Previous studies compared a quantitative 
measurement of apical rocking, defined as the percentage of the cardiac cycle with reverse 
motion of the septum and the apex, with visual assessment of apical rocking and 
demonstrated a comparable accuracy in predicting CRT response [13,25]. We recently 
published our data on the predictive value of apical rocking in 137 patients and showed the 
association of apical rocking with both long-term echocardiographic response and incidence 
of heart failure [15]. 
 
In the current study, we had a much larger number of CRT patients, which consisted of CRT-
D patients (CRT and defibrillator therapy). We used MACE during long-term follow-up as 
outcome measure. CRT results in positive remodelling of the ventricles, and had beneficial 
effects on cardiac function. This is reflected in both reduction in heart failure symptoms and 
hospitalization, and also a reduction of cardiac mortality and ventricular tachyarrhythmias 
(e.g., appropriate ICD therapy). Therefore, MACE is one of the most robust clinical outcome 
measures reflecting CRT success. The current study, to the best of our knowledge, is the first 
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and largest study which assessed the association between apical rocking and long-term 
MACE. The predictive value of absence of apical rocking has been recently studied in a 
relatively small cohort of CRT patients (n=40) in which absence of apical rocking predicted 
early hemodynamic non-response after 1 month of CRT [14]. One of the major issues in 
assessment of  LV dyssynchrony is the applicability of a dyssynchrony index in daily clinical 
practice. One of the advantages of visual assessment of apical rocking, contrary to several 
other dyssynchrony indices, is that it can be assessed relatively easy and is not time 
consuming. Other indices have lower inter- and intra-observer agreement, even in core 
echocardiographic centers [6]. It seems that there is a relationship between QRS duration and 
presence of apical rocking. In our study population apical rocking was present in 45% of 
patients, while in patients with QRS <150 ms it is 30%. One of the disadvantages of apical 
rocking is that not every patient with classic CRT indication shows apical rocking. In our 
study population, apical rocking was present in only 45% of patients, whereas 70% of the 
study population did not have MACE. However, when apical rocking is present the 
percentage of  MACE during long-term follow-up is only 19% compared to 41% when apical 
rocking was not present. Apical rocking was present in 53% of patients without MACE and in 
27% of patient with MACE.  
 
Clinical implication of apical rocking 
Visual assessment of apical rocking is relatively easy and is reproducible. Although current 
patient selection guidelines for CRT utilize QRS width as a surrogate for dyssynchrony, the 
results of our study support the additional value of apical rocking in prediction of long-term 
MACE. Further prospective and multicenter studies are needed to confirm our findings, 
particularly in patients with QRS duration <150 ms. 
 
Strengths and limitations 
Both the large number of the study population and the long-term clinical follow-up are 
probably the major strengths of the current study. There are also several limitations of this 
study. It concerns a prospective registry of consecutive patients treated with CRT-D in a high 
experienced CRT center. A subgroup analysis is limited by limited numbers in each group. 
Visual assessment of apical rocking may be inferior to measuring of the motion and velocities 
of myocardial walls in mm and cm/s. Since the start of the study, several new 
echocardiographic dyssynchrony indices have been introduced, particularly with calculation 
of apical transverse motion [14,22]. However, the study by Tournoux et al. [14] compared a 
quantitative measurement of apical rocking, defined as the percentage of the cardiac cycle 
with reverse motion of the septum and the apex, with visual assessment of apical rocking and 
demonstrated a comparable accuracy in predicting CRT response. The current study 
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population resembles most closely daily practice with inclusion of patients with atrial 
fibrillation, and we demonstrated that visualization of apical rocking was not negatively 
influenced by the inclusion of patients with atrial fibrillation. A new ischemic event in 
patients with ischemic etiology during long-term follow-up can affect the outcome of the 
patients. Unfortunately, data on new ischemic events in our study population are not 
available, which is an important limitation. Suboptimal LV lead placement must also be 
considered. However, care was taken to minimize this risk by coronary venogram-guided lead 
placement and all leads were placed in the posterior or lateral region if possible. 
Unfortunately, we were not able to perform echo-guided optimization after device 
implantation. In the present study the echocardiograms and assessment of apical rocking were 
performed at rest. A recent publication suggested [26], however, that low-dose dobutamine 
stress echocardiography could result in more dyssynchrony and might improve the predictive 
value of apical rocking. 
 
 
CONCLUSION 
 
We demonstrated that apical rocking was present in 45% of the study population. Apical 
rocking before CRT is independently associated with a lower incidence of long-term MACE.  
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ABSTRACT 
 
Background: The level of improvement in left ventricular ejection fraction (LVEF) in super-
responders to CRT is exceptional. However, the long-term prognosis of these patients is not 
yet known in a large population. We determined predictors and long-term outcome of super-
response to CRT.  
Methods: A cohort of 347 patients with CRT-D as primary prevention were registered. Super-
response was defined by LVEF >50% at follow-up echocardiogram. Best-subset regression 
analysis identified predictors of super-response to CRT. End points were major adverse 
cardiac events (MACE), i.e., all-cause mortality or heart failure hospitalization, cardiac death 
and appropriate ICD therapy during follow-up.  
Results: 56 (16%) patients with LVEF >50% were classified as super-responders to CRT. 
Female gender (OR=3.06 95%CI 1.54−6.05), non-ischemic etiology (OR=2.70 95%CI 
1.29−5.68), higher LVEF at baseline (OR=1.07 95%CI 1.02−1.13) and wider QRS duration 
(OR=1.17 95%CI 1.04−1.32) were predictors of super-response. Cumulative incidence of 
MACE at a median of 5.3 years was 18% in super-responders, 22% in responders and 51% in 
non-responders (p<0.001). None of the super-responders died from cardiac death, whereas 
cardiac death rate was 9% in responders and 25% in non-responders (p<0.001). None of the 
super-responders experienced appropriate ICD therapy, whereas this was 10% in responders 
and 21% in non-responders (p<0.001). In super-responders the adjusted HR for MACE was 
0.37 (95%CI 0.19−0.73) and for total mortality 0.44 (95%CI 0.20−0.95). 
Conclusions: Female gender, non-ischemic etiology, higher LVEF at baseline and wider QRS 
duration were independently associated with super-response to CRT. Super-response to CRT 
was associated with persistent excellent prognosis regarding survival and appropriate ICD 
therapy during long-term follow-up.  
 
Introduction 
Several large clinical trials have demonstrated that cardiac resynchronization therapy (CRT) 
reduces symptoms, mortality, heart failure hospitalization and improved cardiac function in 
the majority of patients with symptomatic heart failure and reduced left ventricular ejection 
fraction (LVEF <35%) with wide QRS (>120 ms) [1−3]. There is, however, wide variability 
in the extent of LV remodelling and improvement in LVEF with CRT. Recent studies have 
indicated that in certain patients, i.e., ‘super-responders’, there is an exceptional improvement 
in LV function after CRT leading to an apparent marked recovery with LVEF >50% and 
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improvement of LVEF associated with reduced heart failure deaths, ICD shocks and 
hospitalization [4−6]; also, previous studies demonstrated an excellent long-term prognosis of 
super-responders [7−12]. However, these studies used different definitions for super-
responders and reported different survival and ICD intervention rates. Furthermore, most 
studies had a relative short follow-up period, and did not assess independent predictors of 
super-response. Therefore, the aims of our study were to identify the patient’s characteristics 
associated with super-response to CRT, and to evaluate the long-term all-cause and cardiac 
death, hospitalization due to worsening of heart failure and appropriate defibrillator 
intervention rate in patients with super-response, in a large cohort. 
 
 
METHODS 
 
Selection of patients 
From January 2004 to December 2009, 433 consecutive patients with primary indication for 
CRT-D implantation were included in registry and followed for median 5.5 years (inter-
quartile range [IQR] 4.5−6.5). This registry was approved by institutional review board. 
Patients were excluded from the analyses if: (1) they had been implanted with cardiac 
resynchronization therapy without defibrillator (CRT-P), (2) when pre-implantation LVEF 
was ≥35% accordin g to echocardiographic data, and (3) the patient had had a recent 
myocardial infarction or CABG (<3 months). In order to be included in the final analysis, the 
patients were required to have an echocardiogram before CRT-D implantation and during 
follow-up. Paired echocardiograms from both baseline and follow-up were not available in 86 
(20%) patients (of these 86 patients, 42 (48%) patients died before follow-up echo-
cardiograms were performed). Therefore, these patients were excluded from the analysis 
(Figure 1). LVEF assessment was made in all baseline and follow-up examinations (mean 
echocardiographic follow-up 2.3 years (IQR 1.4−3.9)) examinations. Patients were divided 
into three groups based on LVEF at follow-up echocardiograms. Patients with LVEF >50% 
were labeled as ‘super-responders’ (n=56), those with LVEF=30−50% as ‘responders’ 
(n=153), and those with LVEF <35% as ‘non-responders’ (n=138) [8]. Indication for CRT-D 
implantation was determined according to the guidelines at time of implantation. In all 
patients, LVEF was <35% and QRS duration was >120 ms because of LBBB, RBBB or non-
specific intra-ventricular conduction disorders (IVCD). Heart failure was diagnosed according 
to the European Society of Cardiology guidelines and the severity of symptoms was 
categorized into four functional classes as defined by the New York Heart association 
(NYHA) criteria. Etiology was considered ischemic in the presence of significant coronary 
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artery disease (>50% stenosis in one or more of the major epicardial coronary arteries) and/or 
history of myocardial infarction or prior revascularization by PCI or CABG. Medical therapy 
was optimized to reach the highest tolerated dosages of angiotensin-converting enzyme 
inhibitors and beta-blockers.  
 
Device implantation 
Cardiac resynchronization therapy devices from all major manufacturers (Medtronic, St. Jude 
Medical, Boston Scientific, Biotronik and Sorin Group) were implanted. The majority of 
coronary sinus leads were bipolar and were positioned in the lateral, posterolateral or 
posterior region when feasible (83%). The anterior and anterolateral positions were 
considered suboptimal and avoided if possible (8%). 9% of coronary sinus leads were 
positioned epicardially, mostly during open-heart surgery prior to CRT-D implantation. After 
implantation, tailored device programming was performed before discharge with three 
consecutive zones in large majority of patients. (1) VT monitor zone between 170−200 
beats/min, (2) VT zone with anti-tachycardia pacing (ATP) and shock therapy between 
200−230 beats/min, and (3) VF zone with ICD shock >230 beats/min. In ATP and shock 
therapy zone, arrhythmias were initially attempted to be terminated by two bursts and one 
ramp and defibrillator shocks were used if the ventricular arrhythmia continued.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Flowchart of study population. 
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Follow-up 
Baseline characteristics included age, gender, etiology of heart failure, clinical history, 
medical therapy, NYHA functional class, ECG and procedural data were collected 
prospectively and analyzed retrospectively. Routine follow-up visits were scheduled at 2 
months post implant, and every 6 months thereafter. As part of routine clinical care during 
follow-up, ICD printouts were checked, ICD treatments were registered and intracardiac 
electrograms (EGM) were classified by device-cardiologist. Appropriate ICD therapy (ATP 
and shocks) was defined as ICD therapy delivered in response to sustained ventricular 
tachycardia or ventricular fibrillation. The routine follow-up in some of our patients took 
place in referring hospitals. The clinical status of all survivals at the closure of the study 
(December 2013) was verified. The baseline echocardiographic data were collected just 
before implantation and follow-up echocardiograms were repeated after 6−18 months and 
usually once per year in the years following implantation. The echocardiogram performed 
between 6 and 18 months after the implantation was used to determine the LVEF response to 
CRT. The echocardiography images were obtained on a Vivid 7 ultrasound machine (General 
Electric, Milwaukee, WI) using a 3.5 MHz transducer at a depth of 16 cm in the parasternal 
(long and short axis) and apical (2- and 4-chamber) views. The images were stored in cine-
loop format by well-trained echocardiographists and reviewed by an independent cardiologist 
who was not involved in the study. The left ventricular end-diastolic diameter (LVEDD), left 
ventricular end-diastolic volume (LVEDV), left ventricular end-systolic diameter (LVESD) 
and left ventricular end-systolic volume (LVESV) were measured, if possible, and the LVEF 
was calculated using Simpson’s technique [13]. 
  
Event sub-classification and definitions 
Data on mortality were collected from reviewing our hospital records, referring hospitals and 
by contacting general practitioners. Furthermore, mortality was assessed by linkage of 
national mortality records with the local hospital database. Causes of death were categorized 
into 2 groups, cardiac death and non-cardiac death according to a previous study [14]. Cardiac 
death was further categorized into death from ventricular tachyarrhythmia, heart failure death 
and sudden cardiac death. Non-cardiac death was further divided in (malignancy, infection 
including sepsis and pneumonia, COPD and aorta dissection). In 5 patients (6%), cause of 
death was classified as unknown (in 2 patients the family physician was unknown; in 3 other 
patients the digital files were not present). 
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Endpoints 
The endpoints were defined as follows: (1) Major adverse cardiac event (MACE) was defined 
as combined all-cause mortality and/or hospitalization due to worsening of heart failure. (2) 
All-cause mortality. (3) Cardiac death. (4) Appropriate ICD therapy. 
 
Statistical analysis 
Statistical analysis was performed using SPSS statistical software (IBM Corp., Released 
2011. IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp.). 
Continuous variables are expressed as mean±SD and significance of differences between the 
three groups were calculated using the non-parametric Kruskal-Wallis test. Categorical 
variables are presented as number and percentages and significance of differences between 
groups were calculated using the chi-squared test or the Fisher exact test as appropriate. For 
paired categorical data the McNemar’s test was used. Logistic regression analysis was 
performed to identify predictors of super-response as one group versus non-response or 
response as the other group. Cox regression was used to analyze predictors of time until long-
term clinical outcome (hospitalization due to heart failure and/or death). The following 
variables were entered as predictors into the multivariable logistic and Cox regression 
analysis: age, gender, LVEF, QRS width, NYHA at baseline, atrial fibrillation, percentage of 
biventricular pacing, and ischemic/non-ischemic cardiomyopathy. The pool of variables 
considered were those found to be significant at a p<0.10 in univariable analysis. In a 
stepwise backward regression procedure predictors with a p value greater than 0.05 were 
removed from the model and then the model was refit. Kaplan-Meier estimates for heart 
failure hospitalization or all-cause death as well as cardiac death or appropriate ICD shock or 
ATP therapy across LVEF response categories were determined and statistically evaluated 
with the log-rank test. All p values reported are two-sided with a significance level of p<0.05. 
 
 
RESULTS 
 
Overall population characteristics  
Initially 433 patients with prophylactic CRT-D indication were registered in our hospital 
database. In 86 patients paired echocardiographic evaluations during baseline and follow-up 
were not available. Therefore, the study population consisted of 347 patients. Mean age was 
67±9 years with 70% male gender. Mean NYHA functional class was 2.5±0.6 and 83% had 
LBBB with mean QRS duration of 154±30 ms. Mean LVEF was 24.8%±6.9. Ischemic 
etiology was present in 51% of patients. All patients were on optimal medical therapy for 
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heart failure and 94% experienced adequate biventricular pacing (biventricular pacing ≥94%). 
Echocardiographic follow-up was performed at median 2.3 years (IQR 1.4−3.9). General 
characteristics of study population according to the echocardiographic response are 
summarized in Table 1. A total of 56 (16%) patients were classified as super-responders 
Female gender (OR=4.13 95%CI 2.28−7.48), non-ischemic etiology (OR=3.14 95%CI 
1.68−5.86), higher LVEF at baseline (OR= 1.06 95%CI 1.02−1.11) and wider QRS duration 
(OR=1.16 95%CI 1.05−1.29) were associated with super-response to CRT. Also after 
multivariable analysis, female gender (OR=3.06 95%CI 1.54−6.05), non-ischemic etiology 
(OR=2.70 95%CI 1.29−5.68), higher LVEF at baseline (OR=1.07 95%CI 1.02−1.13) and 
wider QRS duration (OR=1.17 95%CI 1.04−1.32) were independently associated with super-
response to CRT.  
 
 
 
 
 
 
Table 1. General characteristics of study population by responder category 
 
 All 
patients 
(n=347) 
Non-responder 
(LVEF <35%) 
(n=138) 
Responder 
(LVEF=30−50%) 
(n=153) 
Super-responder 
(LVEF >50%) 
(n=56) 
p  
value 
Age (years)    67±9   67±9   66 ±9   66±8   0.453 
Female    30%   20%   28%   57% <0.001 
Baseline LVEF (%)   24.8±6.9   22.2 ±6.0   26.2±6.8   27.1±7.5 <0.001 
Sinus rhythm    75%   77%   72%   78%   0.543 
QRS duration (ms) 154±30 154±28 150±30 165±32   0.009 
LBBB    83%   78%   84%   92%   0.086 
RBBB      6%   10%     5%     2%   0.081 
IVCD    11%   12%   12%     6%   0.498 
NYHA   2.5±0.6  2.5±0.6  2.4±0.7  2.5±0.6   0.194 
Non-ischemic  
   etiology 
  49%   34%   54%   61% <0.001 
Diuretics   80%   85%   75%   82%   0.112 
Βeta-blocker   81%   77%   81%   91%   0.072 
AT-II antagonists   48%   47%   48%   52%   0.839 
ACE-inhibitors   77%   78%   74%   82%   0.404 
Spironolactone   42%   42%   42%   41%   0.992 
 
Abbreviations:  LVEF, left ventricular ejection fraction; LBBB, left bundle branch block; RBBB, right bundle branch 
block; IVCD, intraventricular conduction delay. 
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Table 2. Clinical and echocardiographic outcome of 347 patients by responder category 
 
 All patients 
(n=347) 
Non-
responders 
Responders Super-
responders 
p  
value 
Clinical follow-up duration 
    median (IQR) years 
5.3 (4.5−6.5) 5.1 (4.1−6.3) 5.3 (4.6−6.7) 5.7 (4.6−6.9)   0.05 
NYHA follow-up 
    (mean±SD) 
2.0±0.8  2.1±0.7  1.9±0.8 1.8±0.7   0.07 
LVEF follow-up  
    (mean±SD) 
36.9±12.3 24.4±6.2 41.5±4.3 54.9±6.0 <0.001 
Appropriate therapy  
   (ATP and/or shock) 
13% 21% 10%   0% <0.001 
ATP successful    5%   6%   7%   0%   0.15 
Appropriate ICD shock  10% 19%   7%   0% <0.001 
Inappropriate ICD shock  12% 12% 12% 13%   0.98 
Percentage of Biv-pacing  94±13 93±15 94±10 95±15   0.02 
All-cause mortality  23% 37% 14% 13% <0.001 
HF hospitalization  22% 36% 14%   9% <0.001 
MACE (all-cause 
   mortality and/or heart 
   failure hospitalization) 
33% 51% 22% 18% <0.001 
Cardiac death 14% 25%   9%   0% <0.001 
Non-cardiac and unknown 
   cause of death 
  9% 12%   5% 13%   0.26 
 
Abbreviations: IQR= inter-quartile-range, ATP= anti-tachycardia-pacing. 
 
 
Long-term outcome 
Patients were followed for median 5.3 years (IQR 4.5−6.5). During this period 80 (23%) 
patients died (all-cause mortality). In 75 (94%) patients the cause of death was obtained. The 
cause of death was in 48 cases (14%) cardiac death, in 27 cases (8%) non-cardiac death and in 
5 cases (1%) unknown. During total follow-up, 22% of patients were admitted to hospital due 
to worsening heart failure. In total MACE occurred in 33% and all-cause mortality in 23% of 
the entire population (Table 2). During follow-up, in 13% of patients appropriate (ATP or 
ICD shock) and in 12% of patients inappropriate CRT-D intervention occurred. Patients with 
MACE were significantly older, had more atrial fibrillation, a less wide QRS duration and 
more ischemic etiology compared to patients without MACE. Furthermore, in patients with 
MACE NYHA class during follow-up was significantly higher, appropriate ICD therapy was 
higher and percentage of biventricular pacing was lower compared to patients without MACE 
(Table 3).  
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Table 3. Characteristics of study population according to MACE (all-cause mortality and/or heart failure 
hospitalization)  
 
 All patients 
(n=347) 
Without MACE  
(n=233) 
With MACE  
(n=114) 
p  
value 
Age (years)    67±9   66±9   69±8   0.001 
Female    30%   32%   25%   0.144 
LVEF (%) baseline   24.8±6.9     25.0±7.0   24.2±6.8   0.271 
Sinus rhythm    75%   79%   68%   0.036 
QRS duration (ms) 154.5±30.3 156.8±30.8 149.6±28.7   0.026 
LBBB    83%   84%   81%   0.515 
RBBB      6%     5%     9%   0.301 
IVCD    11%   11%   11%   0.981 
NYHA class baseline 2.5±0.6  2.4±0.6  2.5±0.6   0.083 
Non-ischemic etiology    49%   54%   37%   0.002 
Diuretics    80%   79%   83%   0.293 
Βeta-blocker   81%   83%   77%   0.209 
AT-II receptor blockers   48%   45%   56%   0.044 
ACE -inhibitors   77%   76%   78%   0.728 
Spironolactone   42%   41%   43%   0.752 
NYHA class follow-up  2.0±0.8  1.8±0.7  2.5±0.7 <0.001 
Appropriate therapy 
   (ATP and/or shock) 
  13%     8%   23% <0.001 
Inappropriate ICD shock    12%   11%   15%   0.262 
Percentage of Biv-pacing   94±13   96±10   91±17   0.001 
Super-response to CRT   16%   20%   9% <0.001 
Response to CRT   44%   51%   30% <0.001 
Non-response to CRT   40%   29%   61% <0.001 
 
Abbreviations as in Tables 1 and 2. 
 
 
Super-responders and long-term outcome  
In Figures 2 and 3 the (reverse) Kaplan-Meier survival curves of the clinical endpoints by 
LVEF response categories are depicted. Super response is associated with a lower probability 
of adverse clinical outcomes (p<0.001). The cumulative incidence of all-cause mortality in 
super-responders was significantly lower compared to responders and non-responders (13% 
vs 9% vs 25%, p<0.001). In addition, the cumulative incidence of MACE was significantly 
lower in super-responders compared to the other groups (18% vs 22% vs 51%, p<0.001). The 
cumulative incidence of appropriate CRT-D intervention was (0% vs 10% vs 21%, p<0.001). 
Cardiac death rate was (0% vs 8% vs 38%, p<0.001). The rate of non-cardiac death or 
unknown cause of death was not significantly different between the 3 groups (9% vs 7% vs 
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13%, p=0.43). Inappropriate CRT-D intervention was not significantly different between the 
three groups (p=0.98). Remarkably, in super-responders the rate of inappropriate CRT-D 
intervention was higher than the rate of appropriate intervention (13% vs 0%, p=0.013) (Table 
2). In total 12 (13%) patients in super-responder group experienced inappropriate CRT-D 
intervention with cause of atrial fibrillation in 7 patients, lead malfunctioning in 4 patients and 
T-wave oversensing in 1 patient.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 2. All-cause mortality and/or HF hospitalization by response category. 
 
 
Figure 3. Cardiac death or appropriate ICD therapy by response category. 
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Table 4. Multivariable predictors of all endpoints (MACE, all-cause mortality) 
 
Endpoints                                 Multivariable analysis a 
 
Variables a  
 
HR (95%CI) 
 
p value 
 
MACE 
 
 
   
Super-responders vs other groups 0.37 (0.19−0.73)   0.004 
Biventricular-pacing (per 10%) 0.73 (0.66−0.82) <0.001 
Age (per 10 years) 1.54 (1.22−1.95) <0.001 
All-cause mortality 
 
 
Super-responders vs other groups  0.44 (0.20−0.95)   0.037 
NYHA class baseline 1.68 (1.15−2.46)   0.007 
Age (per 10 years) 1.81 (1.36−2.42) <0.001 
 
a Only significant predictors are listed. 
 
 
 
 
 
Multivariable analyses 
MACE was independently associated with super-response to CRT, percentage of biventricular 
pacing and age. All-cause mortality was independently associated with super-response to 
CRT, NYHA class at baseline and age. Cardiac death, in univariable analysis, was associated 
with age, ischemic etiology, percentage of biventricular pacing and super-response to CRT. 
Multivariable analysis for cardiac death and appropriate ICD-therapy could not be estimated 
because none of the super-responders died from cardiac causes or experienced appropriate 
ICD therapy. Super-responders had at follow-up an independent decreased risk of MACE 
(HR 0.37 95%CI 0.19−0.73) and all-cause mortality (HR 0.44 95%CI 0.20−0.95) (Table 4). 
 
 
DISCUSSION  
 
We demonstrated in a large registry that also after long-term follow-up, super-responders to 
CRT had a much better prognosis than either responders or non-responders. Annual cardiac 
death rate and appropriate CRT-D intervention in super-responders was even zero. Since the 
annual rate of inappropriate intervention in super-responders was high, downgrading CRT-D 
to CRT-P in super-responders can be a matter of debate, although only randomized trials can 
definitely demonstrate whether this can be performed safely. 
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Improvement of LVEF after CRT 
The degree of response to CRT is variable due to different definitions of improvement or 
normalization of LVEF. Reduced LVEF is associated with risk of ventricular arrhythmia and 
sudden death. Randomized controlled trials and guidelines for prophylactic defibrillator 
implantation to prevent sudden death have relied heavily on this LVEF measurement to 
qualify for device candidacy [10]. Given the clinical reliance on LVEF as an indication for 
therapy and for assessing response to CRT-D therapy, we justified the classification of 
responsiveness to CRT-D on the extent of improvement in LVEF among our study patients. 
In our study, super-responders had LVEF of mean 54.9±6.0%. 
A previous study had shown that the maximal amount of functional and LV remodelling 
improvement was reached at 2 years following CRT and these improvements sustained in 5 
years follow-up [3]. In the current study we performed echocardiographic follow-up at 
median 2.8 years (IQR 1.4−3.9), which means that all potential LV remodelling has taken 
place. The definition for super-response to CRT varies between the studies [7−11]. In this 
study we defined super-response as LVEF ≥50%. Some studies used an absolute LVEF ≥35% 
or LVEF ≥50% , while others used the top quartile of LVEF changes as definition for super-
response [6−11]. Using these definitions, super-response was observed in 24−30% [7,11]. 
In the current study we demonstrated that among several baseline characteristics, female 
gender, non-ischemic cardiomyopathy, higher LVEF at baseline and wider QRS duration 
were predictors of super-response to CRT. However, previous studies reported more 
predictors for super-response to CRT. Female gender, non-ischemic cardiomyopathy, wide 
QRS >150 ms, LBBB, body mass index, QRS shortening after CRT and smaller baseline left 
atrial volume index were among the predictors for super-responders [6−17]. This difference 
may be due to slightly different study populations. Our study is smaller, population was older 
(mean age 67 years) and had more severe heart failure symptoms compared to MADIT-CRT 
trial which included younger (mean age 63 years) patients with less severe heart failure 
symptoms.  
 
Long-term outcome in ‘super-responders’ to CRT  
In the current study we observed an excellent long-term prognosis without cardiac death or 
appropriate ICD intervention in super-responders. The all-cause mortality was 13%. One 
recent study [9] with 330 patients and mean follow-up of 4.1 years showed cardiovascular 
death of 4% in patients with LVEF overcrossing 35% by CRT. In MADIT-CRT [6] all-cause 
death occurred in 1.6% and all-cause death or appropriate CRT-D therapy in 5.2% of super-
responders. However, in MADIT-CRT, follow-up was shorter (median 15 months). Another 
recent trial with 259 CRT patients and mean follow-up of 5.6 years showed a cardiovascular 
mortality of 1.5% and all-cause mortality of 6% in super-responders defined as LVEF >50% 
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[8]. One of the largest trials12 with 814 CRT patients, in which 92 (11.7%) patients had an 
LVEF >50% defined as super-responders to CRT, compared the long-term survival in super-
responders with an age- and sex-matched sample from the general population. All-cause 
mortality in super-responders at mean follow-up (5.7±2.4 years) was 16% and 4.4% (3 
patients) received appropriate shocks for VT or VF. The annualized all-cause mortality rate 
for the super-responders was 3.3% and was not significantly different (p=0.53) from the 
calculated survival of the age-and sex-matched sample from the general population. One of 
the major limitations of this latter study [12] is that the investigators reported only data on all-
cause mortality and did not report the rate of cardiac death. A CRT-D device prevents 
specifically cardiac death and not all-cause mortality. Therefore, the findings of our study 
with no cardiac death in super-responders are more important and provide more insight in the 
cause of death of super-responders.  
 
ICD therapy in ‘super-responders’ to CRT 
Appropriate ICD intervention: Reverse remodelling is associated with risk reduction for 
ventricular arrhythmia [18,19] CRT partially restores dyssynchron LV contraction and 
regional heterogeneity of action potential duration which may reduce ventricular arrhythmias 
[20]. In the current study, no appropriate ICD intervention occurred in super-responders. One 
previous study reported an appropriate ICD intervention rate of 7% at 5.6 years in super-
responders [8]. In MADIT-CRT the secondary endpoint of all-cause death or ICD-therapy 
was 5.2% at 2 years. However, follow-up of this study was too short and the investigators did 
not report the exact percentage of ICD therapy. Another study [9] reported no appropriate 
ICD- intervention observed in patients with ‘functional response’ to CRT (i.e., LVEF >35%  
4 months after implantation) at 3-year follow-up; this follow-up is relatively short compared 
to our study. One of the recent trial [20] reported appropriate ICD therapy in 27% of super-
responders compared to 34% in non-responders during 5-year follow-up. The authors 
concluded that after the first year of implantation there was no association between the extent 
of CRT response and reduction of appropriate device therapy. Furthermore, LVEF >45% or 
<45% did not predict ICD-therapy after the first year of implantation. It is remarkable that 
LVEF >45% at follow-up did not predict the ICD therapy.  
There are some differences between this study [20] and our study. In our study we defined the 
super-response as LVEF >50%, whereas, they defined super-response as decreased LVESV 
>30%. Another difference is that the echocardiographic follow-up occurred at 6 months after 
implantation, whereas, we performed at median 2.8 years, which means that all potential LV 
remodelling has taken place. Device therapy zone is also different, which could lead to more 
therapy. In our study the risk of significant ventricular tachyarrhythmia in super-responders 
was entirely eliminated by almost normalization of LVEF as a result of CRT. The most recent 
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meta-analysis [21] showed that recovery of LVEF post-CRT is associated with significantly 
reduced appropriate ICD therapy. Patients with recovery of LVEF to >45% and those with a 
primary prevention indication for ICD with LVEF recovery appear to be at lowest risk. The 
findings of this meta-analysis are entirely in line with our results. 
 
Clinical implications 
Our data showed an excellent prognosis of super-responders regarding cardiac death or 
appropriate ICD intervention. Given, the risks and discomfort portended by inappropriate 
shocks, we suggest that the decision of downgrading CRT-D to CRT-P at the time of elective 
replacement indication (ERI) or shock-lead problems should be discussed very carefully with 
every single patient. Moreover, based on our findings, conducting a randomized trial in super-
responders, when ERI is reached, comparing continued CRT-D with downgrading to CRT-P 
should be encouraged. 
 
Strengths and limitations 
Both the large number of the study population and the long-term clinical and 
echocardiographic follow-up are probably the major strengths of the current study. There are 
also several limitations of this study. It concerns observations of a single center that has a 
great deal of experience with CRT. Furthermore, although the registry was prospective, the 
current analysis was retrospective. We also did not evaluate other echocardiographic 
parameters besides LVEF. Some of the echocardiographic findings such as mitral 
regurgitation, diastolic function and right ventricular function may influence the improvement 
of LVEF and clinical outcomes of patients. One of limitations is that our echocardiographic 
follow-up was performed at a median of 2.8 years from implantation. While the majority of 
studies reported at 6−12 months after implantation, our study focused on patients with 
available baseline and follow-up echocardiograms. A proportion of patients (20%) were 
excluded from the analysis. These patients included those who died before follow-up echo 
and those who were lost to follow-up because of referral to their own regional hospital. 
However, this proportion of 20% is lower compared to the MADIT-CRT trial, which 
excluding 31% of patients [6]. Suboptimal LV lead placement or unfavourable pacemaker 
settings may, at least in part, have contributed to diminished improvement of LVEF and 
poorer outcome after CRT. In our population, there  is no information available on device 
programming and optimization during follow-up. 
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CONCLUSION 
 
Super-responders to CRT have an excellent prognosis during median follow-up of 6 years. 
Female gender, non-ischemic etiology, higher LVEF at baseline and wider QRS duration are 
predictors of super-response. 
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ABSTRACT 
 
Background: Super-responders to cardiac resynchronization therapy (CRT) show an 
exceptional improvement in left ventricular ejection fraction (LVEF). Previous studies 
showed that apical rocking was independently associated with echocardiographic response to 
CRT. However, little is known about the association of apical rocking and super-response to 
CRT.  
Objectives: To determine the independent association of LV apical rocking on super-response 
to CRT in a large cohort. 
Methods: A cohort of 297 consecutive heart failure patients treated with primary indication 
for CRT-D were included in an observational registry. Apical rocking was defined as motion 
of the left ventricular (LV) apical myocardium perpendicular to the LV long axis. ‘Super-
response’ was defined by the top quartile of LVEF response based on change from baseline to 
follow-up echocardiogram. Best-subset regression analysis identified predictors of LVEF 
super-response to CRT.  
Results: Apical rocking was present in 45% of patients. Super-responders had an absolute 
mean LVEF increase of 27% (LVEF 22.0% ±5.7 at baseline and 49.0% ±7.5 at follow-up). 
Apical rocking was significantly more common in super-responders compared to non-super-
responders (76% and 34%, p<0.001). In univariate analysis, female gender (OR 2.39 95%CI 
1.38−4.11), lower LVEF at baseline (OR 0.91 95%CI 0.87−0.95), non-ischemic etiology (OR 
4.15 95%CI 2.33−7.39) and apical rocking (OR 6.19 95%CI 3.40−11.25) were associated 
with super-response. In multivariate analysis, apical rocking was still strongly associated with 
super-response (OR 5.82, 95%CI 2.68−12.61). Super-responders showed an excellent clinical 
prognosis with a very low incidence of heart failure admission, cardiac mortality and 
appropriate ICD therapy. 
Conclusion: Apical rocking is independently associated with super-response to CRT. 
 
 
INTRODUCTION 
 
Cardiac resynchronization therapy with defibrillator (CRT-D) has proven to improve heart 
failure (HF) morbidity, quality of life, and survival in those with reduced left ventricular 
ejection fraction (LVEF), advanced HF symptoms, and increased QRS duration [1−5]. Recent 
studies have indicated super-response in a proportion of patients treated with CRT [6,7]. 
Identifying potential super-responders to CRT is an important issue because of their excellent 
prognosis. Previous studies attempted to find easily identifiable clinical factors to predict 
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super-response to CRT. Female gender, body mass index <30 kg/m2, left bundle branch block 
(LBBB), QRS duration >150 ms, smaller LV and left atrial (LA) dimensions, shorter duration 
of HF symptoms, and non-ischemic cardiomyopathy were factors associated with super-
response to CRT [8−11], albeit with a relatively weak relation. There is an obvious need for a 
stronger predictor for these patients. Apical rocking is an easily measured echocardiographic 
parameter, and has been introduced as a promising predictor of CRT [12−14]. However, to 
our knowledge, there are no data on the value of apical rocking as a predictor of super-
response to CRT. Therefore, the aim of the current study was to assess the value of apical 
rocking as an independent predictor of super-response to CRT in a large cohort of patients 
treated with CRT-D.  
 
 
METHODS 
 
Selection of patients 
Between 2005 and 2009, patients with primary indication for CRT-D were included in a 
prospective registry. This study is an extension of our previous study [14] with larger number 
of patients and longer duration of follow-up. This prospective registry has been approved by 
the Institutional Review Board. Exclusion criteria were: (1) patients with CRT-P, (2) pre-
implantation LVEF >35% according to echocardiographic data, and (3) patients with a history 
of recent myocardial infarction or CABG (<3 months). Indication for CRT-D implantation 
was determined according to the guidelines at the time of implantation. In all patients, LVEF 
was <35% and QRS duration was >120 ms with LBBB, RBBB or non-specific intra-
ventricular conduction disorders (IVCD). Conventional criteria for LBBB were used, which 
include QRS duration >120 ms, QS or rS in lead V1, and a monophasic R wave in leads V6 
and I without Q waves. Heart failure was diagnosed according to the European Society of 
Cardiology guidelines. Medical therapy was optimized to reach the highest tolerated dosages 
of angiotensin-converting enzyme inhibitors and beta-blockers. To be included in the final 
analysis, patients were required to have an echocardiographic examination before CRT-D 
implantation and during follow-up. Based on these criteria, a total of 297 patients were 
eligible for this study as depicted in Figure 1. LVEF assessment was made in all baseline and 
follow-up. LVEF was calculated using the Simpson’s technique [15]. 
 
Device implantation 
Cardiac resynchronization therapy devices from all major manufacturers (Medtronic, St. Jude 
Medical, Boston Scientific, Biotronik and Sorin Group) were implanted. The majority of 
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coronary sinus leads were bipolar. After implantation, tailored device programming was 
performed before discharge with three consecutive zones in the large majority of patients. A 
monitor zone between 170−200 bpm, fast VT zone between 200−230 bpm and VF-zone >230 
bpm. In fast VT zone, arrhythmias were initially attempted to be terminated by two bursts and 
one ramp followed by defibrillator shocks if the arrhythmia continued. Routine follow-up 
visits were scheduled at 2 months post implant, and every 6 months thereafter. During follow-
up, ICD printouts were checked, ICD treatments were registered and intracardiac 
electrograms (EGM) were classified by a dedicated device cardiologist. Appropriate ICD 
therapy (ATP and shocks) was defined as ICD therapy delivered in response to sustained 
ventricular tachycardia or ventricular fibrillation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 1. Flowchart of study population. 
 
 
 
Apical rocking and super-response to CRT 
_______________________________________________________________________________ 
164 
 
Visual assessment of LV apical rocking 
Apical rocking was defined as a short initial septal contraction which results in short inward 
motion of the septum and pulls the apex to the septum and then the delayed activation of the 
lateral wall which pulls the apex laterally during the ejection time while stretching of the 
septum takes place. The presence of apical rocking was visually assessed in 4-chamber apical 
view by three experienced cardiologists who were blinded to the medical history, measured 
LVEF, and clinical outcome of study population. The presence of apical rocking in some 
patients was difficult to assess adequately, in these cases we followed the democratic 
majority. Inter- and intra-observer variability was expressed as kappa coefficients. Values 
higher than 0.8 are considered as excellent, values between 0.6 and 0.8 as good, values 
between 0.4 and 0.6 as moderate, and values below 0.4 as poor agreement.   
 
 
 
 
 
Table 1. General characteristics of study population by apical rocking 
 
 With apical rocking 
(n=134) 
Without apical rocking 
(n=163) 
p value 
Age (years)    65±10   69±8   0.001 
Female    41%   22% <0.001 
LVEF (%)   25.0±6.8   24.7±6.5   0.929 
Sinus rhythm    81%   71%   0.038 
QRS duration (ms) 164±29 148±29 <0.001 
LBBB    91%   73% <0.001 
RBBB      3%     9%   0.055 
IVCD      6%   18%   0.003 
NYHA functional class  2.5±0.7  2.5±0.6   0.637 
Non-ischemic etiology    71%   31% <0.001 
Diuretics   77%   86%   0.044 
Βeta-blocker   85%   80%   0.290 
AT-II receptor blockers   48%   40%   0.137 
ACE inhibitors   77%   75%   0.782 
Spironolacton   42%   45%   0.611 
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Table 2. General characteristics of study population by responder category 
 
 Non-super-responder 
n=221 
Super-responder 
n=76 
p value 
Age (years) median (IQR)   69.3 (61.5−74.3)   67.6 (59.4−72.9)   0.262 
Female    25%   45%   0.002 
LVEF (%) median (IQR)   25.0 (21.0−30.0)   22.0 (18.0−25.5) <0.001 
Sinus rhythm    75%   76%   0.821 
QRS duration (ms) median (IQR) 160 (135−173) 160 (132−182)   0.238 
LBBB    80%   86%   0.281 
RBBB      7%     5%   0.770 
IVCD    13%     9%   0.432 
NYHA functional class median (IQR)  3.0 (2.0−3.0)  3.0 (2.0−3.0)   0.502 
Non-ischemic etiology    40%   74% <0.001 
Diuretics   83%   79%   0.452 
Βeta-blocker   81%    87%   0.216 
AT-II receptor blockers   42%   47%   0.383 
ACE inhibitors   76%   74%   0.625 
Spironolacton   46%   38%   0.253 
Presence of apical rocking   34%   76% <0.001 
 
 
 
Endpoint 
Patients with paired echocardiograms were divided into quartiles of LVEF response to CRT 
based on change from baseline to follow-up echocardiograms. Two groups based on response 
to CRT were defined and labeled as ‘super-responders’ and ‘non-super-responders’ [11]. 
Super-response to CRT was defined by the highest quartile of LVEF change (n=76) and non-
super-response by the lowest, second and third quartiles of LVEF change (n=221).  
 
Statistical analysis 
Statistical analysis was performed using SPSS statistical software (IBM Corp. Released 2011. 
IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp.). Continuous 
variables were expressed as mean±SD and significance of differences between independent 
groups were calculated using the non-parametric Mann-Whitney U-test. Categorical variables 
were presented as number and percentages and significance of differences between groups 
were calculated using the Chi-squared test or Fisher’s exact test as appropriate. Logistic 
regression analysis was performed to assess the univariable and multivariable predictors 
 
Apical rocking and super-response to CRT 
_______________________________________________________________________________ 
166 
 
super-response versus non-super-response. We computed the sensitivity and specificity of 
apical rocking in predicting super-response. The probability of clinical outcomes was plotted 
using Kaplan-Meier estimates, and groups were compared using log-rank tests. p values <0.05 
were considered statistically significant in all analyses. 
 
RESULTS  
 
Baseline characteristics 
Initially 347 patients with prophylactic CRT-D indication were registered in our hospital 
database. Paired echocardiograms from both baseline and follow-up were not available in 50 
(14%) patients. Of these patients, 25 (50%) patients died before follow-up echocardiograms 
were performed. Therefore, these patients were excluded from analysis. The final study 
population consisted of  297 patients (Figure 1). Echocardiographic follow-up was performed 
at median 2.1 years (IQR 1.4−3.2) after device implantation. General characteristics of the 
study population are summarized in Tables 1 and 2. The median age was 68.7 (IQR 58−78) 
years with 30% female gender. Median LVEF was 24.8% (IQR 20−30%), LBBB was present 
in 81%, the median QRS duration was 160 ms (IQR 132−182 ms) and 49% of patients had 
non-ischemic aetiology. The coronary sinus leads were positioned in the lateral, posterolateral 
or posterior region in 83% and anterolateral or anterior in 8% of patients. Furthermore, 9% of 
LV leads were positioned epicardially during open-heart surgery prior to CRT-D 
implantation. A total of 76 patients were classified as super-responders. A higher proportion 
of women, patients with non-ischemic etiology and with baseline apical rocking were present 
in super-responders to CRT. At the follow-up, the median LVEF was 37% (IQR 20−32%) in 
all patients, 38% (IQR 30−43%) in non-super-responders and 49 % (IQR 45−52%) in super-
responders (p<0.001) (Table 3). 
 
Inter- and intra-observer variability 
To quantify the inter- and intra-observer variability for assessment of apical rocking, we 
reviewed 140 (47%) patients by three cardiologists. The inter-observer variability kappa was 
0.85 and intra-observer variability kappa was 0.90 between all three cardiologists. 
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Table 3. LVEF changes and presence of apical rocking between different groups at baseline and follow-up. 
 
 Non-super-responders  
(n=221) 
Super-responder 
(n=76) 
p 
value 
 Non-responders 
(n=73) 
Responders  
(n=148) 
  
 
LVEF (%) at baseline 
    median (IQR) 
25.0 (21.0−29.0) 25.0 (21.0−31.5) 22.0 (18.0−25.5) <0.001 
LVEF (%) during follow-up 
    median (IQR) 
24.0 (20.0−28.0) 38.0 (30.0−43.0) 49.0 (45.0−52.0) <0.001 
LVESV decrease (ml)  
    mean±SD 
4.3±35.8 31.4±37.6 86.5±61.6 <0.001 
Presence of apical rocking 15% 44% 76% <0.001 
 
The groups were defined as: Super-responders the highest quartile of LVEF change, responders the second and third 
quartiles of LVEF change, and non-responders the lowest quartile of LVEF change. 
 
 
 
 
 
Long-term outcome of super-responders  
Patients were followed for a median of 5.2 years (IQR 4.4−6.2). During this period 63 (21%) 
patients died (all-cause mortality). The mode of death was cardiac in 33 patients (11%) and 
non-cardiac or unknown in 30 patients (10%). All-cause mortality in super-responders was 
significantly lower compared to non-super-responders (11% vs 25%, p=0.008, Figure 2A). 
None of super-responders died from a cardiac cause, whereas a cumulative incidence of 
cardiac cause up to 20% was observed in non-super-responders (Figure 2C). During total 
follow-up, 21% of patients were admitted to hospital due to worsening of heart failure. Rate 
of hospitalization was significantly lower in super-responders compared to non-super-
responders (8% vs 25%, p=0.001, Figure 2B). Appropriate CRT-D shock was significantly 
lower in super-responders compared to non-super-responders (1% vs 12%, p=0.006, Figure 
2D). Inappropriate ICD shock did not differ between the super-responders and non-super-
responders (10% vs 11%, p=0.977). 
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Table 4. Multivariate association to CRT super-response 
 
 Odds ratio 95%CI p value 
Age (years)  1.01 0.97−1.05   0.585 
Female 2.14 1.07−4.29   0.032 
LVEF (%) baseline 0.89 0.84−0.94 <0.001 
QRS duration (per 10 ms) 0.98 0.87−1.12   0.795 
LBBB vs non-LBBB 0.91 0.33−2.49   0.858 
Non-ischemic etiology 1.99 0.96−4.12   0.063 
Presence of apical rocking 5.82 2.68−12.61 <0.001 
 
Adjusted for age, gender, LVEF, QRS width, LBBB/RBBB and ischemic/non-ischemic cardiomyopathy. 
 
 
 
Apical rocking and super-response to CRT 
Presence of apical rocking between super-responders and non-super-responders to CRT was 
significantly different (76% and 34%, respectively, p<0.001). Presence of apical rocking 
predicted super-response to CRT with a sensitivity of 76% and a specificity of 66%. The 
positive predictive value of apical rocking in predicting super-response response was 44% and 
the negative predictive value was 89% and the accuracy was 68%. In univariate analysis, 
female gender (OR 2.39 95%CI 1.38−4.11), LVEF at baseline (OR 0.91 95%CI 0.87−0.95), 
non-ischemic etiology (OR 4.15 95%CI 2.33−7.39) and apical rocking (OR 6.19 95%CI 
3.40−11.25) were associated with super-response to CRT. In multivariate analysis, female 
gender (OR 2.14 95%CI 1.07−4.29), LVEF at baseline (OR 0.89 95%CI 0.84−0.94) and 
apical rocking (OR 5.82 95%CI 2.68−12.61) were associated with super-response to CRT 
after adjustment for age, LVEF baseline, QRS duration, LBBB vs non-LBBB, non-ischemic 
etiology and presence of apical rocking (Table 4). 
 
 
DISCUSSION  
 
The present study assessed the association of apical rocking with super-response to CRT in a 
large cohort of patients. Apical rocking was strongly associated with super-response. 
Furthermore, super-responders had a lower incidence of cardiac death, heart failure 
hospitalization and appropriate ICD shocks.  
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Super-response is associated with decreased cumulative probability of HF or all-cause 
mortality and ICD therapy for ventricular tachycardia or ventricular fibrillation. Therefore, 
predicting super-response is important. Previous studies tried to find predictors of super-
response. LBBB and smaller LA volume were previously identified as predictors of super-
response [16,17]. The MADIT-CRT trial [11] identified female gender, no prior myocardial 
infarction, QRS duration >150 ms, LBBB, BMI <30 kg/m2 and smaller left atrial volume 
index as predictors of super-response. 
The present study assessed several general characteristics and apical rocking as echo-
cardiographic parameter to predict the potential super-response and identified lower baseline 
LVEF, female gender and apical rocking as predictors of super-response to CRT. Although 
the association of higher baseline LVEF with ‘normal CRT response’ has been established, in 
current study lower baseline LVEF was associated with ‘super-response to CRT’. One of the 
recent trials [18] demonstrated that super-responders had lower baseline LVEF compared to 
non-/modest-responders (22.6 vs 25.8%, p<0.001). Our results are in line with this trial. 
However, in MADIT-CRT trial [11] there were no significant differences in baseline LVEF 
between super-responders and non-super-responders. Apical rocking, as we recently 
published, predicted the response to CRT [14] and can be visualized in a standard 
echocardiographic 4-chamber view. This is in contrast to several dyssynchrony indices, which 
require well-trained echocardiographist and special imaging software and techniques. 
Previous study compared a quantitative measurement with visual assessment of apical rocking 
and demonstrated a comparable accuracy in predicting CRT response [13]. Therefore, we 
decided in this study to use only visual assessment which can be assessed easily with a good 
inter- and intra-observer variability. In 2007 Jansen et al. [19] described apical shuffle as an 
abnormal systolic septal-to-lateral motion of the left ventricle. Apical shuffle, defined as an 
abnormal systolic septal-to-lateral apical motion of left ventricle, has been shown to be 
predictive of LV reverse remodelling with sensitivity and specificity between 70−90%. The 
investigators, however, did not describe the pathophysiologic mechanism of apical shuffle. In 
recent years, the pathophysiologic mechanism of apical rocking, defined as short-lived early 
septal motion of the apex and a predominantly lateral motion during ejection, has been 
described in two separate publications [12,13]. Apical rocking is the same phenomenon as 
described by Jansen et al. [19]; however, they called this abnormal movement of the apex 
‘apical shuffle’. Septal rebound stretch (SRSsept) is another relatively new dyssynchrony 
parameter. Previous studies [20−22] demonstrated the strong association of SRSsept with 
CRT response. Septal rebound stretch reflects the amount of stretch in septum during systole 
and seems comparable with ’multiphasic septal motion’ which has been described by Jansen 
et al. [19]. However, in current study we did not assess the predictive value of SRSsept on 
‘super-response to CRT’ because we only had data on septal rebound stretch in a minority of 
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patients. Our study, as far as we can ascertain, is the first study to demonstrate the association 
between apical rocking and super-response. Although we predefined our LVEF response 
categories carefully, and found a strong association between apical rocking and super-
response, we realize that our results should be confirmed in large multicenter trials. Although 
apical rocking has a strong association (OR 5.82, 95%CI 2.68−12.61) with super-response as 
compared to patients without apical rocking, we emphasize that even in patients with apical 
rocking only 44% is super-responder. This low positive predictive value of 44% is dependent 
on the definition of super-response and low prevalence of super-response in our cohort. The 
absence of apical rocking is a strong predictor of non-super-response with a negative 
predictive value of 89%. However, the absence of apical rocking was not our focus in the 
current study.  
The response to CRT can change over time, particularly shortly after CRT. In our cohort 
echocardiographic examination after CRT implantation was performed after a mean of 2.1 
years (IQR 1.4−3.2). The time from implantation to follow-up echocardiogram was 
comparable in both groups [in non-super-responders 2.1 years (IQR 1.4−3.3) and in super-
responders 2.1 years (IQR 1.4−3.1), p=0.80)]. So, we do not think that timing of echo-
cardiography caused misclassification of super-responders.  
 
Long-term outcome in ‘super-responders’ to CRT  
The cumulative probability of all-cause mortality, heart failure hospitalization, cardiac death 
and appropriate ICD therapy for ventricular tachycardia or ventricular fibrillation differed 
significantly across LVEF response categories at 6 years of follow-up, with improved event-
free survival based on magnitude of response (Figure 2). In the current study we observed 
11% all-cause mortality, 8% hospitalization due to heart failure and 1% appropriate ICD 
therapy in super-responders. None of super-responders died from cardiac causes. In MADIT-
CRT [11], all-cause death occurred in 1.6% and all-cause death or appropriate CRT-D therapy 
in 5.2% of super-responders. However, in MADIT-CRT, follow-up was shorter (median 15 
months). Another recent trial with 259 CRT patients and mean follow-up of 5.6 years showed 
a cardiovascular mortality of 1.5% and all-cause mortality of 6% in super-responders defined 
as LVEF>50% [23]. One of the largest trials with 92 super-responders (LVEF>50%) 
demonstrated that the survival rate was similar to that of the age- and sex-matched general 
population with appropriate shocks in 4.4% of patients [24] during a mean follow-up of 
5.7±2.4 years. Given the good prognosis of super-responders which is demonstrated in 
previous studies, including the current study, we should be able to identify these patients and 
apical rocking may play an important role. 
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Clinical implications 
Identification of potential super-responders prior to implantation and during follow-up has 
several advantages. Super-responders have very good prognosis in terms of lower rate of heart 
failure hospitalization and all-cause mortality. Furthermore, the incidence of cardiac death or 
appropriate ICD therapy is very low. These are important issues to discus with the patients 
prior to implantation. In super-responders, during the follow-up when device change is 
necessary due to battery depletion or when high voltage RV lead shows dysfunction, 
downgrading from CRT-D to CRT-P can be discussed. Absence of apical rocking has a strong 
relation with ‘non-super-response’. It may therefore be used to identify the non-super-
responders who require possible more intensive monitoring during follow-up.  
 
Strengths and limitations 
Both the large size of the study population and the long-term clinical follow-up are probably 
the major strengths of the current study. For the definition of ‘super-response’ we used the top 
quartile of LVEF response based on change from baseline to follow-up, exactly the same 
definition as MADIT-CRT trial [11], whereas other studies used an absolute LVEF >50% as 
cut-off for super-response. Using changes in LVEF as definition for super-response can be 
difficult to interpret. A patient can show both a decrease and an increase in LVEDV and 
LVESV, so that the LVEF remains relatively unchanged. Therefore, non-response or response 
to CRT can remain unnoticed. The follow-up echocardiographic examinations were 
performed at median 2.1 of years (IQR 1.4−3.2), which means that all potential LV 
remodelling has taken place as demonstrated in a previous study [5]. However, majority of the 
studies performed the follow-up echocardiography at 6−12 months post-implantation. 
Furthermore, our data concern observations of a single center; however, with high experience 
in CRT. Our study focused on patients with available baseline and follow-up 
echocardiograms. Therefore, a proportion of patients (14%) were excluded from the analysis. 
These patients included those who died before follow-up echo or were lost to follow-up 
because of referral to their own regional hospital. Another limitation of the current study is 
that the Kaplan-Meier graphs started immediately after the implantation, whereas defining of 
response group by follow-up echocardiograms took place at mean 2.1 years. The current 
study population most closely resembles real life with inclusion of patients with atrial 
fibrillation. Visualization of apical rocking was not negatively influenced by the inclusion of 
patients with atrial fibrillation. Suboptimal LV lead placement or unfavorable pacemaker 
settings may, at least in part, have contributed to diminished improvement of LVEF and 
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poorer outcome after CRT. In our population, no information is available on optimization 
during follow-up. 
 
CONCLUSION 
 
Apical rocking is independently associated with super-response to CRT. Apical rocking may 
therefore play an important role in identifying these patients, who seem to have a good long-
term prognosis. Absence of apical rocking has a high negative predictive value for prediction 
of non-super-response. 
 
 
 
 
Apical rocking and super-response to CRT 
_______________________________________________________________________________ 
174 
 
REFERENCES 
  
1. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J 
Med 2002;346:1845-53. 
2. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac resynchronization therapy with or without an 
implantable defibrillator in advanced chronic heart failure. N Eng J Med 2004;350:2140-50. 
3. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and 
mortality in heart failure. N Eng J Med 2005;352:1539-49. 
4. Cleland JG, Daubert JC, Erdmann E, et al. Long-term effects of cardiac resynchronization therapy on 
mortality in heart failure. (Care-HF trail extension phase). Eur Heart J 2006;27:1928-32. 
5.  Linde C, Gold MR, Abraham WT, et al. Long-term impact of cardiac of cardiac resynchronization 
therapy in mild heart failure: 5-years results from the Resynchronization reVErses Remodeling in 
Systolic left vEntricular dysfunction (REVERSE) study. Eur Heart J 2013;34:2592-9. 
6.  Gasparini M, Regoli F, Ceriotti C, et al. Remission of left ventricular systolic dysfunction and of heart 
failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors. Am 
Heart J 2008;155:507-14. 
7.  Blanc JJ, Fatemi M, Betault V, et al. Evaluation of left bundle branch block as a reversible cause of non-
ischemic dilated cardiomyopathy with severe heart failure. A new concept of left ventricular 
dyssynchrony-induced cardiomyopathy. Europace 2005;7:604-10. 
8.  Rickard J, Kumbhani DJ, Popovic Z, et al. Characterization of super-response to cardiac 
resynchronization therapy. Heart Rhythm 2010;7:885-9. 
9.  Reant P, Zaroui A, Donal E, et al. Identification and characterization of super-responders after cardiac 
resynchronization therapy. Am J Cardiol 2010;105:1327-35. 
10.  Antonio N, Teixeira R, Coelho L, et al. Identification of “super-responders” to cardiac 
resynchronization therapy: the importance of symptom duration and left ventricular geometry. Europace 
2009;11:343-9. 
11.  Hsu JC, Solomon SD, Bourgoun M, et al. MADIT-CRT Executive Committee. Predictors of super-
response to cardiac resynchronization therapy and associated improvement in clinical outcome. J Am 
Coll Cardiol 2012;59:2366-73. 
12.  Tournoux F, Singh JP, Chan RC, et al. Absence of left ventricular apical rocking and atrial-ventricular 
dyssynchrony predicts non-response to cardiac resynchronization therapy. Eur Heart J. Cardiovasc 
Imaging 2012;13:86-94. 
13.  Szulik M, Tillekaerts M, Vangeel V, et al. Assessment of apical rocking: a new, integrative approach for 
selection of candidates for cardiac resynchronization therapy. Eur J Echocardiogr 2010;11:863-9. 
14.  Ghani A, Delnoy PPHM, Ottervanger JP, et al. Apical rocking is predictive of response to cardiac 
resynchronization therapy. Int J Cardiovasc Imaging 2015;31:717-25. 
15.  Lang RM, Bierig M, Devereux RB, et al. American Society of Echocardiography's Nomenclature and 
Standards Committee; Task Force on Chamber Quantification; American College of Cardiology 
Echocardiography Committee; American Heart Association; European Association of 
Echocardiography, European Society of Cardiology. Eur J Echocardiogr 2006;7:79-108. 
16. Rickard J, Kumbhani DJ, Popovic Z, et al. Characterization of super-response to cardiac 
resynchronization therapy. Heart Rhythm 2010;7:885-9. 
 
Chapter 10 
_______________________________________________________________________________ 
175 
 
17. Reant P, Zaroui A, Donal E, et al. Identification and characterization of super-responders after cardiac 
resynchronization therapy. Am J Cardiol 2010;105:1327-35. 
18.  Killu AM, Grupper A, Friedman PA, et al. Predictors and outcomes of "super-response" to cardiac 
resynchronization therapy. J Card Fail 2014;20:379-86. 
19.  Jansen AH, van Dantzig JM, Bracke F, et al. Qualitative observation of left ventricular multiphasic 
septal motion and septal-to-lateral apical shuffle predicts left ventricular reverse remodeling after 
cardiac resynchronization therapy. Am J Cardiol 2007;99:966-9. 
20.  Ghani A, Delnoy PPHM, Ottervanger JP, et al. Septal rebound stretch as predictor of echocardiographic 
response to cardiac resynchronization therapy. IJC Heart and Vasculature 2015; 7:22-27 
21.  Leenders GE, De Boeck BW, Teske AJ, et al. Septal rebound stretch is a strong predictor of outcome 
after cardiac resynchronization therapy. J Card Fail 2012;18:404-12. 
22.  De Boeck BW, Teske AJ, Meine M, et al. Septal rebound stretch reflects the functional substrate to 
cardiac resynchronization therapy and predicts volumetric and neurohormonal response. Eur J Heart Fail 
2009;11:863-71. 
23.  Zecchin M, Proclemer A, Magnani S, et al. Long-term outcome of ‘super-responders’ patients to cardiac 
resynchronization therapy. Europace 2014;16:363-71. 
24.  Manne M, Rickard J, Varma N, Chung MK, Tchou P. Normalization of left ventricular ejection fraction 
after cardiac resynchronization therapy also normalizes survival. Pacing Clin Electrophysiol 
2013;36:970-7. 
 
 

  
 
CHAPTER 11 
 
 
 
Summary  
and  
General discussion 
 

 
Chapter 11 
_______________________________________________________________________________ 
179 
 
SUMMARY 
 
Cardiac resynchronization therapy improves left ventricular function, NYHA functional class, 
quality of life and reduces mortality and heart failure hospitalization in patients with 
symptomatic heart failure with reduced LVEF and wide QRS duration. Unfortunately, 
30−40% of patients do not show response to CRT. Therefore, a reliable echocardiographic 
tool will be required to predict response to CRT and correctly identify those patients who may 
benefit most from this costly therapy. Since appropriate CRT corrects LV dyssynchrony, it is 
crucial that LV dyssynchrony is recognized. Previous studies have investigated several 
echocardiographic methods to evaluate LV dyssynchrony; however, it was difficult to find a 
response predictor with high efficacy. 
Therefore, the main goals of this thesis were to study the potential role of relatively new 
echocardiographic methods to establish LV dyssynchrony, prediction of response and the 
prognosis of patients who underwent CRT implantation. In the following chapters our results 
are summarized. 
 
In an overview, Chapter 1, general information on definition, prevalence, pathophysiological 
mechanism and pharmacological therapy of heart failure are provided. Additional value of 
ICD implantation on survival in heart failure patients under optimal medical therapy is also 
addressed. Mechanism of action of CRT in heart failure patients with wide QRS duration as 
well as the beneficial effects of CRT on functional class, reverse remodelling of LV, 
reduction in hospitalization and mortality are discussed. Several important issues such as 
response, super-response and non-response to CRT are explained. Finally, the manner in 
which these issues can be predicted by echocardiographic tools is discussed. 
We evaluate device-related re-intervention within 1 year following implantation in Chapter 2. 
We collected the data prospectively, over a period of 2 years, from 1929 patients who had 
been implanted with either pacemaker, ICD or CRT devices. Almost 31% of patients 
underwent a CRT implantation. In total 3909 leads were implanted. To identify the lead-
related complications, the database was searched on re-intervention procedures during the 
first year. Lead-related re-intervention was necessary in 86 (4.4%) patients. The cause of re-
intervention was mainly lead dislodgement (66%), followed by malfunctioning (20%) and 
perforation (18%). Re-intervention was more common in men compared to women and 
younger patients. Coronary sinus lead dislodgement or malfunctioning was 1.4%. Right atrial 
lead dislodgement (1.9%) and ICD lead dislodgement (1.8%) were more common than right 
ventricular pacemaker lead dislodgement (0.3%). The incidence of lead malfunctioning was 
higher (0.8%) in ICD leads. Apical position of the right ventricular lead and lateral wall 
position of the right atrial lead were related to cardiac perforation. 
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We investigated the mechanical activation pattern of LV in pacing-induced LBBB (RV 
pacing) and intrinsic LBBB in order to assess the LV dyssynchrony in these patients 
correctly. We studied 74 patients with heart failure who had been referred for cardiac 
resynchronization therapy, 37 patients with chronic RV apical pacing and 37 patients with 
intrinsic LBBB. Echocardiographic study including 2D speckle tracking longitudinal strain 
and M-mode were performed at baseline in all patients. We present the results in Chapter 3. 
When compared to mechanical activation in intrinsic LBBB, RV pacing results less often in 
early basal activation and more often in early mid-septal and late lateral wall activation. 
Imaging techniques that only visualize the basal or mid-part of the LV may result in a serious 
underestimation of dyssynchrony in patients with pacing-induced LBBB. The differences in 
mechanical activation may have implications for the selection of potential candidates for 
cardiac resynchronization therapy. 
LV dyssynchrony was assessed with time-based speckle tracking longitudinal and radial 
strain in order to predict response to CRT. In Chapter 4, we studied 138 consecutive patients 
with symptomatic heart failure and CRT-D implantation. Six different time-based LV 
dyssynchrony parameters were assessed with longitudinal and radial strain. Response to CRT 
was defined as a reduction in LV end-systolic volume of >15%, or survival without heart 
failure hospitalization. 70% were classified as echocardiographic responders and 83% as 
clinical responders. QRS duration and non-ischemic etiology predicted echocardiographic 
response to CRT. None of the speckle tracking parameters was different between 
echocardiographic responders and non-responders to CRT. Regarding clinical response, only 
the maximal delay between six segments in 4-chamber view measured with longitudinal strain 
was different between responders and non-responders, with 154 ms delay as the optimal cut-
off value. Our conclusion was that only maximal delay between six segments in 4-chamber 
view as assessed with longitudinal strain was associated with clinical response to CRT. 
 
The association between the changes in the extent of LV dyssynchrony as a result of CRT and 
response to CRT was investigated in a cohort of 138 patients. Time-based speckle tracking 
longitudinal strain was used to assess LV dyssynchrony at baseline and during follow-up. 
CRT response was defined as a reduction in LV end-systolic volume of >15%, and 70% were 
classified as responders. In Chapter 5 we present the results. In the total study group, LV 
dyssynchrony decreased from 196±89 ms at baseline to 180±105 ms during follow-up, 
p=0.01. Moreover, in responders there was a pronounced reduction in LV dyssynchrony 
(198±88 ms at baseline versus 154±50 ms after CRT, p<0.001), whereas in non-responders 
there was a significant increase (191±92 ms at baseline versus 243±160 ms after CRT, 
p=0.04). After adjustment for age, gender, QRS duration, baseline LVEF, LBBB/RBBB and 
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non-ischemic/ischemic etiology, decrease in LV dyssynchrony was significantly associated 
with response to CRT. 
 
Septal rebound stretch (SRSsept) is a relatively new imaging technique which uses speckle 
tracking longitudinal strain. It reflects an inefficient deformation of the septum during systole. 
In Chapter 6, we evaluate the predictive value of SRSsept on response to CRT in our cohort 
of 138 patients. Response to CRT was defined as a reduction in LV end-systolic volume of 
≥15%, and 70% were classified as responders. Baseline SRSsept was significantly higher in 
responders compared to non-responders (5.1±3.2 vs 3.0±2.7, p<0.001). The optimal cut-off 
value for SRSsept was 4%. After both univariate (OR 3.74, 95%CI 1.72−8.10) and 
multivariate analyses (OR 3.71, 95%CI 1.49−9.2), a baseline SRSsept of >4% independently 
predicted the response to CRT. 
Apical rocking is a short initial septal contraction which results in a short inward motion of 
the septum that pulls the apex to the septum and then the delayed activation of the lateral wall 
pulls the apex laterally during the ejection time while stretching of the septum takes place. 
Small studies suggested that it may predict CRT response. The predictive value of LV apical 
rocking on response to CRT in our cohort (n=137) is assessed in Chapter 7.  
Echocardiographic response to CRT was defined as a reduction in LV end-systolic volume of 
≥15%, and clinical response as survival without heart failure hospitalization. Apical rocking 
was present in 49% of patients. Apical rocking was more common in females, younger 
patients, and patients with non-ischemic cardiomyopathy. Echocardiographic response to 
CRT was observed in 69%, clinical response in 77% of patients. Apical rocking was 
associated with both echocardiographic response (OR 10.77, 95%CI 4.12−28.13) and clinical 
response to CRT (HR 2.73, 95%CI 1.26−5.91). Also, after multivariable analyses, apical 
rocking was associated with both echocardiographic (OR 9.97, 95%CI 3.48−28.59) and 
clinical response to CRT (HR 2.13, 95%CI 0.94−4.83).  
 
The association between apical rocking and long-term clinical outcome in a large cohort of 
297 patients treated with primary indication for CRT-D is evaluated in Chapter 8. Endpoint 
MACE (Major Adverse Cardiac Event) was defined as combined endpoint of cardiac death 
and/or heart failure hospitalization and/or appropriate therapy (ATP and/or ICD shocks). 
During a mean clinical follow-up of 5.2±1.6 years, 92 (31%) patients reached the endpoint of 
the study (MACE). Patients with MACE had shorter QRS duration, more ischemic 
cardiomyopathy and were more on Amiodarone. Apical rocking was present in 45% of the 
study patients. Apical rocking was significantly more common in patients without MACE 
compared to those with MACE (53% vs 27%, p<0.001). After multivariable analyses, 
baseline apical rocking was associated with MACE (HR 0.44, 95%CI 0.25−0.77). 
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Super-responders are patients with marked recovery of LV function and LVEF >50% as 
results of CRT. We determined predictors and long-term outcome of these patients, results are 
presented in Chapter 9. 347 patients with CRT-D as primary prevention were evaluated. 
Super-response was defined by LVEF >50% at follow-up echocardiogram. End points were 
major adverse cardiac events (MACE), i.e., all-cause mortality or heart failure hospitalization, 
cardiac death and appropriate ICD therapy. 56 (16%) patients were classified as super-
responders. Female gender (OR=3.06 95%CI 1.54−6.05), non-ischemic etiology (OR=2.70 
95%CI 1.29−5.68), higher LVEF at baseline (OR=1.07 95%CI 1.02−1.13) and wider QRS 
duration (OR=1.17 95%CI 1.04−1.32) all were predictors of super-response. Cumulative 
incidence of MACE at a median of 5.3 years was 18% in super-responders, 22% in 
responders and 51% in non-responders (p<0.001). None of the super-responders died from 
cardiac death, whereas cardiac death rate was 9% in responders and 25% in non-responders 
(p<0.001). None of the super-responders experienced appropriate ICD therapy, whereas this 
was 10% in responders and 21% in non-responders (p<0.001). In super-responders the 
adjusted HR for MACE was 0.37 (95%CI 0.19−0.73) and for total mortality 0.44 (95%CI 
0.20−0.95). Super-response to CRT was associated with persistent excellent prognosis 
regarding survival and appropriate ICD therapy during long-term follow-up.  
 
The potential association between super-responders and apical rocking in a cohort of 297 
patients with primary indication for CRT-D implantation is described in Chapter 10. The 
definition of super-response was the top quartile of LVEF response based on change from 
baseline to follow-up echocardiogram after CRT. Apical rocking was present in 45% of 
patients. Apical rocking was significantly more common in super-responders compared to 
non-super-responders (76% and 34%, p<0.001). In univariate analysis, female gender (OR 
2.39 95%CI 1.38−4.11), LVEF at baseline (OR 0.91 95%CI 0.87−0.95), non-ischemic 
etiology (OR 4.15 95%CI 2.33−7.39) and apical rocking (OR 6.19 95%CI 3.40−11.25) were 
associated with super-response to CRT. In multivariate analysis, apical rocking was still 
strongly associated with super-response to CRT (OR 5.82, 95%CI 2.68−12.61). Super-
responders showed an excellent clinical prognosis with a very low incidence of heart failure 
admission, cardiac mortality and appropriate ICD therapy. 
 
GENERAL DISCUSSION AND FUTURE PERSPECTIVES  
 
Although a wide QRS complex of >120 ms is required for CRT implantation, it is not a 
guarantee for response to CRT. Predictive value of electrical dyssynchrony, particularly wide 
QRS duration, on CRT response is generally low. The major target of CRT is restoration of 
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mechanical dyssynchrony. It has become clear that mechanical dyssynchrony is not simply 
reflected by QRS duration alone. Echocardiograpy, despite its own limitations, helps to 
understand the complexity of LV mechanics, has proven to give a better selection of patients 
who will benefit from CRT, and also provides prognostic information. Measuring mechanical 
dyssynchrony, by one way or the other, is in general time-consuming and requires highly 
trained physicians. In this thesis we investigated several echocardiographic tools to assess 
mechanical dyssynchrony in order to predict CRT response. Our intention was to select those 
tools which reflect the dyssynchronous contraction caused by dyssynchronous electrical 
activation, without the need for complicated measurements, relatively easy to use in daily 
clinical practice, available in every clinic and with high positive predictive value. 
Apical rocking, which is investigated in this thesis, has the potential to reflect the 
dyssynchronous contrction pattern of LBBB. It has a high positive predictive value (85−90%) 
on prediction of either clinical or echocardiographic response [1,2]. Furthermore, the visual 
assessment of apical rocking is relatively easy, reproducible and not time-consuming. It 
overcomes several limitations of peak velocity parameters and avoids the challenges of 
myocardial deformation measurements. Its potential value on the prediction of long-term 
outcomes has been confirmed in this thesis. Most recently, the largest trial [3] on the 
predictive value of apical rocking has been published, which provides much more support for 
our results in this thesis. In our view, apical rocking is a very suitable echocardiographic tool 
to assess mechanical dyssynchrony in order to predict CRT response. Therefore, using apical 
rocking as a firstline echocardiographic tool in every CRT candidate to predict the CRT 
response should be considered. However, more multicenter and large prospective registries 
are needed to determine its final place as dyssynchrony marker. We believe that apical 
rocking has the potential to be incorporated in the guidelines as a strong predictor of CRT 
response. 
We must take into account the fact that almost 50% of CRT candidates have apical rocking at 
the baseline. However, in the another 50% of CRT candidates without apical rocking the 
prediction of CRT response is still difficult. A portion of these patients show either clinical or 
echocardiographic response to CRT. Therefore, we should be able to assess the mechanical 
dyssychrony in patients without apical rocking who still respond to CRT. For these patients 
we propose the assessment mechanical dyssynchrony and prediction of CRT response by 
Septal rebound stretch. 
 
Septal rebound stretch (SRSsept) 
SRSsept is based on the degree of stretch in the septal wall after the initial contraction during 
systole. It reflects the dyssynchronous contraction of the septum caused by typical electrical 
activation in LBBB. Although the measurement of SRSsept is derived from longitudinal 
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speckle tracking, it is not a time-based analysis. SRSsept has more advantages: it uses only 
the basal and mid-part of the interventricular septum as region of interest, and the central 
position of the septum in the ultrasound window guarantees adequate image quality. We 
believe that the advantages of SRSsept, especially its reproducibility, make this dyssynchrony 
marker suitable for further validation in multicenter and large prospective registries to 
determine its final role as dyssynchrony marker, especially in patients without apical rocking. 
As we confirmed in this thesis with the largest numbers of patients, SRSsept is a strong 
predictor of CRT response. Therefore, we propose assessment of SRSsept as the secondline 
echocardiographic tool in CRT candidates without apical rocking in order to predict CRT 
response. We believe that SRSsept has the potential to be incorporated in the guidelines as a 
strong predictor of CRT response. Unfortunately, we could not investigate the predictive 
value of SRSsept in patients without apical rocking due to insufficient numbers of patients 
with echocardiography with GE machine at baseline. 
We should emphasis that in this thesis we did not compare apical rocking and SRSsept with 
previous dyssynchrony indices, using M-mode and tissue Doppler techniques. The reason is 
that these indices showed disappointing results in the prediction of CRT response in  
PROSPECT trial.  
 
Time-based dyssynchrony markers 
The majority of the dyssynchrony markers studied in the past decade are derived from the 
time-delays between the motions of LV walls/segments (using M-mode and tissue Doppler 
technique). Most of these markers suffer from limitations such as angle dependency, and are 
not able to differentiate between active and passive motion, and require optimal image 
quality. The PROSPECT study showed a limited value of these time-based dyssynchrony 
markers for the prediction of CRT response due to moderate sensitivity and specificity. In the 
post-PROSPECT era, a new imaging technique, 2D speckle tracking imaging, has been 
introduced. Speckle tracking measures myocardial deformation and can therefore differentiate 
between passive translational motion of the myocardium and active systolic contraction. 
Therefore, it has the potential to assess mechanical dyssynchrony better than previous 
markers. Speckle tracking analysis allows us to use the timing of peak strain/deformation of 
certain segments (time-based dyssynchrony); however, it is also possible to use the amount of 
defromations (SRSsept). The predictive value of time-based speckle tracking on CRT 
response has been investigated [4] with promising results. Moreover, time-based speckle 
tracking has also been used for targeting of LV lead placement and the results showed an 
additional value above the routine placement of LV lead [5]. However, no multicenter trials of 
indices derived from speckle tracking have been performed. Although previous studies 
showed the predictive value of time-based speckle tracking radial strain on CRT response, 
 
Chapter 11 
________________________________________________________________________________________ 
185 
 
recent data [6] and our data presented in this thesis could not confirm the previous findings. It 
seems that recognizing strain patterns is more relevant than using the peak strain for 
quantifying mechanical dyssynchrony. However, the problem is how to quantify the strain 
patterns of mechanical dyssynchrony. SRSsept can be one of the methods. Another way to 
quantify strain patterns is to use speckle tracking while focusing on strain patterns rather than 
peak strain. Quantifying the strain of the opposite walls within the LV (mechanical 
discoordination) can be a useful method to predict CRT response. Future studies should focus 
on recognizing the mechanical discoordination rather than time-based dyssynchrony to predict 
CRT response.   
Super-responders to CRT have a good short- and long-term prognosis in terms of cardiac 
mortality, appropriate ICD shocks, heart failure hospitalization and a very favorable 
functional NYHA class after CRT. Therefore, it is very important to identify these patients 
prior to CRT so as to discuss the expectations from the CRT implantation. As we 
demonstrated in this thesis, apical rocking is independently association with super-response to 
CRT. Therefore, we recommend using presence/absence of apical rocking in prediction of 
super-response to CRT. Moreover, one can argue whether to implant CRT-P instead of CRT-
D in patients who will be super-responders on the basis of their clinical characteristics and 
presence of apical rocking. However, randomized controlled trials are needed to compare 
CRT-P with CRT-D in patients who are expected to be super-responders.    
 
Other imaging modalities to assess mechanical dyssynchrony have been introduced in the past 
few years. Cardiac Magnetic Resonance (CMR) has gained increasing attention for 
dyssynchrony assessment due to  its high tissue and spatial contrast. The combination of 
dyssynchrony markers by CMR such as myocardial tagging and strain-coded CMR with 
delayed enhancement has shown to predict CRT response. Assessment of mechanical 
dyssynchrony by nuclear imaging has been performed with gated blood-pool 
ventriculography and phase analysis. However, the studies are small-scaled and with these 
imaging modalities the experiences are limited. CMR might be a very good alternative 
imaging modality to assess mechanical dyssynchrony in patients with a poor 
echocardiographic window.  
Non-response to CRT has been an important issue in the last decade. The most important 
determinants of non-response to CRT are patient selection (high degree of scar burden, lack 
of mechanical dyssynchrony, relatively narrow QRS duration and co-morbidities), suboptimal 
position of LV lead and device programming. Improvements in delivery catheters, new LV 
leads with different curved tip and even with active fixation, enable us to reach the target 
region in order to minimize the non-responder rate. Another tool is multi-polar LV lead, 
which is able to deliver multi-point pacing in order to depolarize a large area of myocardial 
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tissue to increase the response rate to CRT. Multi-point pacing is currently under investigation 
in a large prospective randomized control trial. Hopefully these new technologies can further 
increase the response rate to CRT. For some of the current non-responders with persistent 
mechanical dyssynchrony there are new tools which enable us to reach the target region. We 
hope that in the future wireless endocardial pacing of the LV [7] will be available for daily 
use. This wireless device can reach every part of the LV and therefore it will be possible to 
reach the optimal pacing site. 
 
In patients who will not benefit from CRT on the basis of comorbidities (end-stage renal 
failure, sever RV dysfunction, pulmonary hypertension and valvular disease), a high degree of 
scar tissue, or a QRS duration 120−150 ms without mechanical dyssynchrony, it may be 
better to implant a shock-only ICD device to prevent sudden cardiac death instead of CRT. In 
these patients CRT will not improve their symptoms. For these patients, new technologies are 
under investigation, including baroreflex modulation (8), spinal cord stimulation (SCS) and 
vagus nerve stimulation (VNS) [9,10].  
In order to maximize the response rate in CRT patients we recommend based on the existing 
literature and our experience with regard to CRT in Zwolle the following approaches. (1) In 
all patients with LBBB or non-LBBB with a QRS duration of >150 ms, CRT should be 
considered, while in those with a large amount of posterolateral and/or apical scar tissue 
additional targeting of the LV lead is recommended to reach the target region by strain-based 
echocardiography or invasive measurements during implantation. (2) In patients with LVEF 
<35% and LBBB or non-LBBB with a QRS 120−150 ms, additional dyssynchrony 
assessment is recommended, especially in those with functional NYHA class III. (3) Patients 
with RBBB are very unlikely to show response to CRT. CRT can be considered only in those 
with severe symptoms and LV dyssynchrony on echocardiography. 
 
In summary, we showed that several echocardiographic techniques have high potential in 
predicting response to CRT. We advice the use of apical rocking as first choice to predict 
CRT response. In patients without apical rocking, septal rebound stretch can also be used to 
predict CRT response. However, more prospectively, multicenter studies should confirm our 
results. Identification of patients who may be super-responders to CRT is important because 
of their excellent prognosis;moreover, it can potentially influence the choice of device (CRT-
P instead of CRT-D) at initial implantation or during device replacement due to ERI. Finally, 
new device-related techniques should be developed for those patients who are non-responders 
with the current CRT techniques. 
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Nederlandse samenvatting 
 
 
 
Cardiale resynchronisatie therapie (CRT) verbetert de linker ventrikel functie, functionele 
NYHA klasse, kwaliteit van leven en de overleving van patiënten met systolische hartfalen en 
een breed QRS complex. Helaas reageert ongeveer 30−40% van de patiënten niet of 
onvoldoende op deze therapie, de zogenaamde “non-responders”. Daarom is het voorspellen 
en identificeren van patiënten die een gunstige respons zullen hebben op deze dure en 
invasieve therapie van cruciaal belang. CRT corrigeert de LV-dyssynchronie, daarom is het 
belangrijk dat LV-dyssynchronie herkend wordt. Eerdere studies hebben verschillende 
echocardiografische technieken onderzocht om LV-dyssynchronie te onderkennen en 
kwantificeren, om op die manier de kans op een CRT respons te kunnen voorspellen. Het was 
echter niet gemakkelijk om een krachtige en betrouwbare voorspeller voor de CRT respons te 
vinden. 
In dit proefschrift worden verschillende onderzoeken beschreven naar relatief nieuwe 
echocardiografische parameters die in staat zijn LV-dyssynchronie te beoordelen om zo de 
respons op CRT te kunnen voorspellen.. 
 
In hoofdstuk 1 worden definitie, prevalentie, pathofysiologisch mechanisme en de 
farmacologische behandeling van hartfalen toegelicht. Verder wordt de toegevoegde waarde 
van ICD implantatie voor de overleving van hartfalen patiënten besproken. Daarnaast worden 
de manier waarop CRT werkt en de gunstige effecten van CRT op functionele klasse, reverse 
remodeling van de LV, vermindering van de ziekenhuisopname en sterfte samengevat. Een 
aantal belangrijke onderwerpen zoals respons, super-respons en non-respons op CRT worden 
toegelicht. Tenslotte wordt het voorspellen van deze issues door middel van 
echocardiografische parameters  besproken.  
 
De device gerelateerde re-interventies binnen het 1e jaar na implantatie worden in hoofdstuk 
2 geëvalueerd. We hebben de gegevens van 1929 patiënten met een pacemaker, ICD of CRT 
implantatie prospectief verzameld. Bijna 31% van de patiënten onderging een CRT 
implantatie. In totaal werden 3909 leads geïmplanteerd. Lead gerelateerde re-interventie was 
nodig bij 86 (4,4%) van de patiënten. De oorzaak van re-interventie was vooral lead dislocatie 
(66%), gevolgd door lead malfunctie (20%) en perforatie (18%). Re-interventie kwam vaker 
voor bij mannen  en jongere patiënten. De LV-lead dislocatie of malfunctie betrof 1,4%. RA-
lead dislocatie (1,9%) en ICD lead dislocatie (1,8%). Dit bleek vaker voor te komen  dan RV-
pacemaker lead dislocatie (0,3%). De incidentie van lead malfunctie was hoger (0,8%) bij de 
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ICD leads. Apicale positie van de RV-lead en laterale positie van de RA-lead waren 
gerelateerd aan hartperforatie.  
 
In hoofdstuk 3 wordt het mechanische activatie patroon van de linker ventrikel bij patiënten 
met pacing geïnduceerde LBTB (RV-pacing) en intrinsieke LBTB  geëvalueerd voor een 
correcte beoordeling van de LV-dyssynchronie. We onderzochten 74 patiënten met hartfalen 
die waren verwezen voor cardiale resynchronisatietherapie, 37 patiënten met chronische RV-
apicale pacing en 37 patiënten met een intrinsieke LBTB. Als imaging techniek werden 2D 
speckle tracking longitudinal strain en M-mode gebruikt. We hebben vastgesteld dat 
vergeleken met intrinsieke LBTB, RV-pacing resulteert in minder vroege activatie van het 
basale septum en een meer vroegere activatie van de midseptale en laterale wand van de 
linker ventrikel. Beeldvormingstechnieken die alleen het basale of mid gedeelte van de LV 
visualiseren kunnen de dyssynchronie belangrijk onderschatten bij patiënten met pacing 
geïnduceerde LBTB. De verschillen in mechanische activatie kunnen gevolgen hebben voor 
de selectie van potentiële kandidaten voor cardiale resynchronisatietherapie  
 
De voorspellende waarde van “time-based speckle tracking dyssynchronie” voor het 
beoordelen van LV-dyssynchronie wordt in hoofdstuk 4 onderzocht. Bij 138 patiënten met 
symptomatisch hartfalen en een CRT-D implantatie werden zes verschillende time-based LV-
dyssynchronie parameters gemeten met longitudinale en radiale strain. Respons op CRT werd 
gedefinieerd als een afname van het LV eind-systolisch volume met >15%, of door overleving 
zonder ziekenhuisopname voor hartfalen. 70% werd geclassificeerd als echocardiografische 
responders en 83% als klinische responders. QRS-duur en niet-ischemische etiologie waren 
voorspellers van een echocardiografische respons op CRT. Er was geen verschil in speckle 
tracking parameters tussen echocardiografische responders en non-responders. Wat betreft de 
klinische respons op CRT, was de maximale delay tussen zes segmenten gemeten in 4-
chamber view met longitudinale strain verschillend tussen responders en niet-responders, met 
154 ms delay als optimale afkapwaarde. Onze conclusie was dat alleen het maximale delay 
tussen de zes segmenten, gemeten in 4-chamber view met longitudinale strain, geassocieerd 
was met een klinische respons op CRT. 
 
Het verband tussen de omvang van de veranderingen in LV-dyssynchronie door CRT en de 
respons op CRT wordt in hoofdstuk 5 onderzocht. In een cohort van 138 patiënten werd de 
“time-based speckle tracking longitudinale strain” gebruikt om LV-dyssynchronie te 
beoordelen. CRT respons werd gedefinieerd als een afname van LV eind-systolisch volume 
van >15%, en 70% werd geclassificeerd als responders. In de totale studiegroep nam LV-
dyssynchronie significant af, van 196±89 ms in de baseline naar 180±105 ms tijdens de 
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follow-up, p=0,01. Echter, bij de responders was er een duidelijke afname van de LV-
dyssynchronie (198±88 ms bij baseline versus 154±50 ms na CRT, p<0,001), terwijl er bij de 
non-responders een significante stijging te zien was (191±92 ms bij baseline versus 243±160 
ms na CRT, p=0,04). Na correctie voor leeftijd, geslacht, QRS-duur, de baseline LVEF, 
LBTB/RBBB en niet-ischemische/ischemische etiologie, was de afname van LV-
dyssynchronie significant geassocieerd met de respons op CRT. 
 
Septal rebound stretch (SRSsept) is een relatief nieuwe beeldvormende techniek welke 
gebruik maakt van speckle tracking longitudinale strain. SRSsept weerspiegelt de inefficiënte 
vervorming van het septum tijdens systole. We evalueerden in hoofdstuk 6 de voorspellende 
waarde van SRSsept voor CRT respons bij ons cohort van 138 patiënten. Respons op CRT 
werd gedefinieerd als een afname van LV eind-systolisch volume van ≥15%, en 70% werd als 
responders geclassificieerd. Baseline SRSsept was significant hoger bij responders vergeleken 
met niet-responders (5,1±3,2 versus 3,0±2,7, p<0,001). De optimale cut-off waarde voor 
SRSsept bedroeg 4%. Na univariate (OR 3,74, 95%CI 1,72−8,10) en multivariate analyse 
(OR 3,71, 95%CI 1,49−9,2), bleek een baseline SRSsept van >4% een onafhankelijk 
voorspeller te zijn van CRT respons. 
 
Apical rocking is een korte initiële contractie van het septum waardoor de apex naar het 
septum toe beweegt en vervolgens door de vertraagde activatie van de laterale wand de apex 
naar de laterale wand toe beweegt. Kleine studies suggereerden al dat apical rocking de CRT 
respons kan voorspellen. In hoofdstuk 7 wordt de voorspellende waarde van apical rocking in 
ons cohort (n=137) bestudeerd. Echocardiografische respons op CRT werd gedefinieerd als 
een afname van het LV eind-systolisch volume van >15% en de klinische respons als 
overleving zonder ziekenhuisopname wegens hartfalen. Apical rocking was aanwezig bij 49% 
van de patiënten. Apical rocking kwam vaker voor bij vrouwen, jongere patiënten en bij 
patiënten met niet-ischemische cardiomyopathie. Een echocardiografische respons op CRT 
werd waargenomen bij 69% en een klinische respons in 77% van de patiënten. Apical rocking 
was geassocieerd met zowel de echocardiografische respons (OR 10.77, 95%CI 4,12−8,13) 
als de klinische respons op CRT (HR 2,73, 95%CI 1,26−5,91). Ook na multivariabele 
analyse, bleek apical rocking geassocieerd te zijn met zowel de echocardiografische (OR 9,97, 
95%CI 3,48−28,59) als de klinische respons op CRT (HR 2,13, 95%CI 0,94−4,83). 
 
Hoofdstuk 8 beschrijft de associatie tussen apical rocking en de klinische uitkomsten op 
lange termijn in een groot cohort van 297 patiënten met primaire indicatie voor CRT-D. Het 
klinisch eindpunt MACE (Major Adverse Cardiac Event) werd gedefinieerd als de combinatie 
van cardiale sterfte en/of ziekenhuisopname wegens hartfalen en/of terechte therapie (ATP 
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en/of ICD schok). Tijdens de follow-up van 5,2±1,6 jaar, bereikten 92 (31%) patiënten de 
eindfase van het onderzoek (MACE). De groep met MACE bestond uit meer patiënten met 
een kortere QRS-duur, meer patiënten met ischemische cardiomyopathie en meer patiënten 
die amiodarone gebruikten. Apical rocking was aanwezig bij 45% van de onderzochte 
patiënten. Apical rocking kwam significant vaker voor bij patiënten zonder MACE 
vergeleken met patiënten met MACE (53% vs 27%, p<0,001). Na multivariabele analyse 
bleek baseline apical rocking geassocieerd met MACE (HR 0,44, 95% CI 0,25−0,77). 
 
Super-responders zijn patiënten met een duidelijk herstel van LV functie met een LVEF 
>50% als resultaat van CRT. In hoofdstuk 9 bepalen we de voorspellers en de lange termijn 
uitkomsten van 347 patiënten met een CRT-D als primaire preventie. Super-respons werd 
gedefinieerd als LVEF >50% tijdens de follow-up. Eindpunt was MACE, gedefinieerd als 
totale sterfte of ziekenhuisopname wegens hartfalen, cardiale sterfte of terechte ICD therapy. 
56 (16%) patiënten werden geclassificeerd als super-responders. Vrouwelijk geslacht 
(OR=3,06 95%CI 1,54−6,05), non -ischemische etiologie (OR=2,70 95%CI 1,29−5,68), een 
hogere LVEF bij baseline (OR=1,07 95%CI 1,02−1,13) en bredere QRS-duur (OR=1,17 
95%CI 1,04−1,32) waren voorspellers van super-respons. Cumulatieve incidentie van MACE 
bij mediaan follow-up na 5,3 jaar was 18% in super-responders, 22% in responders en 51% in 
non-responders (p<0,001). Van de super-responders overleed niemand als gevolg van cardiaal 
lijden, terwijl cardiale sterfte 9% in responders en 25% in non-responders (p<0,001) bedroeg. 
Terechte ICD-therapie kwam niet voor in super-responders, terwijl 10% van de responders en 
21% van de non-responders terechte ICD therapie (p<0,001) kreeg. In super-responders was 
de gecorrigeerde HR voor MACE 0,37 (95%CI 0,19−0,73) en voor totale sterfte 0,44 (95%CI 
0,20−0,95). Super-respons op CRT bleek geassocieerd met een uitstekende prognose met 
betrekking tot overleving en terechte ICD-therapie gedurende lange-termijn follow-up. 
 
In hoofdstuk 10 wordt de mogelijke associatie beschreven tussen super-responders en apical 
rocking in een cohort van 297 patiënten met primaire indicatie voor CRT-D implantatie. 
Super-respons was gedefinieerd als het hoogste kwartiel van LVEF gebaseerd op 
veranderingen ten opzichte van baseline. Apical rocking was aanwezig in 45% van de 
patiënten. Apical rocking kwam significant vaker voor bij super-responders vergeleken met 
non-super-responders (76% en 34%, p<0,001). In univariate analyse waren vrouwelijk 
geslacht (OR 2.39 95%CI 1,38−4,11), LVEF in baseline (OR 0.91 95%CI 0,87−0,95), non-
ischemische etiologie (OR 4.15 95%CI 2,33−7,39) en apical rocking (OR 6.19 95%CI 
3,40−11,25) geassocieerd met super-respons op CRT. In multivariate analyse was apical 
rocking nog steeds sterk geassocieerd met super-respons op CRT (OR 5,82, 95%CI 
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2,68−12,61). Super-responders hadden een uitstekende prognose met een zeer lage incidentie 
van ziekenhuisopname wegens hartfalen, cardiale sterfte en terechte ICD-therapie. 
 
 
ALGEMENE DISCUSSIE EN TOEKOMSTPERSPECTIEVEN 
 
Hoewel een breed QRS complex van >120 ms een belangrijke voorwaarde is voor  CRT 
implantatie, is het geen garantie voor CRT respons. De voorspellende waarde van elektrische 
dyssynchronie, zeker als alleen naar QRS duur wordt gekeken, voor CRT respons is over het 
algemeen laag. Het belangrijkste doel van CRT is het herstel van de mechanische 
dyssynchronie. Het is duidelijk dat mechanische dyssynchronie niet alleen weerspiegeld 
wordt door QRS-duur. Hoewel echocardiografie beperkingen heeft, helpt het ons de 
complexiteit van de linker ventrikel mechanica te begrijpen. Er is aangetoond dat echo-
cardiografie beter in staat is patiënten te selecteren voor wie CRT een gunstige uitkomst zal 
hebben, en daarbij verschaft echocardiografie ook prognostische informatie. Het meten van 
mechanische dyssynchronie is in het algemeen tijdrovend, vereist zeer getrainde cardiologen 
en er is geen eenduidige gevalideerde methode voorhanden. In dit proefschrift onderzochten 
we verschillende nieuwe echocardiografische technieken om mechanische dyssynchronie te 
evalueren, om daarmee de respons op CRT te kunnen voorspellen. Onze intentie was om 
echocardiografische methoden te gebruiken die mechanische dyssynchronie makkelijk 
zichtbaar konden maken, zonder ingewikkelde metingen, zodat de methode relatief eenvoudig 
toepasbaar zou zijn in de dagelijkse klinische praktijk, en beschikbaar kan zijn in elke kliniek. 
Daarnaast diende de methode een hoge positief voorspellende waarde hebben. 
 
Apical rocking, dat werd onderzocht in dit proefschrift, heeft de potentie om het 
dyssynchrone contractie patroon van LBTB te laten zien en heeft een hoge positieve 
voorspellende waarde (85−90%) voor zowel de klinische als de echocardiografische respons 
op CRT [1,2]. Bovendien is de visuele beoordeling van apical rocking relatief eenvoudig, 
reproduceerbaar en niet tijdrovend. De potentiële waarde voor het voorspellen van de lange-
termijn resultaten werd bevestigd in dit proefschrift. Onlangs is de grootste trial [3] over de 
voorspellende waarde van apical rocking gepubliceerd, hetgeen de resultaten in dit 
proefschrift verder ondersteunt. Naar onze mening is apical rocking een zeer geschikte 
echocardiografische methode om mechanische dyssynchronie te evalueren en daarmee CRT 
respons te voorspellen. Daarom wordt apical rocking door ons als eerste echocardiografisch 
instrument bij elke CRT kandidaat aanbevolen om CRT respons te voorspellen. Er zijn echter 
meer multicenter en grote prospectieve registers nodig om de definitieve plaats van apical 
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rocking als dyssynchronie marker te bepalen. Wij zijn van mening dat de apical rocking de 
potentie heeft om in de richtlijnen opgenomen te worden als een sterke voorspeller van CRT 
respons. 
 
Een van de beperkingen van apical rocking is dat slechts bij 50% van de potentiele CRT 
kandidaten aanwezig is op het baseline echo. De andere 50% van de CRT kandidaten heeft 
geen apical rocking en is de voorspelling van CRT respons nog steeds moeilijk. Een deel van 
deze patiënten vertonen ook een klinische of een echocardiografische respons op CRT. Het is 
daarom van klinisch belang om ook mechanische dyssychronie bij deze patiënten te 
beoordelen. Voor deze patiënten wordt het bepalen van Septal rebound stretch als 
dyssynchronie marker aanbevolen. 
 
Septal rebound stretch (SRSsept) is gebaseerd op de hoeveelheid rek in de septale wand na 
de aanvankelijke contractie tijdens systole. Het weerspiegelt de dyssynchrone samentrekking 
van het septum veroorzaakt door typische elektrische activatie in LBTB. Hoewel de meting 
van SRSsept is afgeleid van longitudinale speckle tracking, is het niet time-based. Daarnaast 
heeft SRSsept het voordeel dat  het  mid en basale deel van het septum als “region of interest”  
gebruikt. . Deze centrale positie van het septum in het echo venster is vaak een garantie voor 
voldoende beeldkwaliteit en goede reproduceerbaarheid hetgeen van cruciaal belang is voor 
het beoordelen van dyssynchronie. Wij zijn van mening dat de voordelen van SRSsept, maken 
dat deze dyssynchronie marker geschikt is voor verdere bestudering en validatie in 
multicenter prospectief onderzoek om zo zijn definitieve plaats als dyssynchronie marker te 
bepalen. Wij zijn van mening dat SRSsept ook de potentie heeft om in de richtlijnen te 
worden opgenomen als een sterke voorspeller van CRT respons. 
 In dit proefschrift, hebben we bevestigd in een relatief groot patienten cohort dat SRSsept een 
sterke voorspeller is van CRT respons. Daarom stellen wij voor om SRSsept als 2e 
echocardiografische instrument te gebruiken bij CRT kandidaten zonder apical rocking om 
CRT respons te voorspellen. We benadrukken dat in dit proefschrift apical rocking en 
SRSsept niet zijn vergeleken met eerdere dyssynchronie indices zoals M-mode en tissue 
Doppler technieken. De reden hiervoor is dat deze indices in de PROSPECT trial 
teleurstellende resultaten lieten zien bij het voorspellen van een CRT respons. 
 
Time-based dissynchronie markers: Over de afgelopen 10 jaar zijn de meeste 
dyssynchronie markers gebaseerd op de “time delay” tussen verschillende wanden/segmenten 
van de LV, en is dit delay gemeten met M-mode of tissue Doppler techniek. De meeste van 
deze markers hebben beperkingen zoals hoek afhankelijkheid en moeite om onderscheid te 
maken tussen actieve en passieve motion. De PROSPECT studie toonde een beperkte waarde 
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van deze op tijd gebaseerde dyssynchronie markers bij het voorspellen van CRT respons. In 
het post-PROSTPECT tijdperk, is er een nieuwe beeldvormingstechniek, 2D speckle tracking-
imaging, geïntroduceerd. Speckle tracking meet myocardiale deformatie en kan daarom 
onderscheid maken tussen de passieve beweging van de hartspier en de actieve systolische 
contractie. Daarom heeft speckle tracking de potentie mechanische dyssynchronie beter te 
herkennen dan de vorige markers. Met speckle tracking kunnen we naar de timing van 
piekstrain/deformatie van segmenten kijken (time-based dyssynchrony), maar het is ook 
mogelijk om de hoeveelheid deformatie te meten (SRSsept). De voorspellende waarde van 
time-based speckle tracking op CRT respons is onderzocht [4] met veelbelovende resultaten. 
Daarnaast is de toegevoegde waarde van time-based speckle tracking bij het bepalen van de 
juiste positie van de LV-lead boven de routinematige implantatie van de LV-lead aangetoond 
[5]. Er zijn echter nog geen multicenter studies die de voorspellende waarde van time-based 
speckle-tracking voor CRT respons hebben aangetoond. Hoewel eerdere studies de 
voorspellende waarde van time-based speckle-tracking radiale strain op CRT respons hebben 
aangetoond, konden recente data [6] en onze data in dit proefschrift dit niet bevestigen. Het 
lijkt erop dat het herkennen van strain-patronen meer relevant is dan het gebruik van de piek-
strain voor het kwantificeren van mechanische dyssynchronie. De vraag blijft, hoe kunnen we 
op basis van strain-patronen de mate van mechanische dyssynchronie betrouwbaar 
vaststellen? SRSsept is één van de methoden die ons kan helpen strain-patronen 
kwantificeren. Een andere manier om strain-patronen te kwantificeren is het gehele strain-
patroon te gebruiken in plaats van piek-strain. Het hierbij kwantificeren van de strain van de 
tegenover elkaar liggende wanden in de LV (mechanische discoördination) kan een bruikbare 
methode zijn om een CRT respons te voorspellen. Toekomstig onderzoeken moeten zich 
daarom richten op het herkennen van de mechanische discoördination in plaats van time-
based dyssynchronie. 
Om de respons in CRT kandidaten te maximaliseren adviseren we op basis van de bestaande 
literetuur en onze ervaringen met betrekking tot CRT implantatie in Zwolle bij patienten met 
hartfalen de volgende benaderingen. (1) Bij alle patiënten met een LBTB of non-LBTB en 
een QRS duur van >150 ms moet CRT worden overwogen;  Indien deze patiënten een groot 
posterolateraal en/of apicale litteken hebben, dan wordt “targeting van de LV-lead” 
aanbevolen middels echocardiografie of invasieve metingen tijdens de implantatie. (2) Bij 
patiënten met LBTB of non-LBTB en een QRS duur van 120−150 ms  wordt extra 
dyssynchronie beoordeling aanbevolen, vooral bij patiënten met functionele NYHA klasse III. 
(3) Het is zeer onwaarschijnlijk dat RBTB patiënten een respons op CRT laten zien. CRT kan 
alleen worden overwogen indien ze ernstige symptomen van hartfalen hebben en er 
echografisch aanwijzingen zijn LV-dyssynchronie. 
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Super-responders hebben een goede prognose, zeer lage cardiale sterfte, terechte ICD-shocks, 
ziekenhuisopname wegens hartfalen en een zeer gunstige functionele NYHA klasse na CRT. 
Daarom is het erg belangrijk dat deze patiënten herkend worden, mede om de verwachtingen 
van de CRT te bespreken. We hebben in dit proefschrift aangetoond dat apical rocking 
onafhankelijk is geassocieerd met een super-respons op CRT. Dit zou mogelijk consequenties 
kunnen hebben voor de keuze van het te implanteren device. Er zou een voorkeur voor het 
implanteren van een CRT-P in plaats van een CRT-D kunnen zijn bij patiënten die een grote 
kans hebben om super-responders te worden gebaseerd op hun klinische kenmerken en 
aanwezigheid van apical rocking. Echter, er zijn gerandomiseerde en gecontroleerde studies 
nodig om CRT-P met CRT-D te vergelijken bij patiënten die naar verwachting super-
responders zullen zijn. 
In de afgelopen jaren zijn er andere beeldvormende modaliteiten geïntroduceerd om 
mechanische dyssynchronie te beoordelen. Cardiac Magnetic Resonance (CMR) heeft veel 
aandacht gekregen voor het evalueren van dyssynchronie vanwege de hoge weefsel en 
spatiele resolutie van deze modaliteit. De combinatie van myocardiale tagging en strain-coded 
CMR met late-enhancement lijkt een goede voorspeller te zijn van CRT respons. Evaluatie 
van mechanische dyssynchronie door nucleaire beeldvorming werd uitgevoerd met gated 
blood-pool ventriculografie en fase analyse. Echter, deze studies zijn kleinschalig en de 
ervaring met deze beeldvormende modaliteiten is beperkt. CMR zou een goed alternatief 
kunnen zijn voor patiënten die echocardiografisch nauwelijks opneembaar zijn. 
 
In de afgelopen decennium is non-respons op CRT is een belangrijk issue geweest. De 
belangrijkste determinanten van non-respons op CRT zijn selectie van patiënten (hoge mate 
van littekenvorming, het ontbreken van mechanische dyssynchronie, relatief smalle QRS duur 
en co-morbiditeit), suboptimale positie van de LV-lead en niet optimale programmering van 
het apparaat. De nieuwe ontwikkelingen rond het implanteren van LV-leads, zoals diverse 
katheters en binnen sheaths, nieuwe LV-leads met verschillende bochten aan de tip en zelfs 
met actieve fixatie, stellen ons in staat via de zijtakken van de sinus coronarius beter de 
“target region” te bereiken om zo de non-responder rate te minimaliseren. Een andere  
positieve ontwikkeling is de multipolaire LV-lead die ons niet alleen in staat stelt om in een 
groter segment de LV te stimuleren maar het ook mogelijk maakt multi-point te pacen. 
Hierbij wordt gelijktijdig op 2 posities/electroden de LV gedepolariseerd met als doel sneller 
een groot gebied van de linker kamer te activeren. Er zijn voorzichtige aanwijzingen dat de 
respons rate op de CRT toeneemt bij het gebruik van quadripolaire leads en bij multi-point 
pacing. Multi-point pacing wordt momenteel onderzocht in een grote prospectief en 
gerandomiseerde studie. Hopelijk kunnen deze nieuwe technologieën bijdragen aan een 
toename van de respons rate op CRT. Voor een aantal van de huidige non-responders met 
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persisterende mechanische dyssynchronie bestaan er nieuwe technieken die ons in staat 
stellen de “target region” te bereiken. Hopelijk is draadloze endocardiale pacing van de LV 
[7] in de toekomst beschikbaar voor dagelijks gebruik. Dit draadloos apparaat kan elk deel 
van de LV bereiken en maakt het mogelijk een optimale stimulatie site te vinden. 
Bij patiënten die niet zullen  profiteren van CRT wegens co-morbiditeit (eindstadium 
nierfalen, ernstige RV dysfunctie, pulmonale hypertensie en hartklepafwijkingen), hoge mate 
van littekenweefsel, QRS-duur 120−150 ms zonder mechanische dyssynchronie, kan het beter 
zijn een shock-only ICD  ter preventie van plotse hartdood te implanteren in plaats van CRT. 
Bij deze patiënten zal de CRT de symptomen niet verbeteren en kan soms zelfs een 
verslechtering tot gevolg hebben. Om de symptomen bij deze patiënten te verbeteren kunnen 
nieuwe technologieën zoals baroreflex modulatie [8], spinal cord stimulation (SCS) en nervus 
vagus stimulatie (NVS) [9,10] overwogen worden. 
 
Samenvattend, hebben we aangetoond dat verschillende echocardiografische technieken een 
hoge potentie hebben voor het voorspellen van een respons op CRT. Wij adviseren het 
gebruik van apical rocking als eerste keuze om CRT respons te voorspellen. Bij patiënten 
zonder apical rocking, kan septal rebound stretch worden gebruikt om CRT respons te kunnen 
voorspellen. Echter, er zijn meer prospectieve, multicenter studies nodig om onze resultaten te 
bevestigen. Identificatie van super-responders kan belangrijke klinische implicaties hebben 
vanwege hun uitstekende prognose. Super-respons kan de device keuze (CRT-P in plaats van 
CRT-D) bij initiële implantatie of tijdens vervanging van het device door ERI beïnvloeden. 
Tenslote moeten nieuwe device gerelateerde technieken ontwikkeld worden voor patiënten 
die niet reageren op de huidige CRT technieken. 
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Dankwoord 
 
 
 
Dit proefschrift is tot stand gekomen dankzij de hulp en ondersteuning van velen. Ik zou dan 
ook willen besluiten met iedereen te bedanken die, op wat voor wijze dan ook, een bijdrage 
heeft geleverd. Een aantal mensen wil ik in het bijzonder bedanken. 
 
Allereerst wil ik de gehele maatschap cardiologie bedanken. Jullie hebben me opgeleid tot 
cardioloog en aansluitend in de gelegenheid gesteld verder te specialiseren als device-
cardioloog. Dit proefschrift was natuurlijk niet tot stand gekomen zonder jullie vertrouwen, 
steun en geduld. 
 
Mijn promotoren Prof. dr. M.J. de Boer en Prof. dr. H.S. Suryapranata. Jullie beiden wil ik 
erg bedanken voor het mogelijk maken van dit promotietraject, heldere commentaren op de 
manuscripten en goede begeleiding. Ondanks de drukke agenda is het toch gelukt alles op tijd 
af te ronden.  
 
Mijn grote dank gaat uit naar mijn twee copromotoren. 
 
Eerst begin ik met Dr. P.P.H.M. Delnoy. Beste Peter Paul, het begon allemaal ongeveer 6−7 
jaar geleden. Op de HCK werkten we steeds vaker samen. Het beoordelen van LV-
dyssynchronie was voor ons een uitdaging. De fundamenten voor de onderzoeken in dit 
proefschrift zijn door jou gelegd. Door jouw aanmoediging en prikkelen maakte ik een 
database van onze CRT patiënten. Van je kennis en kunde op het gebied van dyssynchronie 
heb ik veel geleerd. Je wist in grote lijnen inhoudelijke input te geven en je gaf me de vrijheid 
voor verdere aanvulling. Door je positie binnen de maatschap en buiten het ziekenhuis heb je 
het steeds drukker, maar voor me was je altijd bereikbaar en zelfs in het vliegtuig ging je mijn 
stukken nakijken. Zonder jouw steun en vertrouwen was ik nooit zo ver gekomen. Ik ben je 
dan ook zeer dankbaar voor je deskundigheid en plezierige begeleiding.  
 
Dr. J.P. Ottervanger, mijn tweede copromotor. Beste Jan Paul, je bent niet alleen een echte 
wetenschapper maar je bent ook een persoonlijke begeleider. Schrijven van 
wetenschappelijke artikelen is je met de paplepel ingegoten. Je unieke eigenschap is 
stroomlijnen en op papier zetten van de gedachten. Van jou heb ik geleerd moeilijke 
onderwerpen te simplificeren. Vaak was ik vóór die wekelijkse dinsdag middag uurtje 
gespannen en soms ook radeloos, maar je wist me altijd op de goede weg te helpen. Zonder 
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jouw structurele begeleiding en kritische commentaren was ik nooit zo ver gekomen. Ik ben je 
dan ook zeer dankbaar en hoop dat je me zolang mogelijk van levensadviezen blijft voorzien. 
 
De leden van beoordelingscommissie, Prof. Dr. W.J. Morshuis, Prof. Dr. F.W. Prinzen en Dr. 
M. Meine, wil ik bedanken voor het kritisch doorlezen en becommentariëren van dit 
proefschrift. 
 
Dr. Adiyaman, beste Ahmet en beste collega, je bent een cardioloog maar we kunnen je beter 
een “lopende encyclopedie” noemen. Je hebt enorm veel ervaring met het uitzetten van 
onderzoekslijnen, je heldere blik op de statistiek maakt het van je een top wetenschapper op 
deze jonge leeftijd. Je hebt me enorm veel geholpen met formuleren van onderzoeksvragen uit 
mijn database, eigenlijk ben je samen met Peter Paul de grondlegger van onze manuscripten. 
Je hebt me geweldig goed geholpen met het schrijven van artikelen. Ik ben je dan ook zeer 
dankbaar en ben heel blij dat je als paranimf mij op deze belangrijke dag wilt bijstaan. 
 
Dr. Ramdat Misier, beste Anand, mijn laatste opleider, ik heb veel van je opmerkingen tijdens 
de ochtendoverdrachten geleerd. Je bent politiek altijd zeer correct en weet iedereen aan zich 
te binden, dit vind ik een uniek eigenschap van je. In afgelopen jaren adviseerde je regelmatig 
privé en werk in balans te houden. Twee jaar geleden gaf je me 4 dagen vrij om aan mijn 
onderzoek te werken. Anand, zonder je steun en aanmoedigingen was ik nooit zo ver 
gekomen. Ik ben je dan ook zeer dankbaar. 
 
Dr. Elvan, beste Arif, je bent een zeergetalenteerde electrofysioloog. Ik heb tijdens dit 
promotietraject veel van je geleerd, je was altijd bereid onze manuscripten grondig na te 
kijken en te corrigeren. Laagdrempeligheid en vriendelijkheid zijn je unieke eigenschappen. 
Arif, zonder jouw belangrijke bijdrage was dit proefschrift niet tot stand gekomen. 
 
Dr. Smit, beste Jaap-Jan, ook bedankt voor je bijdrage aan dit proefschrift, de gezellige sfeer 
en je hoorbare bulderende lach! 
 
Onze leden van gedreven interventiegroep, Arnoud, Jan-Henk, Marcel, Elvin, Vincent en 
Wouter, Aize en Hans, hartelijk dank voor de prettige en leerzame samenwerking. 
 
Onze imagingteam, collegae Jorik, Marleen, Marc en Shu: bedankt voor de leerzame en 
prettige samenwerking.  
 
Mevrouw Derks, beste Vera, ik ben je zeer dankbaar voor je bijdrage aan dit proefschrift. 
Prepareren, submitten en snelle berichtgeving van manuscripten doe je fantastisch. Jouw 
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ervaring en je zorgvuldigheid maken je een unieke persoon voor ons. Vera, ik wil je heel erg 
bedanken voor alles wat je voor me hebt gedaan. 
 
Mevrouw Koopmans, beste Petra, in de afgelopen jaren hebben we intensief contact gehad, je 
bent een zeer gewaarde statisticus. Wat ik niet goed kan, kan jij heel goed. Petra, ik wil je heel 
erg bedanken voor je belangrijke bijdrage aan dit proefschrift.  
 
Prof. dr. Hoorntje, beste Jan, mijn eerste opleider. Ik wil je bedanken voor de leerzame 
periode als opleider. Na je vertrek naar het zuiden wilde ik aanvankelijk ook mee, maar op het 
laatst is het anders gelopen. Of dit een wijs besluit is geweest zal de tijd leren.  
 
Dokter Oude Luttikhuis, ik heb een korte periode van uw expertise in device-implantatie 
mogen genieten. Ik zie echter nog steeds patiënten bij wie u een pacemaker heeft 
geïmplanteerd, ze zijn u allemaal zeer dankbaar en ik ook.  
 
De bestuurders, managers, leidinggevenden en secretaresses van Hartcentrum en in het 
bijzonder Ed, Gea, Jikke en Astrid wil ik bedanken voor het creëren van faciliteiten. Zodat we 
onze dagelijkse werkzaamheden goed kunnen uitvoeren. 
 
Onze collegae thoraxchirurgen en in het bijzonder collega Thanasie Markou wil ik erg 
bedanken voor de goede samenwerking. Thanasie, je bent altijd bereid mij te helpen op de 
HCK.   
 
De collegae fellows en arts-assistenten wil ik bedanken voor prettige samenwerking.  
 
De medewerkers van non-invasief en in het bijzonder de echo-laboranten wil ik bedanken. De 
dyssynchronie-echo’s zijn van cruciaal belang geweest voor mijn onderzoek.  
 
De pacemakertechnici wil ik in het bijzonder bedanken voor hun bijdrage aan dit proefschrift. 
Jullie hebben me geholpen met status-onderzoek waarbij we geïnteresseerd waren in ICD-
therapie bij CRT patiënten.  
 
De medewerkers van invasief en in het bijzonder EP-laboranten wil ik bedanken voor een 
prettige sfeer op de HCK’s om de lange en complexe procedures goed uit te kunnen voeren.  
 
Secretariaat cardiologie, artsenplanning, opname planning, leidinggevenden en PA-ers wil ik 
bedanken voor prettige en vriendelijke sfeer. 
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Thea Schenk wil ik bedanken voor haar inzet om de layout van dit proefschrift te verzorgen. 
 
Mijn goede vriend en collega Rouzbeh Zobin, huisarts, ik wil je bedanken voor je interesse 
omtrent de voortgang van mijn onderzoek. Ik vind het geweldig dat je als paranimf mij op 
deze belangrijke dag wilt bijstaan.  
 
 
 
 
 
 
 
 
 
 
 
(Mijn lieve ouders, jullie beiden zijn inmiddels oud en hulpbehoevend, ik ben al 25 jaar weg 
van huis. De meedogenloze oorlog in ons land heeft ons gezin uit elkaar gedreven en we 
leven duizenden kilometers ver van elkaar, we missen elkaar elke dag. Ik had graag gewild 
dat jullie op deze belangrijke dag aanwezig waren maar dit is ons lot in deze wrede wereld. Ik 
heb alles te danken aan de geweldige opvoeding die jullie me hebben gegeven). 
 
Mijn dierbare vrouw, Somayeh, al 16 jaar doe je heel veel voor me, je steunt me, je geeft me 
tijd en ruimte. Soms wordt het te veel voor je en dat realiseer ik me goed. Ik ben je eeuwig 
dankbaar en ik hou van je.  
 
Lieve Arsalan, al jaren vraag je waarom ik elke avond moet studeren, je vroeg regelmatig 
“papa wil je iets langer bij me blijven liggen totdat ik in slaap val?”. Lieve Arsalan, ik had het 
te druk met met mijn onderzoek. Ik hoop voortaan meer tijd voor je vrij te kunnen maken. 
Lieve Sogand, sinds je geboorte voelen we ons veel gelukkiger en we zijn trots op je.  
  
 
 
 
 
 
Chapter 12 
________________________________________________________________________________________ 
207 
 
Curriculum vitae 
 
 
 
The author was born on 24 November 1974 in Herat (Afghanistan). He attended secondary 
school in Herat (1986−1990). In 1990 he fled the country with his family because of the civil 
war, and went to Iran. In 1991, he moved from Iran to The Netherlands. Between 1991−1995 
he learned the Dutch language, followed the higher laboratory education at the High School 
of Amsterdam and 1 year of medicine at the University of Antwerpen (Belgium). In 1995 he 
moved back to Amsterdam and started the study of Medicine at the University of Amsterdam, 
graduating in September 2002. After graduation, he started working as a resident of 
cardiology at the Isala klinieken, location Weezenlanden. He started his cardiology training in 
2004 at the Isala klinieken (supervisor Dr. J.C.A. Hoorntje), which he completed in July 2010. 
In 2010, he started the fellowship Device Implantation, and successfully completed the 
curriculum of the European training programme in cardiac pacing and Implantable cardiac 
defibrillators in 2012. Alongside his fellowship, he joined Dr. P.P.M. Delnoy and Dr. J.P. 
Ottervanger in the research of echocardiographic markers of mechanical dyssynchrony to 
predict the response to cardiac resynchronization therapy, which resulted in this thesis.  
He is married with Somayeh, and they have two children, Arsalan and Sogand. His hobby is 
playing volleyball and he is interested in news and politics.  
 
